<SEC-DOCUMENT>0001641172-25-011246.txt : 20250516
<SEC-HEADER>0001641172-25-011246.hdr.sgml : 20250516
<ACCEPTANCE-DATETIME>20250516160531
ACCESSION NUMBER:		0001641172-25-011246
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20250512
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250516
DATE AS OF CHANGE:		20250516

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NanoVibronix, Inc.
		CENTRAL INDEX KEY:			0001326706
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36445
		FILM NUMBER:		25959064

	BUSINESS ADDRESS:	
		STREET 1:		969 PRUITT AVE,
		CITY:			TYLER
		STATE:			TX
		ZIP:			77569
		BUSINESS PHONE:		(914) 233-3004

	MAIL ADDRESS:	
		STREET 1:		969 PRUITT AVE,
		CITY:			TYLER
		STATE:			TX
		ZIP:			77569

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nano Vibronix, Inc.
		DATE OF NAME CHANGE:	20111206

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nano Vibronix Inc
		DATE OF NAME CHANGE:	20050510
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:NAOV="http://nanovibronix.com/20250512">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_NAOV_nanovibronix.com_20250512 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20250512_20250512 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001326706 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000005" name="dei:EntityCentralIndexKey">0001326706</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="naov-20250512.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326706</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-12</xbrli:startDate>
        <xbrli:endDate>2025-05-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_902_edei--DocumentType_c20250512__20250512_zYhO0Vh3aNAf"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the
Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_907_edei--DocumentPeriodEndDate_c20250512__20250512_zEQxIVzFPb43"><ix:nonNumeric contextRef="AsOf2025-05-12" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">May 12, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_90F_edei--EntityRegistrantName_c20250512__20250512_zP6T1F4qae7l"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000012" name="dei:EntityRegistrantName">NanoVibronix,
Inc.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20250512__20250512_zbC1FQOTVIC2"><ix:nonNumeric contextRef="AsOf2025-05-12" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityFileNumber_c20250512__20250512_zKCjC5AgM2Qk"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000014" name="dei:EntityFileNumber">001-36445</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20250512__20250512_zvPFLgeqYqMh"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000015" name="dei:EntityTaxIdentificationNumber">01-0801232</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 66%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--EntityAddressAddressLine1_c20250512__20250512_zScNmKFNzPb6"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000016" name="dei:EntityAddressAddressLine1">969
    Pruitt Ave</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityAddressCityOrTown_c20250512__20250512_zbDw5ryxAvsg"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000017" name="dei:EntityAddressCityOrTown">Tyler</ix:nonNumeric></span>,
    <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20250512__20250512_z4OJcf0ZGEj2"><ix:nonNumeric contextRef="AsOf2025-05-12" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityAddressPostalZipCode_c20250512__20250512_zZlt3H8s1Pcf"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000019" name="dei:EntityAddressPostalZipCode">77569</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <span id="xdx_903_edei--CityAreaCode_c20250512__20250512_zwPgpnuB66sk"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000020" name="dei:CityAreaCode">(914)</ix:nonNumeric></span> <span id="xdx_905_edei--LocalPhoneNumber_c20250512__20250512_zPR52kKdp6O5"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000021" name="dei:LocalPhoneNumber">233-3004</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20250512__20250512_zxqhEloJ2mJd"><ix:nonNumeric contextRef="AsOf2025-05-12" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--SolicitingMaterial_c20250512__20250512_zTLZK0L058dh"><ix:nonNumeric contextRef="AsOf2025-05-12" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--PreCommencementTenderOffer_c20250512__20250512_zbr5QMjTr9Kh"><ix:nonNumeric contextRef="AsOf2025-05-12" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20250512__20250512_z6DAXiJmRJ2g"><ix:nonNumeric contextRef="AsOf2025-05-12" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20250512__20250512_zIIYMx84wDje"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20250512__20250512_zHTkMfGRLzRd"><ix:nonNumeric contextRef="AsOf2025-05-12" id="Fact000027" name="dei:TradingSymbol">NAOV</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_900_edei--SecurityExchangeName_c20250512__20250512_zVihcP5eqzza"><ix:nonNumeric contextRef="AsOf2025-05-12" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20250512__20250512_zg4JSa35dA0d"><ix:nonNumeric contextRef="AsOf2025-05-12" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Underwritten
Public Offering</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 14, 2025, NanoVibronix, Inc. (the &#8220;<b><i>Company</i></b>&#8221;) entered into an underwriting agreement (the &#8220;<b><i>Underwriting
Agreement</i></b>&#8221;) by and between the Company and Dawson James Securities, Inc. as representative of the underwriters named on
Schedule I of the Underwriting Agreement (the &#8220;<b><i>Representative</i></b>&#8221;), pursuant to which the Company agreed to issue
in a firm commitment underwritten offering (the &#8220;<b><i>Offering</i></b>&#8221;) (i) 400,000 shares (the &#8220;<b><i>Preferred
Shares</i></b>&#8221;) of the Company&#8217;s newly designated Series G Convertible Preferred Stock, $0.001 par value per share (the
&#8220;<b><i>Preferred Stock</i></b>&#8221;), initially convertible into up to 4,901,982 shares (the &#8220;<b><i>Conversion Shares</i></b>&#8221;)
of common stock, par value $0.001 per share (the &#8220;<b><i>Common Stock</i></b>&#8221;) and (ii) warrants (the &#8220;<b><i>Common
Warrants</i></b>&#8221;) to purchase up to 4,901,982 shares of Common Stock (the &#8220;<b><i>Common Warrant Shares</i></b>&#8221;).
The combined public offering price per share of Preferred Stock and accompanying Warrant was $25.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants have an exercise price of $2.04 per share, are exercisable immediately upon issuance and have a term of five years from
the date of issuance. A holder will not have the right to exercise any portion of the Common Warrants if the holder (together with its
affiliates) would beneficially own in excess of 4.99% or 9.99%, as applicable, of the number of shares of Common Stock outstanding immediately
after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the terms of the Certificate of Designations of the Preferences, Rights and Limitations of the Series G Convertible Preferred
Stock (the &#8220;<b><i>Certificate of Designations</i></b>&#8221;), the holders of the Preferred Stock are entitled to receive cumulative
dividends at the rate per share of 9% per annum of the stated value per share until the fifth anniversary of the date of issuance of
the Preferred Stock, which such dividends may be paid, at the Company&#8217;s option, in shares of Common Stock. The Offering also related
to up to 2,205,883 shares of Common Stock issuable upon payment of all dividends accrued on the Preferred Stock (the &#8220;<b><i>Dividend
Shares</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Underwriting Agreement, the Company agreed not to issue, enter into any agreement to issue or announce the issuance
or proposed issuance of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common
Stock or file any registration statement or prospectus, or any amendment or supplement thereto for 90 days after the closing date of
the Offering. In addition, the Company has agreed not to effect or enter into an agreement to effect any issuance of Common Stock or
any securities convertible into or exercisable or exchangeable for shares of Common Stock involving a variable rate transaction (as defined
in the Underwriting Agreement) until the six-month anniversary of the closing date of the Offering, subject to certain exceptions. The
Underwriting Agreement additionally contains certain representations, warranties, covenants and indemnification provisions customary
for similar transactions. The representations, warranties and covenants contained in the Underwriting Agreement were made solely for
the benefit of the applicable parties to the Purchase Agreement and may be subject to limitations agreed upon by the applicable contracting
parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate gross proceeds from the Offering were approximately $10 million before deducting underwriting discounts and commissions and
estimated offering expenses payable by the Company. The Company intends to use the net proceeds from the Offering for (i) the redemption
of the principal amount of its outstanding debenture with an aggregate principal amount of $1,300,000, initially issued on February 14,
2025, pursuant to the terms and conditions of such debenture and up to $700,000 to be applied to the partial repayment of an outstanding
note issued on January 17, 2025, in the aggregate principal amount of $2,497,308 and (ii) general corporate purposes. On May 16, 2025,
the Offering closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an engagement letter, dated as of February 11, 2025, between the Company and the Representative (as amended, the
&#8220;<b><i>Engagement Letter</i></b>&#8221;), the Company agreed to pay (i) underwriting discounts and commissions equal to 7% of
the aggregate gross proceeds of the Offering and (ii) $150,000 for road show, diligence and legal expenses of the Representative,
including reasonable &#8220;blue sky&#8221; fees and expenses. In addition, pursuant to the Engagement Letter, the Company agreed to
issue to the Representative, warrants (the &#8220;<b><i>Representative&#8217;s Warrants</i></b>&#8221;) to purchase up to 245,099
shares of Common Stock (the &#8220;<b><i>Representative&#8217;s Warrant Shares</i></b>&#8221;). The Representative&#8217;s Warrants
have substantially the same terms as the Common Warrants issued in the Offering, except that the Representative&#8217;s Warrants
have a term of five years from the date of the commencement of sales in the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Preferred Shares, the Conversion Shares, the Common Warrants, the Common Warrant Shares, the Dividend Shares, the Representative&#8217;s
Warrants and the Representative&#8217;s Warrant Shares were offered by the Company pursuant to a Registration Statement on Form S-1 (File
No. 333-284973) (the &#8220;<b><i>Registration Statement</i></b>&#8221;), initially filed with the Securities and Exchange Commission
(the &#8220;<b><i>SEC</i></b>&#8221;) on February 14, 2025, as amended on April 22, 2025, April 29, 2025, May 12, 2025, and May 14, 2025
(including the prospectus forming a part of such Registration Statement), under the Securities Act of 1933, as amended, and declared
effective by the SEC on May 14, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Underwriting Agreement, the Common Warrants and the Representative&#8217;s Warrants are qualified in their
entirety by reference to the full text of the form of Underwriting Agreement, the Common Warrants and the Representative&#8217;s Warrants,
copies of which are filed as Exhibits 1.1, 4.1 and 4.2, respectively, to this Current Report on Form 8-K and are incorporated by reference
herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series
G Convertible Preferred Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Preferred Stock are set forth in the Certificate of Designations, which was filed with the Secretary of State for the State
of Delaware on May 15, 2025, prior to the closing of the Offering. The Preferred Stock has a par value of $0.001 per share and a stated
value equal to $25.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Preferred Stock is convertible into shares of Common Stock (subject to the beneficial ownership limitations as provided in the Certificate
of Designations), on or after the date of issuance at an initial conversion price equal to $2.04 per share of Common Stock, subject to
adjustment as provided in the Certificate of Designations, at any time at the option of the holder prior to the fifth anniversary of
the date of issuance, at which time all shares of outstanding Preferred Stock shall automatically and without any further action by the
holder be converted into shares of Common Stock at the then effective conversion price, provided that the holder will be prohibited from
converting the Preferred Stock into shares of Common Stock if, as a result of such conversion, the holder, together with its affiliates,
would own more than 4.99% of the total number of shares of the Common Stock then issued and outstanding. However, any holder may increase
or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be
effective until 61 days after such notice to the Company. Notwithstanding the foregoing, in no event shall the conversion price be less
than the Floor Price (as defined herein).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of Preferred Stock will be entitled to receive cumulative dividends at the rate per share of 9% per annum of the stated value
per share, until the fifth anniversary of the date of issuance of the Preferred Stock. The dividends become payable, at the Company&#8217;s
option, in either cash, out of any funds legally available for such purpose, or in shares of Common Stock, (i) upon any conversion of
the Preferred Stock, (ii) on each such other date as the Company&#8217;s board of directors may determine, subject to written consent
of the holders of Preferred Stock holding a majority of the then issued and outstanding Preferred Stock, (iii) upon the Company&#8217;s
liquidation, dissolution or winding up, and (iv) upon occurrence of a fundamental transaction, including any merger or consolidation,
sale of all or substantially all of the Company&#8217;s assets, exchange or conversion of all of the Common Stock by tender offer, exchange
offer or reclassification; provided, however, that if Preferred Stock is converted into shares of Common Stock at any time prior to the
fifth anniversary of the date of issuance of the Preferred Stock, the holder will receive a make-whole payment in an amount in cash equal
(i) to all of the dividends that, but for the early conversion, would have otherwise accrued on the applicable shares of Preferred Stock
being converted for the period commencing on the issuance date of the Preferred Stock and ending on the Mandatory Conversion
Date (as defined in the Certificate of Designations) minus (ii) the amount of all prior dividends paid on such converted Preferred Stock
before the relevant Conversion Date (as defined in the Certificate of Designations), less the amount of all prior dividends paid on such
converted Preferred Stock before the date of conversion. Make-whole payments are payable at the Company&#8217;s option in either cash,
out of any funds legally available for such purpose, or in shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to any dividend payments and make-whole payments paid in shares of Common Stock, the number of shares of Common Stock to be issued
to a holder of Preferred Stock will be an amount equal to the quotient of (i) the amount of the dividend payable to such holder divided
by (ii) the conversion price then in effect, provided that the conversion price shall not be less than the Floor Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Preferred Stock, to the extent that it has not been converted previously, is subject to full ratchet anti-dilution price protection upon
the issuance of equity or equity-linked securities at an effective Common Stock purchase price of less than the conversion price then
in effect, subject to adjustment as provided in the Certificate of Designations. Notwithstanding the foregoing, in no event shall the
conversion price be less than the Floor Price, which such Floor Price shall equal 50% of the &#8220;Minimum Price&#8221; (as such term
is defined in Rule 5635 of the Listing Rules of the Nasdaq Stock Market) on the date of the Underwriting Agreement (subject to adjustment
for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) or, in any case, such lower amount
as permitted, from time to time, by the Nasdaq Capital Market (the &#8220;<b><i>Floor Price</i></b>&#8221;). Additionally, in the event
that the conversion price has been adjusted pursuant to the Certificate of Designations, and the Dilutive Issuance (as defined in the
Certificate of Designations) that triggered such adjustment does not occur, is not consummated, is unwound, or is cancelled after the
fact for any reason whatsoever, the conversion price shall be readjusted to the conversion price in effect prior to such Dilutive
Issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of the Company&#8217;s liquidation, dissolution, or winding up, holders of the Preferred Stock will be entitled to receive
the amount of cash, securities or other property to which such holder would be entitled to receive with respect to such shares of Preferred
Stock if such shares had been converted to shares of Common Stock immediately prior to such event (without giving effect for such purposes
to the 4.99% or 9.99% beneficial ownership limitation, as applicable) subject to the preferential rights of holders of any class or series
of the Company&#8217;s capital stock specifically ranking by its terms senior to the Preferred Stock as to distributions of assets upon
such event, whether voluntarily or involuntarily.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Preferred Stock have no voting rights, except as required by law. There is no established public trading market for the
Preferred Stock and the Company does not intend to list the Preferred Stock on any national securities exchange or nationally recognized
trading system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Certificate of Designations is qualified in its entirety by reference to the full text of the Certificate
of Designations, a copy of which is filed as Exhibit 3.2 to this Current Report on Form 8-K and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series
X Amendment Agreement; Series X Certificate of Amendment</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, in connection with the entry into that certain Agreement and Plan of Merger, dated as of February 14, 2025, by
and among the Company, NVEH Merger Sub I, Inc., NVEH Merger Sub II, LLC, and ENvue Medical Holdings, Corp., on February 14, 2025,
the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series X Non-Voting Convertible Preferred
Stock with the Secretary of State of the State of Delaware (the &#8220;<b><i>Series X Certificate of Designations</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 12, 2025, the Company entered into that certain Amendment Agreement (the &#8220;<b><i>Series X Amendment Agreement</i></b>&#8221;)
with the Requisite Series X Holders (as defined in the Series X Certificate of Designations). Pursuant to the Series X Amendment Agreement,
the Requisite Series X Holders agreed to amend the Series X Certificate of Designations by filing a Certificate of Amendment (&#8220;<b><i>Series
X Certificate of Amendment</i></b>&#8221;) to the Series X Certificate of Designations with the Secretary of State of the State of Delaware
to (i) increase the number of authorized shares of Series X Preferred Non-Voting Convertible Preferred Stock, par value $0.001 per share
(the &#8220;<b><i>Series X Preferred Stock</i></b>&#8221;) from 57,720 shares to 62,220 shares and (ii) upon the closing of the Offering,
to reduce the conversion price of the Series X Preferred Stock to the conversion price of the Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 12, 2025, the Company filed the Series X Certificate of Amendment with the Secretary of State of the State of Delaware, thereby amending
the Series X Certificate of Designations. The Series X Certificate of Amendment became effective with the Secretary of State of the State
of Delaware upon filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of the Series X Amendment Agreement and the Series X Certificate of Amendment are qualified in their entirety
by reference to the full text of each such document, copies of which are filed as Exhibit 10.1 and Exhibit 3.1, respectively, to this
Current Report on Form 8-K and are incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.03. Material Modification to Rights of Security Holders.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
matters described in Item 1.01 of this Current Report on Form 8-K related to the Preferred Stock, the Series X Preferred Stock, the
Certificate of Designations and the Series X Certificate of Amendment are incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
matters described in Item 1.01 of this Current Report on Form 8-K related to the filing of the Certificate of Designations and the
Series X Certificate of Amendment are incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2025, the Company issued a press release announcing the pricing of the Offering. A copy of such press release is attached as
Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(d)
Exhibits.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
    of Exhibit</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex1-1.htm">Underwriting Agreement, by and between the Company and Dawson James Securities, Inc., dated as of May 14, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-1.htm">Certificate of Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series X Non-Voting Convertible Preferred Stock.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-2.htm">Certificate of Designation of the Preferences, Rights and Limitations of Series G Convertible Preferred Stock.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Common Warrant issued on May 16, 2025.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Form
    of Representative&#8217;s Warrant issued on May 16, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Amendment Agreement, dated as of May 12, 2025, by and among the Company and the holders party thereto.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release, dated May 15, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 16, 2025</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>NANOVIBRONIX,
    Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Stephen Brown</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Brown</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZi6bBbLq0qIhVpIi4jXYqwTZTJvHvSN7S2CIOA8Pw3veeECOxpIVtkOE4KwvYY9s1JiCUWCOjO2N05Kt1BvGWeLE+sHGhf39gTpHByOix0qco9Na79VhlIPUk1ROlQU4zqWC3EclXz8nVtkIXrGnAuAp2TB1bDIZfQ8LePMlR++qrDsjekssgHctBfoOSqYIt3c2D+OqhKHKRjPpJxJLp1kXX/BnQfUmYN9jGOj/Q/00+B+ZKjg== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>400,000
<FONT STYLE="text-transform: uppercase">SHARES OF SERIES G CONVERTIBLE PREFERRED STOCK </FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>(CONVERTIBLE
INTO 4,901,982 SHARES OF COMMON STOCK), AND </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>4,901,982
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>COMMON Warrants
(exercisable for 4,901,982 shares of common stock) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NANOVIBRONIX,
INC. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITING
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
14, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dawson
James Securities, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Representative of the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several
underwriters, if any, named in <U>Schedule I</U> hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
North Federal Highway &ndash; 6th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boca
Raton, FL 33432</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, NanoVibronix, Inc., a Delaware corporation (collectively with its subsidiaries, including, without limitation, all entities
disclosed or described in the Registration Statement as being subsidiaries of NanoVibronix, Inc., the &ldquo;<U>Company</U>&rdquo;),
hereby confirms its agreement (this &ldquo;<U>Agreement</U>&rdquo;) with the several underwriters (such underwriters, including the Representative
(as defined below), the &ldquo;<U>Underwriters</U>&rdquo; and each an &ldquo;<U>Underwriter</U>&rdquo;) named in <U>Schedule I</U> hereto
for which Dawson James Securities, Inc. is acting as representative to the several Underwriters (the &ldquo;<U>Representative</U>&rdquo;
and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term
Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is understood that the several Underwriters are to make a public offering of the Public Securities as soon as the Representative deems
it advisable to do so. The Public Securities are to be initially offered to the public at the public offering price set forth in the
Prospectus. The Representative may from time to time thereafter change the public offering price and other selling terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is further understood that you will act as the Representative for the Underwriters in the offering and sale of the Closing Securities
in accordance with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, (a) capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Certificate of Designation (as defined herein) and (b) the following terms have the
meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls or is controlled
by or is under common control with such Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Certificate
of Designation</U>&rdquo; means the Certificate of Designation to be filed prior to the Closing by the Company with the Secretary of
State of Delaware, in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Closing Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the hour and the date on the Trading Day on which all conditions precedent to (i) the Underwriters&rsquo; obligations
to pay the Closing Purchase Price and (ii) the Company&rsquo;s obligations to deliver the Closing Securities, in each case, have been
satisfied or waived, but in no event later than 12:00 p.m. (New York City time) on the first Trading Day following the date hereof or
at such earlier time as shall be agreed upon by the Representative and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Preferred Shares</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b), which aggregate purchase price shall be net
of the underwriting discounts and commissions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Securities</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Combined
Preferred Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase warrants delivered to the Underwriters in accordance with Section
2.1(a)(ii) and Section 2.2(a), which warrants shall be exercisable immediately and have a term of exercise equal to five (5) years, in
the form of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Auditor</U>&rdquo; means Zwick CPA, PLLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Haynes and Boone LLP, with offices located at 30 Rockefeller Plaza, 26th Floor, New York, New York 10112.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; shall have the meaning ascribed to such term in the Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Execution
Date</U>&rdquo; shall mean the date on which the parties execute and enter into this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, options, restricted stock units or other equity awards to employees,
officers or directors of the Company pursuant to any stock or option plan or other equity award plan duly adopted for such purpose by
a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors
established for such purpose, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or
other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this
Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such securities, and
(c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the
Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration
rights that require or permit the filing of any registration statement in connection therewith within 90 days following the Closing Date,
and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its
subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities, and
(d) securities issued by the Company with the prior written consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FINRA</U>&rdquo;
means the Financial Industry Regulatory Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
means (a) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the
ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others,
whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c)
the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreements</U>&rdquo; means the lock-up agreements that are delivered at Closing by each of the Company&rsquo;s officers and directors
and each holder of Common Stock that beneficially owns more than 5% of the Company&rsquo;s issued and outstanding Common Stock, in the
form of <U>Exhibit C</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; means (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document,
(ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document; provided that a change in the market price or trading volume
of the Common Stock alone shall not be deemed, in and of itself, to constitute a Material Adverse Effect and adverse effects resulting
solely from or relating solely to the following shall be not be taken into account in determining whether there has been a Material Adverse
Effect, except, in the case of clauses (a), (b) and (d) below, to the extent the impact of the event described therein has an adverse
effect on the Company taken as a whole that is materially disproportionate to the Company taken as a whole compared to other companies
operating in the same industry: (a) general economic conditions, or conditions in financial, banking or securities markets; (b) general
conditions in the industry or any industry sector in which the Company operates or participates; (c) any natural disaster or any national
or international political or social conditions or any act of terrorism, sabotage, military action or war or any escalation or worsening
thereof or (d) any changes in applicable laws or governmental regulations or the interpretation thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Offering</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.1(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>PC</U>&rdquo;
means Pryor Cashman LLP, with offices located at 7 Times Square, New York, New York 10036.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock</U>&rdquo; means up to 400,000 shares of the Company&rsquo;s Series G Convertible Preferred Stock issued or issuable pursuant to
Section 2.1(a)(i) and having the rights, preferences and privileges set forth in the Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preliminary
Prospectus</U>&rdquo; means, if any, any preliminary prospectus relating to the Securities included in the Registration Statement or
filed with the Commission pursuant to Rule 424(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means, if any, any supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed
with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Securities</U>&rdquo; means, collectively, the Closing Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means, collectively, the various parts of the registration statement prepared by the Company on Form S-1 (File No.
333-284973) with respect to the Securities, each as amended as of the date hereof, including the Prospectus and Prospectus Supplement,
if any, the Preliminary Prospectus, if any, and all exhibits filed with or incorporated by reference into such registration statement,
and includes any Rule 462(b) Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Representative&rsquo;s
Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(c)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Representative&rsquo;s
Warrant Shares</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Minimum</U>&rdquo; means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially issuable
in the future pursuant to the Transaction Documents, including any Underlying Shares issuable upon exercise in full of all Warrants and
Representative&rsquo;s Warrants or conversion in full of all shares of Preferred Stock, ignoring any conversion or exercise limits set
forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
462(b) Registration Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Closing Securities,
which was filed with the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated
by the Commission pursuant to the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Closing Securities, the Representative&rsquo;s Warrants, and the Underlying Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Time
of Sale Prospectus</U>&rdquo; means the Preliminary Prospectus most recently filed with the Commission before the time of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Certificate of Designation, the Common Warrants, the Representative&rsquo;s Warrants,
the Lock-Up Agreements, and any other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, with a mailing address at 18 Lafayette Place, Woodmere, New York 11598, and any successor
transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underlying
Shares</U>&rdquo; means, collectively, the Conversion Shares, the Representative&rsquo;s Warrant Shares and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the terms and subject to the conditions set forth herein, the Company agrees to sell in the aggregate 400,000 shares of Preferred
Stock and Common Warrants exercisable for an aggregate of 4,901,982 shares of Common Stock, and each Underwriter agrees to purchase,
severally and not jointly, at the Closing, the following securities of the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the number of shares of Preferred Stock (the &ldquo;<U>Closing Preferred Shares</U>&rdquo;) set forth opposite the name of such Underwriter
on <U>Schedule I</U> hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Common Warrants to purchase up to 100% of the aggregate number of Conversion Shares underlying the Closing Preferred Shares set forth
opposite the name of such Underwriter on <U>Schedule I</U> hereof (the &ldquo;<U>Closing Warrants</U>&rdquo; and, collectively with the
Closing Preferred Shares, the &ldquo;<U>Closing Securities</U>&rdquo;), which Common Warrants shall have an exercise price of $2.04,
subject to adjustment as provided therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The aggregate purchase price for the Closing Securities shall equal the amount set forth opposite the name of such Underwriter on <U>Schedule
I</U> hereto (the &ldquo;<U>Closing Purchase Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The combined purchase price for one Closing Preferred Share and corresponding number of Warrants shall be $25.00 (the &ldquo;<U>Combined
Preferred Purchase Price</U>&rdquo;), which Combined Preferred Purchase Price shall be allocated as $24.99 per Preferred Share (the &ldquo;<U>Preferred
Stock Purchase Price</U>&rdquo;) and $0.01 per Common Warrant (the &ldquo;<U>Common Warrant Purchase Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
On the Closing Date, the Company hall issue to the Representative (and/or its designees), a warrant (the &ldquo;<U>Representative&rsquo;s
Warrants</U>&rdquo;), in form and substance acceptable to the Representative for the purchase of an aggregate number of shares of Common
Stock representing 5% of the Closing Securities sold on the Closing Date, which shall be registered in the name or names and shall be
in such denominations as the Representative may request at least one (1) business day before the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
On the Closing Date, each Underwriter shall deliver or cause to be delivered to the Company, via wire transfer, immediately available
funds equal to such Underwriter&rsquo;s Closing Purchase Price and the Company shall deliver to, or as directed by, such Underwriter
its respective Closing Securities and the Company shall deliver the other items required pursuant to Section 2.3 deliverable at the Closing.
Upon satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4, the Closing shall occur at the offices of PC or
such other location as the Company and Representative shall mutually agree. The Public Securities are to be offered initially to the
public at the offering price set forth on the cover page of the Prospectus (the &ldquo;<U>Offering</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Company acknowledges and agrees that, with respect to any Notice(s) of Conversion (as defined in the Certificate of Designation)
delivered by a Holder (as defined in the Certificate of Designation) on or prior to 10:00 a.m. (New York City time) on the Closing Date,
which Notice(s) of Conversion may be delivered at any time after the time of execution of this Agreement, the Company shall deliver the
Conversion Shares (as defined in the Certificate of Designation) subject to such notice(s) to the Holder by 4:00 p.m. (New York City
time) on the Closing Date. The Company acknowledges and agrees that the Holders are third-party beneficiaries of this covenant of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Reserved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>. The Company shall deliver or cause to be delivered to each Underwriter (if applicable) the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
At the Closing Date, the Closing Preferred Shares, which shares shall be delivered via The Depository Trust Company Deposit or Withdrawal
at Custodian system for the accounts of the several Underwriters;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
At the Closing Date, the Closing Warrants registered in the name of such person as directed by the Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
At the Closing Date, the Representative&rsquo;s Warrants registered in the name of the Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
At the Closing Date, evidence of the filing and acceptance of the Certificate of Designation from the Secretary of State of Delaware;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
At the Closing Date, the Transfer Agent is duly appointed as the transfer agent and conversion agent for the Preferred Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
At the Closing Date, a legal opinion of Company Counsel addressed to the Underwriters, including, without limitation, a negative assurance
letter, in the form and substance reasonably satisfactory to the Representative, a bring-down opinion, including a negative assurance
letter, from Company Counsel in form and substance reasonably satisfactory to the Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
On the Closing Date, a cold comfort letter, addressed to the Underwriters and in form and substance reasonably satisfactory in all respects
to the Representative from the Company Auditor dated, respectively, as of the date of this Agreement and a bring-down letter dated as
of the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
On the Closing Date, the duly executed and delivered Officer&rsquo;s Certificate, in the form and substance reasonably satisfactory to
the Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
On the Closing Date, the duly executed and delivered Secretary&rsquo;s Certificate, in the form and substance reasonably satisfactory
to the Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
On the Closing Date, the duly executed and delivered Lock-Up Agreements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
On the Closing Date, the Representative and PC shall have received such information and documents as they may reasonably require for
the purposes of enabling them to pass upon the issuance and sale of the Securities as contemplated herein, or in order to evidence
the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein
contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>. The respective obligations of each Underwriter hereunder in connection with the Closing are subject to the
following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects when made and on the date in question (other than representations and warranties of the Company
already qualified by materiality or Material Adverse Effect, which shall be true and correct in all respects) of the representations
and warranties of the Company contained herein (unless as of a specific date therein);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the date in question shall have been
performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.3 of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Registration Statement shall be effective on the date of this Agreement and at each of the Closing Date, no stop order suspending
the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been instituted
or shall be pending or contemplated by the Commission and any request on the part of the Commission for additional information shall
have been complied with to the reasonable satisfaction of the Representative; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
by the Execution Date, if required by FINRA, the Underwriters shall have received clearance from FINRA as to the amount of compensation
allowable or payable to the Underwriters as described in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. The Company represents and warrants to the Underwriters as of the Execution Date,
as of the Closing Date, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly
or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued
and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities. If the Company has no Subsidiaries, all other references to the Subsidiaries
or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents to which it is a party and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection
herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
the Company is a party has been (or upon delivery or filing will have been) duly executed by the Company and, when delivered in accordance
with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws
relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement, the other Transaction Documents to which
it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary
debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the
Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of
any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the
Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of
the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filing
with the Commission of the Prospectus, (ii) the registration of the Securities under the Securities Act; (iii) the filing of the Certificate
of Designation with the Delaware Secretary of State; (iv) the application to the Trading Market for the listing of the Underlying Shares
for trading thereon and (v) such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required
Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Registration Statement</U>. The Company has filed with the Commission the Registration Statement, including any related Prospectus
or Prospectuses, for the registration of the Securities under the Securities Act, which Registration Statement has been prepared by the
Company in all material respects in conformity with the requirements of the Securities Act and the rules and regulations of the Commission
under the Securities Act. The Registration Statement has been declared effective by the Commission on May 14, 2025 (the &ldquo;<U>Effective
Date</U>&rdquo;). No stop order suspending the effectiveness of the Registration Statement or the use of the Prospectus or any Prospectus
Supplement has been issued, and no proceeding for any such purpose is pending or has been initiated or, to the Company&rsquo;s knowledge,
is threatened by the Commission. For purposes of this Agreement, &ldquo;<U>free writing prospectus</U>&rdquo; has the meaning set forth
in Rule 405 under the Securities Act. The Company will not, without the prior consent of the Representative, prepare, use or refer to,
any free writing prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Issuance of Securities</U>. The Shares and the Warrants are duly authorized, and when issued and paid for in accordance with the terms
of this Agreement, the Shares will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the
Company. The Underlying Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully
paid and nonassessable, and free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital
stock a number of shares of Common Stock for issuance of the Underlying Shares at least equal to the Required Minimum. The Securities
are not subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company.
All corporate action required to be taken for the authorization, issuance and sale of the Securities has been duly and validly taken.
The Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth in the SEC Reports. Except as set forth
in the SEC Reports, the Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act,
other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of
Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise
of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. Except as set
forth in the SEC Reports, no Person has any right of first refusal, preemptive right, right of participation, or any similar right to
participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities
and as set forth in the SEC Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving
any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments,
understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock
or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company
or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Representative). Except as set forth
in the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts
the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any
Subsidiary. Except as set forth in the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary
that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the
Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any
stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance
with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others
is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements
with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among
any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Time of Sale Prospectus,
Prospectus and any Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely
basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such
extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act
and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at
the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly
present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there has been no event, occurrence
or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred
any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business
consistent with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to
GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has
not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements
to purchase or redeem any shares of its capital stock, (v) other than as disclosed in the SEC Reports, the Registration Statement and/or
the Prospectus, the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
equity plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except for
the issuance of the Securities contemplated by this Agreement or as set forth in the SEC Reports, no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries
or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least 1 Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Litigation</U>. Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). Except as set forth in the SEC Reports, there is no Action which (i) adversely affects
or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there
were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary,
nor, to the Company&rsquo;s knowledge, any current director or officer thereof, is or has been the subject of any Action involving a
claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been,
and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company
or, to the Company&rsquo;s knowledge, any current director or officer of the Company. The Commission has not issued any stop order or
other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act
or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (each, a &ldquo;<U>Material
Permit</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit. The disclosures in the Registration Statement concerning the effects of Federal, State, local and all foreign
regulation on the Company&rsquo;s business as currently contemplated are correct in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to, or have valid and marketable
rights to lease or otherwise use, all real property and all personal property that is material to the business of the Company and the
Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and
do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens
for the payment of federal, state or other taxes, for which appropriate reserves have been made in accordance with GAAP and the payment
of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except
where the failure to be in compliance could not reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights as described in the SEC Reports as necessary or required for use in connection with their respective businesses as
described in the SEC Reports and which the failure to do so could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual
Property Rights</U>&rdquo;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any
of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned,
within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest
audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual
Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to have a Material
Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement
by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures
to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that
it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions With Affiliates and Employees</U>. Except as set forth in the SEC Reports, the Registration Statement or the Prospectus,
none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the
Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring
payments to or from, any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director,
or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in
excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred
on behalf of the Company and (iii) other employee benefits, including stock option agreements under any equity incentive plan of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in material compliance with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and
designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it
files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s
rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of
the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act
(such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as
such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely
to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates,
except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Registration Rights</U>. Except as set forth in the SEC Reports, no Person has any right to cause the Company or any Subsidiary to
effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration, except as disclosed in the SEC Reports. Except as disclosed in the SEC Reports, the Company has not, in the 12 months
preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect
that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no
reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors or a duly authorized committee thereof have taken
all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation
(or similar charter documents) or the laws of its state of incorporation that is or could become applicable as a result of the Underwriters
and the Company fulfilling their obligations or exercising their rights under the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Disclosure; 10b-5</U>. The Registration Statement contains all exhibits and schedules as required by the Securities Act. Each of the
Registration Statement and any post-effective amendment thereto, if any, at the time it became effective, complied in all material respects
with the Securities Act and the Exchange Act and the applicable rules and regulations under the Securities Act and did not and, as amended
or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading. The Preliminary Prospectus, the Time of Sale Prospectus,
the Prospectus and any Prospectus Supplement, each as of its respective date, comply in all material respects with the Securities Act
and the Exchange Act and the applicable rules and regulations. Each of the Preliminary Prospectus, the Time of Sale Prospectus, the Prospectus
and any Prospectus Supplement, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of
a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under
which they were made, not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising
after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is
required to be filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction
contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite
time period. There are no contracts or other documents required to be described in the Time of Sale Prospectus, the Prospectus or any
Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which have not been described or filed
as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Integrated Offering</U>. Neither the Company, nor, to the Company&rsquo;s knowledge, any of its Affiliates or any Person acting
on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes
of any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. The SEC Reports set forth as of the date hereof all outstanding secured
and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA. The Company
has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all
material respects with the FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Accountants</U>. To the knowledge and belief of the Company, the Company Auditor (i) is an independent registered public accounting
firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the
Company&rsquo;s Annual Report for the fiscal year ending December 31, 2025. Except as set forth in the SEC Reports, the Company Auditor
has not, during the periods covered by the financial statements incorporated by reference in the Prospectus, provided to the Company
any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>FDA</U>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under
the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured,
packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical
Product</U>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed
by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration,
investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices,
good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure
to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company&rsquo;s knowledge, threatened,
action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation)
against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter
or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration,
or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and
promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical
hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company
or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of
its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries,
and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of
the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations
of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United
States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving
or clearing for marketing any product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Treasury Department.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Representative&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries owns or controls, directly or indirectly, five percent (5%) or more
of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any
entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the
Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in material compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering
Laws</U>&rdquo;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any
Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>D&amp;O Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires completed by each of
the Company&rsquo;s directors and officers immediately prior to the Offering as well as in the Lock-Up Agreement provided to the Underwriters
is true and correct in all respects and the Company has not become aware of any information which would cause the information disclosed
in such questionnaires become inaccurate and incorrect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>FINRA Affiliation</U>. To the Company&rsquo;s knowledge, no officer, director or any beneficial owner of 5% or more of the Company&rsquo;s
unregistered securities has any direct or indirect affiliation or association with any FINRA member (as determined in accordance with
the rules and regulations of FINRA) that is participating in the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to the Representative
or PC shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Board of Directors</U>. The qualifications of the persons serving as board members and the overall composition of the Board of Directors
comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder applicable to the Company and the rules of the Trading
Market. At least one member of the Board of Directors qualifies as a &ldquo;financial expert&rdquo; as such term is defined under the
Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the Trading Market. In addition, at least a majority
of the persons serving on the Board of Directors qualify as &ldquo;independent&rdquo; as defined under the rules of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Amendments to Registration Statement</U>. The Company has delivered, or will as promptly as practicable deliver, to the Underwriters
complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part
thereof, and conformed copies of the Registration Statement (without exhibits), the Time of Sale Prospectus, the Prospectus and the Prospectus
Supplement, as amended or supplemented, in such quantities and at such places as an Underwriter reasonably requests. Neither the Company
nor any of its directors and officers has distributed and none of them will distribute, prior to the Closing Date, any offering material
in connection with the offering and sale of the Securities other than the Time of Sale Prospectus, the Prospectus, the Prospectus Supplement,
the Registration Statement, any Permitted Free Writing Prospectus, and copies of the documents incorporated by reference therein. The
Company shall not file any such amendment or supplement to which the Representative shall reasonably object in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Federal Securities Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Compliance</U>. During the time when a Prospectus is required to be delivered under the Securities Act, the Company will use its reasonable
best efforts to comply with all requirements imposed upon it by the Securities Act and the rules and regulations thereunder and the Exchange
Act and the rules and regulations thereunder, as from time to time in force, so far as necessary to permit the continuance of sales of
or dealings in the Securities in accordance with the provisions hereof and the Prospectus. If at any time when a Prospectus relating
to the Securities is required to be delivered under the Securities Act, any event shall have occurred as a result of which, in the opinion
of counsel for the Company or counsel for the Underwriters, the Prospectus, as then amended or supplemented, includes an untrue statement
of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading, or if it is necessary at any time to amend the Prospectus to comply
with the Securities Act, the Company will notify the Underwriters promptly and prepare and file with the Commission, subject to Section
4.1 hereof, an appropriate amendment or supplement in accordance with Section 10 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Filing of Final Prospectus</U>. The Company will file the final Prospectus (in form and substance reasonably satisfactory to the Representative)
with the Commission pursuant to the requirements of Rule 424.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exchange Act Registration</U>. For a period of two (2) years from the Execution Date, the Company will use its best efforts to maintain
the registration of the Common Stock under the Exchange Act. The Company will not deregister the Common Stock under the Exchange Act
without the prior written consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Free Writing Prospectuses</U>. The Company represents and agrees that it has not made and will not make any offer relating to the
Securities that would constitute an issuer free writing prospectus, as defined in Rule 433 of the rules and regulations under the Securities
Act, without the prior written consent of the Representative. Any such free writing prospectus consented to by the Representative is
herein referred to as a <B>&ldquo;</B><U>Permitted Free Writing Prospectus</U>.&rdquo; The Company represents that it will treat each
Permitted Free Writing Prospectus as an &ldquo;issuer free writing prospectus&rdquo; as defined in rule and regulations under the Securities
Act, and has complied and will comply with the applicable requirements of Rule 433 of the Securities Act, including timely Commission
filing where required, legending and record keeping.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Delivery to the Underwriters of Prospectuses</U>. The Company will deliver to the Underwriters, without charge, from time to time
during the period when the Prospectus is required to be delivered under the Securities Act or the Exchange Act such number of copies
of each Prospectus as the Underwriters may reasonably request and, if requested, as soon as the Registration Statement or any amendment
or supplement thereto becomes effective, deliver to the Representatives two original executed Registration Statements, including exhibits,
and all post-effective amendments thereto and copies of all exhibits filed therewith or incorporated therein by reference and all original
executed consents of certified experts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Effectiveness and Events Requiring Notice to the Underwriters</U>. The Company will use its reasonable best efforts to cause the Registration
Statement to remain effective with a current prospectus until the later of nine (9) months from the Execution Date and the date on which
the Common Warrants and Representative&rsquo;s Warrants are no longer outstanding. During the period when a prospectus relating to the
Offered Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities
Act or any similar rule) (the &ldquo;Notice Period&rdquo;), the Company shall, in writing, promptly advise the Underwriters and holders
of the Common Warrants and Representative&rsquo;s Warrants: (i)&nbsp;of the time and date of the filing and the effectiveness of any
post-effective amendment to the Registration Statement; (ii)&nbsp;of the issuance by the Commission of any stop order or of the initiation,
or the threatening, of any proceeding for that purpose; (iii)&nbsp;of the issuance by any state securities commission of any proceedings
for the suspension of the qualification of the Securities for offering or sale in any jurisdiction or of the initiation, or the threatening,
of any proceeding for that purpose; (iv)&nbsp;of the mailing and delivery to the Commission for filing of any amendment or supplement
to the Registration Statement, the Time of Sale Prospectus or Prospectus; (v)&nbsp;of the receipt of any comments or request for any
additional information from the Commission; and (vi)&nbsp;of the happening of any event during the Notice Period that, in the judgment
of the Company, makes any statement of a material fact made in the Registration Statement, the Time of Sale Prospectus or the Prospectus
untrue or that requires the making of any changes in the Registration Statement, the Time of Sale Prospectus or the Prospectus in order
to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Commission or any state
securities commission shall enter a stop order or suspend such qualification at any time, the Company will make every reasonable effort
to obtain promptly the lifting of such order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Expenses</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>General Expenses Related to the Offering</U>. The Company hereby agrees to pay on each of the Closing Date, to the extent not paid
at the Closing Date, all expenses incident to the performance of the obligations of the Company under this Agreement, including, but
not limited to: (a) all filing fees and communication expenses relating to the registration of the Securities to be sold in the Offering
with the Commission; (b) all FINRA Public Offering Filing System fees associated with the review of the Offering by FINRA; all fees and
expenses relating to the listing of the Underlying Shares on the Trading Market and such other stock exchanges as the Company and the
Representative together determine; (c) all fees, expenses and disbursements relating to the registration or qualification of such Securities
under the &ldquo;blue sky&rdquo; securities laws of such states and other foreign jurisdictions as the Representative may reasonably
designate not to exceed $5,000; (d) the costs of all mailing and printing of the underwriting documents (including, without limitation,
the Underwriting Agreement and, if appropriate, any Agreement Among Underwriters, Selected Dealers&rsquo; Agreement, Underwriters&rsquo;
Questionnaire and Power of Attorney), Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and
as many preliminary and final Prospectuses as the Representative may reasonably deem necessary; (e) the costs and expenses of the Company&rsquo;s
public relations firm; (f) the costs of preparing, printing and delivering the Securities; (g) fees and expenses of the Transfer Agent
for the Securities (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the
Company), including, without limitation, fees and expenses pursuant to the Representative&rsquo;s Warrants and appointment of the Transfer
Agent as the transfer agent and warrant for the Preferred Stock; (h) stock transfer and/or stamp taxes, if any, payable upon the transfer
of securities from the Company to the Underwriters; (i) the fees and expenses of the Company&rsquo;s accountants; (j) &ldquo;road show&rdquo;
expenses, diligence expenses and legal fees of the Representative&rsquo;s counsel not to exceed in the aggregate of $150,000; (k) the
Underwriters&rsquo; costs of mailing prospectuses to prospective investors; (l) the costs associated with advertising the Offering in
the national editions of the Wall Street Journal and New York Times after the Closing Date; and <U>(m) the Underwriters&rsquo; use of
i-Deal&rsquo;s book-building, prospectus tracking and compliance software (or other similar software) for the Offering. </U>The Underwriters
may also deduct from the net proceeds of the Offering payable to the Company on the Closing Date, the expenses set forth herein to be
paid by the Company to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Application of Net Proceeds</U>. The Company will apply the net proceeds from the Offering received by it in a manner consistent with
the application described under the caption &ldquo;Use of Proceeds&rdquo; in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Delivery of Earnings Statements to Security Holders</U>. The Company will timely file such reports pursuant to the Exchange Act as
are necessary in order to make generally available to its securityholders as soon as practicable an earnings statement for the purposes
of, and to provide to the Underwriters the benefits contemplated by, the last paragraph of Section 11(a) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Stabilization</U>. Neither the Company, nor, to its knowledge, any of its employees or directors (without the consent of the Representative)
has taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to
cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Internal Controls</U>. The Company will use its reasonable best efforts to maintain a system of internal accounting controls sufficient
to provide reasonable assurances that: (i)&nbsp;transactions are executed in accordance with management&rsquo;s general or specific authorization;
(ii)&nbsp;transactions are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to
maintain accountability for assets; (iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s general or specific
authorization; and (iv)&nbsp;the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate
action is taken with respect to any differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Lock-Up Agreements</U>. The Company shall authorize its Transfer Agent to decline to make any transfer of shares in violation of the
Lock-Up Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>FINRA</U>. The Company shall advise the Underwriters (who shall make an appropriate filing with FINRA) if it is aware that any 5%
or greater shareholder of the Company becomes an affiliate or associated person of an Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>No Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company is solely
contractual and commercial in nature, based on arms-length negotiations and that neither the Underwriters nor their affiliates or any
selected dealer shall be deemed to be acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its
affiliates in connection with the Offering and the other transactions contemplated by this Agreement. Notwithstanding anything in this
Agreement to the contrary, the Company acknowledges that the Underwriters may have financial interests in the success of the Offering
that are not limited to the difference between the price to the public and the purchase price paid to the Company by the Underwriters
for the shares and the Underwriters have no obligation to disclose, or account to the Company for, any of such additional financial interests.
The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters
with respect to any breach or alleged breach of fiduciary duty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Underlying Shares</U>. If all or any portion of (i) a Common Warrant or Representative&rsquo;s Warrant is exercised (ii) Preferred
Stock is converted, in each case, at a time when there is an effective registration statement to cover the issuance of the applicable
Underlying Shares, the Underlying Shares issued pursuant to any such exercise or conversion shall be issued free of all restrictive legends.
If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering the sale of
the Underlying Shares) is not effective or is not otherwise available for the sale of the Underlying Shares, the Company shall promptly
notify the holders of the Preferred Stock, Common Warrants and Representative&rsquo;s Warrants in writing that such registration statement
is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and available
for the sale of the Underlying Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to
issue, or any holder thereof to sell, any of the Underlying Shares in compliance with applicable federal and state securities laws).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Board Composition and Board Designations</U>. The Company shall ensure that: (i)&nbsp;the qualifications of the persons serving as
board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated
thereunder and with the listing requirements of the Trading Market and (ii)&nbsp;if applicable, at least one member of the Board of Directors
qualifies as a &ldquo;financial expert&rdquo; as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated
thereunder, in each case, subject to any exceptions and exemptions contained in continued listing requirements of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Securities Laws Disclosure; Publicity</U>. At the request of the Representative, by 9:00 a.m. (New York City time) on the date hereof
(or on the next Trading Day if this Agreement is signed after 9:00 a.m. (New York City time), the Company shall issue a press release
disclosing the material terms of the Offering. The Company and the Representative shall consult with each other in issuing any other
press releases with respect to the Offering, and neither the Company nor any Underwriter shall issue any such press release nor otherwise
make any such public statement without the prior consent of the Company, with respect to any press release of such Underwriter, or without
the prior consent of such Underwriter, with respect to any press release of the Company, which consent shall not unreasonably be withheld
or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with
prior notice of such public statement or communication. The Company will not issue press releases or engage in any other publicity without
one Business Day&rsquo;s prior written notice to the Representative for a period ending at 5:00 p.m. (New York City time) on the first
business day following the 30th day following the Closing Date, other than normal and customary releases issued in the ordinary course
of the Company&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, that any Underwriter
of the Securities is an &ldquo;Acquiring Person&rdquo; under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Underwriter of Securities could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue the Required Minimum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18
<U>Listing of Common Stock</U>. From the date hereof until the two year anniversary of the Execution Date, the Company hereby agrees
to use reasonable best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently
listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Underlying Shares on such Trading Market
and promptly secure the listing of all of the Underlying Shares on such Trading Market. The Company further agrees, if the Company applies
to have the Common Stock traded on any other Trading Market, it will then include in such application all of Underlying Shares, and will
take such other action as is necessary to cause all of the Underlying Shares to be listed or quoted on such other Trading Market as promptly
as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a
Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules
of the Trading Market. The Company agrees to use reasonable best efforts to maintain the eligibility of the Common Stock for electronic
transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment
of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until ninety (90) days following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until six (6) months following the Closing Date, the Company shall be prohibited from effecting or entering into
an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which
the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include
the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price
that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial
issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some
future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly
or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction
under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined
price. For the avoidance of doubt, the issuance of equity awards to the Company&rsquo;s employees, directors and consultants under the
Company&rsquo;s equity incentive plans, and the exercise and settlement of equity awards granted or to be granted to the Company&rsquo;s
employees, directors and consultants under the Company&rsquo;s equity incentive plans, are not Variable Rate Transactions. Any Underwriter
shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to
any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.19 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20
<U>Research Independence</U>. The Company acknowledges that each Underwriter&rsquo;s research analysts and research departments, if any,
are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal
policies, and that such Underwriter&rsquo;s research analysts may hold and make statements or investment recommendations and/or publish
research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby
waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect
to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research
departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter&rsquo;s investment
banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time,
subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short
position in debt or equity securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFAULT
BY UNDERWRITERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
on the Closing Date, any Underwriter shall fail to purchase and pay for the portion of the Closing Securities, which such Underwriter
has agreed to purchase and pay for on such date (otherwise than by reason of any default on the part of the Company), the Representative,
or if the Representative is the defaulting Underwriter, the non-defaulting Underwriters, shall use their reasonable efforts to procure
within 36 hours thereafter one or more of the other Underwriters, or any others, to purchase from the Company such amounts as may be
agreed upon and upon the terms set forth herein, the Closing Securities, which the defaulting Underwriter or Underwriters failed to purchase.
If during such 36 hours the Representative shall not have procured such other Underwriters, or any others, to purchase the Closing Securities
agreed to be purchased by the defaulting Underwriter or Underwriters, then (a) if the aggregate number of Closing Securities, with respect
to which such default shall occur does not exceed 10% of the Closing Securities covered hereby, the other Underwriters shall be obligated,
severally, in proportion to the respective numbers of Closing Securities, which they are obligated to purchase hereunder, to purchase
the Closing Securities, which such defaulting Underwriter or Underwriters failed to purchase, or (b) if the aggregate number of Closing
Securities with respect to which such default shall occur exceeds 10% of the Closing Securities, covered hereby, the Company or the Representative
will have the right to terminate this Agreement without liability on the part of the non-defaulting Underwriters or of the Company except
to the extent provided in Article VI hereof. In the event of a default by any Underwriter or Underwriters, as set forth in this Article
V, the applicable Closing Date may be postponed for such period, not exceeding seven days, as the Representative, or if the Representative
is the defaulting Underwriter, the non-defaulting Underwriters, may determine in order that the required changes in the Prospectus or
in any other documents or arrangements may be effected. The term &ldquo;Underwriter&rdquo; includes any person substituted for a defaulting
Underwriter. Any action taken under this Section shall not relieve any defaulting Underwriter from liability in respect of any default
of such Underwriter under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VI.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEMNIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Indemnification of the Underwriters</U>. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless
the Underwriters, and each dealer selected by each Underwriter that participates in the offer and sale of the Securities (each a &ldquo;<U>Selected
Dealer</U>&rdquo;) and each of their respective directors, officers and employees and each Person, if any, who controls such Underwriter
or any Selected Dealer (&ldquo;<U>Controlling Person</U>&rdquo;) within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act, against any and all loss, liability, claim, damage and expense whatsoever (including but not limited to any and
all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened,
or any claim whatsoever, whether arising out of any action between such Underwriter and the Company or between such Underwriter and any
third party or otherwise) to which they or any of them may become subject under the Securities Act, the Exchange Act or any other statute
or at common law or otherwise or under the laws of foreign countries, arising out of or based upon any untrue statement or alleged untrue
statement of a material fact contained in (i) any Preliminary Prospectus, if any, the Registration Statement, the Time of Sale Prospectus
or the Prospectus (as from time to time each may be amended and supplemented); or (ii) any materials or information provided to investors
by, or with the approval of, the Company in connection with the marketing of the offering of the Securities, including any &ldquo;road
show&rdquo; or investor presentations made to investors by the Company (whether in person or electronically) (&ldquo;<U>Marketing Materials</U>&rdquo;);
or (iii) any application or other document or written communication (in this Article VI, collectively called &ldquo;<U>application</U>&rdquo;)
executed by the Company or based upon written information furnished by the Company in any jurisdiction in order to qualify the Securities
under the securities laws thereof or filed with the Commission, any state securities commission or agency, Trading Market or any securities
exchange; or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, unless such statement or omission was made in reliance
upon and in conformity with written information furnished to the Company with respect to the applicable Underwriter by or on behalf of
such Underwriter expressly for use in any Preliminary Prospectus, if any, the Registration Statement, the Time of Sale Prospectus or
Prospectus, or any amendment or supplement thereto, or in any Marketing Materials or application, as the case may be. With respect to
any untrue statement or omission or alleged untrue statement or omission made in the Preliminary Prospectus, if any, the indemnity agreement
contained in this Section 6.1 shall not inure to the benefit of an Underwriter to the extent that any loss, liability, claim, damage
or expense of such Underwriter results from the fact that a copy of the Prospectus was not given or sent to the Person asserting any
such loss, liability, claim or damage at or prior to the written confirmation of sale of the Securities to such Person as required by
the Securities Act and the rules and regulations thereunder, and if the untrue statement or omission has been corrected in the Prospectus,
unless such failure to deliver the Prospectus was a result of non-compliance by the Company with its obligations under this Agreement.
The Company agrees promptly to notify each Underwriter of the commencement of any litigation or proceedings against the Company or any
of its officers, directors or Controlling Persons in connection with the issue and sale of the Public Securities or in connection with
the Registration Statement, the Time of Sale Prospectus or Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Procedure</U>. If any action is brought against an Underwriter, a Selected Dealer or a Controlling Person in respect of which indemnity
may be sought against the Company pursuant to Section 6.1, such Underwriter, such Selected Dealer or Controlling Person, as the case
may be, shall promptly notify the Company in writing of the institution of such action and the Company shall assume the defense of such
action, including the employment and fees of counsel (subject to the reasonable approval of such Underwriter or such Selected Dealer,
as the case may be) and payment of actual expenses. Such Underwriter, such Selected Dealer or Controlling Person shall have the right
to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such Underwriter,
such Selected Dealer or Controlling Person unless (i) the employment of such counsel at the expense of the Company shall have been authorized
in writing by the Company in connection with the defense of such action, or (ii) the Company shall not have employed counsel to have
charge of the defense of such action, or (iii) such indemnified party or parties shall have reasonably concluded that there may be defenses
available to it or them which are different from or additional to those available to the Company (in which case the Company shall not
have the right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events the reasonable
fees and expenses of not more than one additional firm of attorneys selected by such Underwriter (in addition to local counsel), Selected
Dealer and/or Controlling Person shall be borne by the Company. Notwithstanding anything to the contrary contained herein, if any Underwriter,
Selected Dealer or Controlling Person shall assume the defense of such action as provided above, the Company shall have the right to
approve the terms of any settlement of such action which approval shall not be unreasonably withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>Indemnification of the Company</U>. Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company,
its directors, officers and employees and agents who control the Company within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the foregoing indemnity from the Company
to such Underwriter, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions
made in any Preliminary Prospectus, if any, the Registration Statement, the Time of Sale Prospectus or Prospectus or any amendment or
supplement thereto or in any Marketing Materials or application, in reliance upon, and in strict conformity with, written information
furnished to the Company with respect to such Underwriter by or on behalf of such Underwriter expressly for use in such Preliminary Prospectus,
if any, the Registration Statement, the Time of Sale Prospectus or Prospectus or any amendment or supplement thereto or in any such Marketing
Materials or application. In case any action shall be brought against the Company or any other Person so indemnified based on any Preliminary
Prospectus, if any, the Registration Statement or Prospectus or any amendment or supplement thereto or any Marketing Materials or application,
and in respect of which indemnity may be sought against such Underwriter, such Underwriter shall have the rights and duties given to
the Company, and the Company and each other Person so indemnified shall have the rights and duties given to such Underwriter by the provisions
of this Article VI. Notwithstanding the provisions of this Section 6.3, no Underwriter shall be required to indemnify the Company for
any amount in excess of the underwriting discounts and commissions applicable to the Securities purchased by such Underwriter. The Underwriters&rsquo;
obligations in this Section 6.3 to indemnify the Company are several in proportion to their respective underwriting obligations and not
joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
<U>Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Contribution Rights</U>. In order to provide for just and equitable contribution under the Securities Act in any case in which (i)
any Person entitled to indemnification under this Article VI makes a claim for indemnification pursuant hereto but it is judicially determined
(by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of
the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Article VI provides
for indemnification in such case, or (ii) contribution under the Securities Act, the Exchange Act or otherwise may be required on the
part of any such Person in circumstances for which indemnification is provided under this Article VI, then, and in each such case, the
Company and each Underwriter, severally and not jointly, shall contribute to the aggregate losses, liabilities, claims, damages and expenses
of the nature contemplated by said indemnity agreement incurred by the Company and such Underwriter, as incurred, in such proportions
that such Underwriter is responsible for that portion represented by the percentage that the underwriting discount appearing on the cover
page of the Prospectus bears to the initial offering price appearing thereon and the Company is responsible for the balance; provided,
that, no Person guilty of a fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution from any Person who was not guilty of such fraudulent misrepresentation. For purposes of this Section, each director,
officer and employee of such Underwriter or the Company, as applicable, and each Person, if any, who controls such Underwriter or the
Company, as applicable, within the meaning of Section 15 of the Securities Act shall have the same rights to contribution as such Underwriter
or the Company, as applicable. Notwithstanding the provisions of this Section 6.4, no Underwriter shall be required to contribute any
amount in excess of the underwriting discounts and commissions applicable to the Securities purchased by such Underwriter. The Underwriters&rsquo;
obligations in this Section 6.4 to contribute are several in proportion to their respective underwriting obligations and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Contribution Procedure</U>. Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of notice
of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made
against another party (&ldquo;<U>contributing party</U>&rdquo;), notify the contributing party of the commencement thereof, but the failure
to so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution
hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or
its representative of the commencement thereof within the aforesaid fifteen days, the contributing party will be entitled to participate
therein with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable
to any party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution
without the written consent of such contributing party. The contribution provisions contained in this Section 6.4 are intended to supersede,
to the extent permitted by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VII.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Termination</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Termination Right</U>. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date,
(i)&nbsp;if any domestic or international event or act or occurrence has materially disrupted, or in its opinion will in the immediate
future materially disrupt, general securities markets in the United States and which such event makes it impracticable to market the
Securities in the manner and on the terms described in the Time of Sale Prospectus or the Prospectus or to enforce contracts for the
sale of securities; or (ii)&nbsp;if trading on any Trading Market shall have been suspended or materially limited, or minimum or maximum
prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of
the Commission or any other government authority having jurisdiction over the Company, or (iii)&nbsp;if the United States shall have
become involved in a new war or an increase in major hostilities that materially adversely impacts the United States securities markets
and which such hostilities impracticable to market the Securities in the manner and on the terms described in the Time of Sale Disclosure
Package or the Prospectus or to enforce contracts for the sale of securities, or (iv)&nbsp;if a banking moratorium has been declared
by a New York State or federal authority, or (v)&nbsp;if a moratorium on foreign exchange trading has been declared which materially
adversely impacts the United States securities markets, or (vi)&nbsp;if the Company shall have sustained a material loss by fire, flood,
accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have been insured,
will, in the Representative&rsquo;s opinion, make it inadvisable to proceed with the delivery of the Securities, or (vii)&nbsp;if the
Company is in material breach of any of its representations, warranties or covenants hereunder, or (viii)&nbsp;if the Representative
shall have become aware after the date hereof of such a material adverse change in the conditions or prospects of the Company, or such
adverse material change in general market conditions as in the Representative&rsquo;s judgment would make it impracticable to proceed
with the offering, sale and/or delivery of the Securities or to enforce contracts made by the Underwriters for the sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Indemnification</U>. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination
of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Article VI shall not be in any way effected
by such election or termination or failure to carry out the terms of this Agreement or any part hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, and the Prospectus and the Prospectus
Supplement contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or e-mail attachment at the email address set forth on the signature pages attached hereto
at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice
or communication is delivered via facsimile at the facsimile number or e-mail attachment at the e-mail address as set forth on the signature
pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second
(2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon
actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as
set forth on the signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and the Representative. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any action, suit or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Article VI, the prevailing party in such action, suit or proceeding
shall be reimbursed by the other party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing, and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
(including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method, such signature shall be deemed
to have been duly and validly delivered and shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.11
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
the Underwriters and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary
damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents
and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at
law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.12
<U>Saturdays, Sundays, Holidays, etc</U>.&#9;If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.13
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.14
<B><U>WAIVER OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY ARISING
OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST
EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVE FOREVER ANY RIGHT TO TRIAL BY
JURY. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided
below for that purpose, whereupon this letter shall constitute a binding agreement among the Company and the several Underwriters in
accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>NANOVIBRONIX, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD><U>/s/ Stephen Brown</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Stephen Brown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><U>Address for Notice</U>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">969 Pruitt Place</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Tyler, TX 75703</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Attn: Stephen Brown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><U>Copy to</U>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Haynes and Boone, LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">30 Rockefeller Plaza, 26<SUP>th</SUP> Floor</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">New York, New York 10112</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Attn: Rick Werner</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
on the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DAWSON
JAMES SECURITIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Representative of the several</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters
listed on Schedule I</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Robert D. Keyser, Jr.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    D. Keyser, Jr.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for Notice</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
North Federal Highway &ndash; 6th Floor<BR>
Boca Raton, FL 33432</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Copy
to</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pryor
Cashman LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7
Times Square</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:
(212) 326-0806</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
M. Ali Panjwani, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Schedule
of Underwriters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Underwriters</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Closing Preferred Shares</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Closing Warrants</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Closing Purchase Price</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Dawson James Securities, Inc.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">400,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right"> 4,901,982 </TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">9,300,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">400,000</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right"> 4,901,982 </TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">9,300,000</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Final
Term Sheet</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuer:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NanoVibronix,
    Inc. (the &ldquo;Company&rdquo;)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Symbol:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NAOV</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,000
    shares of Series G Convertible Preferred Stock, $0.001 par value $0.001 per share (the &ldquo;Preferred Stock&rdquo;), of the Company
    and 4,901,982 warrants to purchase shares of our common stock (the &ldquo;Warrants&rdquo;)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering price:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25.00
    per share of Preferred Stock and corresponding Warrants</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    discount:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.75
    per share of Preferred Stock and corresponding Warrants</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    net proceeds:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
    $9,300,000 (after deducting the underwriting discount).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    15, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlement
    date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    19, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dawson
    James Securities, Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
of Designation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Common Warrant</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Lock-up Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>ex3-1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Certificate
of Amendment of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Certificate
of Designations of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PREFERENCES,
RIGHTS AND LIMITATIONS OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Series
X NON-VOTING Convertible Preferred Stock of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NANOVIBRONIX,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Pursuant
to Section 242 of the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Delaware
General Corporation Law</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Certificate of Amendment to the Certificate of Designations of Preferences, Rights and Limitations of Series X Non-Voting Convertible
Preferred Stock (the &ldquo;<B><I>Amendment</I></B>&rdquo;) is dated as of May 12, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the board of directors (the &ldquo;<B><I>Board</I></B>&rdquo;) of NanoVibronix, Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;),
pursuant to the authority granted to it by the Company&rsquo;s Certificate of Incorporation (the &ldquo;<B><I>Certificate of Incorporation</I></B>&rdquo;)
and Section 151(g) of the Delaware General Corporation Law (the &ldquo;<B><I>DGCL</I></B>&rdquo;), has previously fixed the rights, preferences,
restrictions and other matters relating to a series of the Company&rsquo;s preferred stock, consisting of 57,720 authorized shares of
preferred stock, classified as Series X Non-Voting Convertible Preferred Stock (the &ldquo;<B><I>Preferred Stock</I></B>&rdquo;) and
the Certificate of Designations of Preferences, Rights and Limitations of the Preferred Stock (the &ldquo;<B><I>Certificate of Designations</I></B>&rdquo;)
was initially filed with the Secretary of State of the State of Delaware on February 14, 2025, evidencing such terms;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
(i) pursuant to Section 4.1 of the Certificate of Designations, the Certificate of Designations or any provision thereof may not be amended
without the affirmative vote or written approval, agreement or waiver of the holders of seventy percent (70%) of the then outstanding
shares of the Preferred Stock (the &ldquo;<B><I>Required Holders</I></B>&rdquo;), and (ii) pursuant to Section 4.2 of the Certificate
of Designations, any vote or written approval, agreement or waiver required or permitted under Section 4.1 may be taken at a meeting
of the holders of the Preferred Stock or through a written consent executed by the Required Holders;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Required Holders pursuant to the Certificate of Designations have consented, in accordance with the DGCL, on May 5, 2025, to this
Amendment on the terms set forth herein; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Board has duly adopted resolutions proposing to adopt this Amendment and declaring this Amendment to be advisable and in the best
interest of the Company and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, this Amendment has been duly adopted in accordance with Section 151 of the DGCL and has been executed by a duly authorized
officer of the Company as of the date first set forth above to amend the terms of the Certificate of Designations as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    2 of the Certificate of Designations is hereby amended and restated to read as follows (emphasis added):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;2.
<U>Designation, Amount and Par Value</U>. The series of preferred stock shall be designated as its Series X Non-Voting Convertible Preferred
Stock and the number of shares so designated shall be 62,220 (which shall not be subject to increase without the written consent of all
of the holders of the Preferred Stock (each, a &ldquo;<B><I>Holder</I></B>&rdquo; and collectively, the &ldquo;<B><I>Holders</I></B>&rdquo;)).
Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value equal to $606.3756 (the &ldquo;<B><I>Stated
Value</I></B>&rdquo;).&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    7 of the Certificate of Designations is hereby amended to include a new subsection 7.6 as follows:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;7.6.
<U>Adjustment of Conversion Price</U>. Notwithstanding the foregoing, the Conversion Price shall be adjusted to the Conversion Price
of the Series G Convertible Preferred Stock of the Corporation, par value $0.001 per share, as defined in the Certificate of Designations
of the Preferences, Rights and Limitations of the Series G Convertible Preferred Stock, to be issued in the public offering of the Corporation&rsquo;s
securities pursuant to the registration statement on Form S-1 (File No. 333-284973) (the &ldquo;<B><I>Public Offering</I></B>&rdquo;
and such adjustment, the &ldquo;<B><I>Public Offering Conversion Price Adjustment</I></B>&rdquo;), which such Public Offering Conversion
Price Adjustment shall be adjusted upon the closing of the Public Offering only and a one-time occurrence. Notwithstanding the foregoing,
the Conversion Price shall not be adjusted, and this Section 7.6 shall not be applicable, if the Public Offering of the Corporation is
not consummated or effectuated and such Public Offering does not close.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page Follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Amendment to be signed by its duly authorized officer this 12<SUP>th</SUP> day of May, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NANOVIBRONIX,
    INC. </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stephen Brown</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Brown</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>4
<FILENAME>ex3-2.htm
<DESCRIPTION>EX-3.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NANOVIBRONIX,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATION OF PREFERENCES,<BR>
RIGHTS AND LIMITATIONS<BR>
OF<BR>
SERIES G CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURSUANT
TO SECTION 151 OF THE<BR>
DELAWARE GENERAL CORPORATION LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NANOVIBRONIX,
INC.</B>, a Delaware corporation (the &ldquo;<B><I>Corporation</I></B>&rdquo;), in accordance with the provisions of Section 103 of the
Delaware General Corporation Law (the &ldquo;<B><I>DGCL</I></B>&rdquo;) does hereby certify that, in accordance with Sections 141(c)
and 151 of the DGCL, the following resolution was duly adopted by the Board of Directors of the Corporation as of May 14, 2025:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESOLVED</B>,
that the Board of Directors of the Corporation pursuant to authority expressly vesting in it by the provisions of the Amended and Restated
Certificate of Incorporation of the Corporation (as amended, the &ldquo;Certificate of Incorporation&rdquo;), hereby authorizes the issuance
of a series of Preferred Stock designated as the Series G Convertible Preferred Stock, par value $0.001 per share, of the Corporation
and hereby fixes the designation, number of shares, powers, preferences, rights, qualifications, limitations and restrictions thereof
(in addition to any provisions set forth in the Certificate of Incorporation of the Corporation which are applicable to the Preferred
Stock of all classes and series) as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
G CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Affiliate</I></B>&rdquo;
means any person or entity that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under
common control with a person or entity, as such terms are used in and construed under Rule 144 under the Securities Act. With respect
to a Holder, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as such Holder
will be deemed to be an Affiliate of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Alternate
Consideration</I></B>&rdquo; shall have the meaning set forth in Section 7(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Beneficial
Ownership Limitation</I></B>&rdquo; shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Board
of Directors</I></B>&rdquo; means the Board of Directors of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Business
Day</I></B>&rdquo; means any day except Saturday, Sunday, any day which shall be a federal legal holiday in the United States or any
day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Certificate
of Designation</I></B>&rdquo; means this Certificate of Designation of Preferences, Rights and Limitations of Series G Convertible Preferred
Stock filed by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Closing
Sale Price</I></B>&rdquo; means, for any security as of any date, the last closing trade price for such security prior to 4:00 p.m.,
New York City time, on the principal securities exchange or trading market where such security is listed or traded, as reported by Bloomberg,
L.P. (or an equivalent, reliable reporting service mutually acceptable to and hereafter designated by Holders of a majority of the then-outstanding
Series G Preferred Stock and the Corporation), or if the foregoing do not apply, the last trade price of such security in the over-the-counter
market on the electronic bulletin board for such security as reported by Bloomberg, L.P., or, if no last trade price is reported for
such security by Bloomberg, L.P., the average of the bid prices of any market makers for such security as reported on the any over the
counter market operated by OTC Markets Group, Inc. If the Closing Sale Price cannot be calculated for a security on a particular date
on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as determined in good
faith by the Board of Directors of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Commission</I></B>&rdquo;
means the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Common
Stock</I></B>&rdquo; means the Corporation&rsquo;s common stock, par value $0.001 per share, and stock of any other class of securities
into which such securities may hereafter be reclassified or changed into.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Common
Stock Equivalents</I></B>&rdquo; means any securities of the Corporation or its subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument
that is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Conversion
Date</I></B>&rdquo; shall have the meaning set forth in Section 6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Conversion
Price</I></B>&rdquo; shall have the meaning set forth in Section 6(a), as adjusted pursuant to Section 7 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Conversion
Shares</I></B>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series G Preferred Stock
in accordance with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>DGCL</I></B>&rdquo;
shall mean the Delaware General Corporation Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Dividend
Payment Date</I></B>&rdquo; shall have the meaning set forth in Section 3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Dividend
Share Amount</I></B>&rdquo; shall have the meaning set forth in Section 3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>DWAC
Delivery</I></B>&rdquo; shall have the meaning set forth in Section 6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Exchange
Act</I></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Exempt
Issuance</I></B>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Corporation
pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Corporation,
(b) warrants to the Underwriter in connection with the transactions pursuant to the Underwriting Agreement and any securities upon exercise
of the warrants to the Underwriter, if applicable, and/or securities upon the exercise or exchange of or conversion of any securities
issued pursuant to the Underwriting Agreement and/or other securities exercisable or exchangeable for or convertible into shares of Common
Stock issued and outstanding on the date of the Underwriting Agreement, provided that such securities have not been amended since the
date of the Underwriting Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion
price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, (c) securities
issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Corporation, provided
that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that
require or permit the filing of any registration statement in connection therewith during the prohibition period set forth in the Underwriting
Agreement, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Corporation and shall
provide to the Corporation additional benefits in addition to the investment of funds, but shall not include a transaction in which the
Corporation is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities, and (d) the shares of Series G Preferred Stock and Warrants issued to other purchasers pursuant to the Prospectus concurrently
with the Closing (each as defined in the Underwriting Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Floor
Price</I></B>&rdquo; shall equal $1.02, which shall be 50% of the &ldquo;Minimum Price&rdquo; (as such term is defined in Rule 5635 of
the Listing Rules of the Nasdaq Stock Market) on the date of the Underwriting Agreement (subject to adjustment for stock splits, stock
dividends, stock combinations, recapitalizations or other similar events) or, in any case, such lower amount as permitted, from time
to time, by the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Fundamental
Transaction</I></B>&rdquo; shall have the meaning set forth in Section 7(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Holder</I></B>&rdquo;
means any holder of Series G Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Issuance
Date</I></B>&rdquo; means the date of the &ldquo;Closing&rdquo; as defined in the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Junior
Securities</I></B>&rdquo; means the Common Stock and all other Common Stock Equivalents of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Make-Whole
Amount</I></B>&rdquo; means, with respect to the applicable date of determination, an amount in cash equal to all of the dividends that,
but for the applicable conversion prior the Mandatory Conversion Date, would have otherwise accrued pursuant to Section 3 with respect
to the applicable shares of Series G Preferred Stock being so converted for the period commencing on the applicable Conversion Date and
ending on the Mandatory Conversion Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Make-Whole
Payment</I></B>&rdquo; shall have the meaning set forth in Section 3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Mandatory
Conversion Date</I></B>&rdquo; means the date that is the five (5) year anniversary of the Issuance Date, or if such day is not a Business
Day, on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Notice
of Conversion</I></B>&rdquo; shall have the meaning set forth in Section 6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Person</I></B>&rdquo;
means any individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Underwriter</I></B>&rdquo;
means Dawson James Securities, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Required
Holders</I></B>&rdquo; means the holders of at least a majority of the outstanding shares of Series G Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Securities
Act</I></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Underwriting
Agreement</I></B>&rdquo; means that certain underwriting agreement dated May 14, 2025, by and among the parties signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Series
G Preferred Stock</I></B>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Series
G Preferred Stock Register</I></B>&rdquo; shall have the meaning set forth in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Share
Delivery Date</I></B>&rdquo; shall have the meaning set forth in Section 6(d)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Standard
Settlement Period</I></B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Corporation&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Stated
Value</I></B>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Trading
Day</I></B>&rdquo; means a day on which the Common Stock is traded for any period on the principal securities exchange or if the Common
Stock is not traded on a principal securities exchange, on a day that the Common Stock is traded on another securities market on which
the Common Stock is then being traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Trading
Market</I></B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the
date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New
York Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Transfer
Agent</I></B>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Corporation, with a mailing address of 18 Lafayette
Place, Woodmere, New York 11598, and any successor transfer agent of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Underlying
Shares</I></B>&rdquo; means the shares of Common Stock issued and issuable (i) upon conversion of the Series G Preferred Stock and (ii),
to the extent that the Corporation elects to pay dividends on the Series G Preferred Stock pursuant to Section 3 hereof in duly authorized,
validly issued, fully paid and non-assessable shares of Common Stock, as payment of dividends upon any conversion of Series G Preferred
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Designation, Amount and Par Value; Assignment</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
series of preferred stock designated by this Certificate of Designation shall be designated as the Corporation&rsquo;s Series G Convertible
Preferred Stock (the &ldquo;<B><I>Series G Preferred Stock</I></B>&rdquo;) and the number of shares so designated shall be 500,000 (which
shall not be subject to increase without the written consent of the Holders holding a majority of the then issued and outstanding Series
G Preferred Stock). Each share of Series G Preferred Stock shall have a par value of $0.001 per share and a stated value equal to $25
(the &ldquo;<B><I>Stated Value</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Corporation shall register shares of the Series G Preferred Stock, upon records to be maintained by the Corporation or any duly registered
transfer agent for that purpose (the &ldquo;<B><I>Series G Preferred Stock Register</I></B>&rdquo;), in the name of the Holders thereof
from time to time. The Corporation may deem and treat the registered Holder of shares of Series G Preferred Stock as the absolute owner
thereof for the purpose of any conversion thereof and for all other purposes. The Corporation shall register the transfer of any shares
of Series G Preferred Stock in the Series G Preferred Stock Register, upon surrender of the certificates evidencing such shares to be
transferred, duly endorsed by the Holder thereof, to the Corporation at its address specified herein. Upon any such registration or transfer,
a new certificate evidencing the shares of Series G Preferred Stock so transferred shall be issued to the transferee and a new certificate
evidencing the remaining portion of the shares not so transferred, if any, shall be issued to the transferring Holder, in each case,
within three Business Days. The provisions of this Certificate of Designation are intended to be for the benefit of all Holders from
time to time and shall be enforceable by any such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Dividends</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Series G Preferred Stock Dividend</U>. Holders shall be entitled to receive, and the Corporation shall pay, but only out of any funds
legally available for the declaration of dividends, cumulative dividends payable as provided in Section 3(b) below at the rate per share
(as a percentage of the Stated Value per share of Series G Preferred Stock) of nine (9%) percent per annum. Dividends on shares of Series
G Preferred Stock shall accrue and be cumulative from the Issuance Date and shall accrue from day to day thereafter for so long as Series
G Preferred Stock is outstanding. Dividends may be declared and paid on Series G Preferred Stock when and as determined by the Board
of Directors of the Corporation, out of any funds legally available for such purpose, subject to written consent of the Holders holding
a majority of the then issued and outstanding Series G Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Payment
of Dividends in Cash or in Kind; Make-Whole Payment</U>. Dividends are payable (i) on each Conversion Date (with respect only to Series
G Preferred Stock being converted); (ii) on each such other date as the Board of Directors of the Corporation may determine pursuant
to Section 3(a) above; (iii) upon Liquidation as set forth in Section 5; and (iv) upon occurrence of a Fundamental Transaction (each
such date, a &ldquo;<B><I>Dividend Payment Date</I></B>&rdquo;), at the option of the Corporation, in cash or in duly authorized, validly
issued, fully paid and non-assessable shares of Common Stock as set forth in this Section 3(b), or a combination thereof (the amount
to be paid in shares of Common Stock, the &ldquo;<B><I>Dividend Share Amount Payment</I></B>&rdquo;); <I>provided, however</I>, that
upon the conversion of Series G Preferred Stock prior to the Mandatory Conversion Date, the Corporation shall also pay to the Holders
of Series G Preferred Stock so converted, an amount equal to the Make-Whole Amount (the &ldquo;<B><I>Make-Whole Payment</I></B>&rdquo;),
payable at the option of the Corporation, in cash or in duly authorized, validly issued, fully paid and non-assessable shares of Common
Stock. With respect to any Dividend Share Amount Payments and Make-Whole Payments paid in shares of Common Stock, the number of shares
of Common Stock to be issued to a Holder pursuant to this Section 3(b) shall be an amount equal to the quotient of (i) the amount of
the dividend payable to such Holder divided by (ii) the Conversion Price then in effect, provided that the Conversion Price shall not
be less than the Floor Price. If the Corporation intends to pay any Dividend Share Amount Payment or Make-Whole Payment in cash it shall
provide the Holders with not less than five Trading Days&rsquo; notice of such intention, which notice may be provided by filing a Form
8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Dividend Calculations</U>. Dividends on the Series G Preferred Stock shall be calculated on the basis of a 365-day year, and shall
accrue daily commencing on the Issue Date, and shall be deemed to accrue from such date whether or not earned or declared and whether
or not there are profits, surplus or other funds of the Corporation legally available for the payment of dividends. Payment of dividends
and Make-Whole Payments in shares of Common Stock shall otherwise occur pursuant to Section 3(b) and, solely for purposes of the payment
of dividends in shares, the Dividend Payment Date shall be deemed the Conversion Date. Dividends shall cease to accrue with respect to
any Series G Preferred Stock converted, provided that, the Corporation actually delivers the Conversion Shares and Make-Whole Payment
within the time period required by Section 3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Voting Rights</U>. Except as otherwise provided by law or in this Section 4, the Series G Preferred Stock shall have no voting
rights. So long as any shares of Series G Preferred Stock are outstanding, the Corporation shall not (by merger, consolidation or otherwise),
without the written consent or affirmative vote of the holders of at least a majority of the then-outstanding shares of Series G Preferred
Stock, consenting or voting (as the case may be) separately as a class, amend, alter or repeal any provision of the Corporation&rsquo;s
Certificate of Incorporation, Amended and Restated Bylaws, as amended, or this Certificate of Designation in a manner that would adversely
affect the powers, preferences or rights of the Series G Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Rank; Liquidation</U>. Upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary (a
&ldquo;<B><I>Liquidation</I></B>&rdquo;), each Holder shall be entitled to receive the amount of cash, securities or other property to
which such holder would be entitled to receive with respect to such shares of Series G Preferred Stock if such shares had been converted
to Common Stock immediately prior to such Liquidation (without giving effect for such purposes to the Beneficial Ownership Limitation
set forth in Section 6(c)), subject to the preferential rights of holders of any class or series of Capital Stock of the Corporation
specifically ranking by its terms senior to the Series G Preferred Stock as to distributions of assets upon Liquidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Automatic
Conversion</U>. On the Mandatory Conversion Date, all outstanding shares of Series G Preferred Stock and, to the extent that the Corporation
elects to pay dividends pursuant to Section 3 hereof in duly authorized, validly issued, fully paid and non-assessable shares of Common
Stock, all accrued but unpaid dividends thereon through and including the Mandatory Conversion Date shall be automatically converted
into shares of Common Stock (an &ldquo;<B><I>Automatic Conversion</I></B>&rdquo;) at a price of $2.04 per share (as adjusted pursuant
to Section 7 hereof) (the &ldquo;<B><I>Conversion Price</I></B>&rdquo;); provided, however, that to the extent that an Automatic Conversion
would result in a Holder and its other Attribution Parties (as defined below) exceeding the Beneficial Ownership Limitation set forth
in Section 6(c), if applicable, then such Holder&rsquo;s Series G Preferred Stock shall not be automatically converted into Common Stock
and shall remain outstanding, and such Holder shall benefit from all preferences and rights set forth in this Certificate of Designations
(except that the provisions set forth in Section 7(c) shall immediately terminate and be of no further force and effect) to such extent
(and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Automatic Conversion (and beneficial
ownership) to such extent), and the shares of Common Stock issuable upon the automatic conversion of Series G Preferred Stock to such
extent shall be held in abeyance for such Holder until such time or times as conversion of such Series G Preferred Stock would not result
in such Holder and its other Attribution Parties exceeding the Beneficial Ownership Limitation set forth in Section 6(c), at which time
or times such Holder shall be issued such shares of Common Stock (and any shares of Common Stock granted or issued with respect to the
shares of Common Stock issuable upon conversion of Series G Preferred Stock to be held similarly in abeyance) to the same extent as if
there had been no such limitation. Upon an Automatic Conversion, subject to the limitations set forth in the preceding sentence, the
outstanding shares of Series G Preferred Stock shall be converted automatically without any further action by the Holders of such shares
and whether or not the certificates representing such shares are surrendered to the Corporation or its transfer agent; provided, however,
that the Corporation shall not be obligated to issue certificates evidencing any Underlying Shares issuable upon such conversion unless
the certificates evidencing such shares of Series G Preferred Stock are either delivered to the Corporation or its transfer agent, or
the holder notifies the Corporation or its transfer agent that such certificates have been lost, stolen or destroyed and executes an
agreement satisfactory to the Corporation to indemnify the Corporation from any loss incurred by it in connection with such certificates.
Upon the occurrence of an Automatic Conversion of the Series G Preferred Stock, the Holders of such shares shall surrender the certificates
representing the Series G Preferred Stock at the office of the Corporation or any transfer agent for the Series G Preferred Stock. Thereupon,
there shall be issued and delivered to such Holder promptly at such office and in its name as shown on such surrendered certificate or
certificates, a certificate or certificates for the number of Underlying Shares issuable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Conversions
at Option of Holder</U>. Each share of Series G Preferred Stock shall be convertible, at any time and from time to time from and after
the Issuance Date through the Mandatory Conversion Date, at the option of the Holder thereof, into a number of shares of Common Stock
(subject to the limitations set forth in Section 6(c)) equal to the quotient of (i) the sum of the aggregate Stated Value of those shares
being converted and, to the extent that the Corporation elects to pay dividends pursuant to Section 3 hereof in duly authorized, validly
issued, fully paid and non-assessable shares of Common Stock, all accrued but unpaid dividends thereon, divided by (ii) the Conversion
Price then in effect. Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto
as <U>Annex A</U> (a &ldquo;<B><I>Notice of Conversion</I></B>&rdquo;), duly completed and executed. Provided the Corporation&rsquo;s
transfer agent is participating in the Depository Trust Company (&ldquo;<B><I>DTC</I></B>&rdquo;) Fast Automated Securities Transfer
program and the applicable Conversion Shares are either registered for issuance, registered for resale or eligible for resale without
restriction pursuant to Rule 144 of the Securities Act, the Notice of Conversion may specify, at the Holder&rsquo;s election, whether
the applicable Conversion Shares shall be credited to the account of the Holder&rsquo;s prime broker with DTC through its Deposit Withdrawal
Agent Commission system (a &ldquo;<B><I>DWAC Delivery</I></B>&rdquo;). The &ldquo;<B><I>Conversion Date</I></B>&rdquo;, or the date on
which a conversion pursuant to this Section 6(b) shall be deemed effective, shall be defined as the Trading Day that the Notice of Conversion,
completed and executed, is sent by email or facsimile to, and received during regular business hours by, the Corporation. To effect conversions
of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Series G Preferred
Stock to the Corporation unless all of the shares of Series G Preferred Stock represented thereby are so converted, in which case such
Holder shall deliver the certificate representing such shares of Series G Preferred Stock promptly following the Conversion Date at issue.
Shares of Preferred Stock converted into Common Stock shall be canceled and shall not be reissued. The calculations set forth in the
Notice of Conversion shall control in the absence of manifest or mathematical error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">(c) <U>Beneficial
Ownership Limitation</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Corporation shall not
effect any conversion of the Series G Preferred Stock, and a Holder shall not have the right to convert any shares of Series G Preferred
Stock, pursuant to this Section 6 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on
the applicable Notice of Conversion, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group
together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B><I>Attribution Parties</I></B>&rdquo;)), would
beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares
of Common Stock issuable upon conversion of the shares of Series G Preferred Stock with respect to which such determination is being
made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, non-converted
portion of the shares of Series G Preferred Stock beneficially owned by the Holder or any of its Affiliates or Attribution Parties and
(ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Corporation (including, without
limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence,
for purposes of this Section 6(c), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and
the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Corporation is not representing to the
Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules
required to be filed in accordance therewith. To the extent that the limitation contained in this Section 6(c) applies, the determination
of whether the shares of Series G Preferred Stock are convertible (in relation to other securities owned by the Holder together with
any Affiliates and Attribution Parties) and of which shares of Series G Preferred Stock are convertible shall be in the sole discretion
of the Holder, and the submission of a Notice of Conversion shall be deemed to be the Holder&rsquo;s determination of whether the shares
of Series G Preferred Stock are convertible (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of the shares of Series G Preferred Stock are convertible , in each case subject to the Beneficial Ownership
Limitation, and the Corporation shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination
as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder. For purposes of this Section 6(c), in determining the number of outstanding shares of Common Stock,
a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Corporation&rsquo;s most recent periodic
or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Corporation or (C) a more
recent written notice by the Corporation or its Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the
written or oral request of a Holder, the Corporation shall within one (1) Trading Day confirm orally and in writing to the Holder the
number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Corporation, the shares of Series G Preferred Stock, by the Holder
or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The
&ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon conversion of the shares of Series G Preferred Stock. The
Holder, upon notice to the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 6(c),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon conversion of the shares of Series G Preferred Stock held by the Holder
and the provisions of this Section 6(c) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective
until the 61<SUP>st</SUP> day after such notice is delivered to the Corporation. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 6(c) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of the shares of Series G Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Mechanics
of Conversion</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">i. <U>Delivery
of Certificate or Electronic Issuance Upon Conversion</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
the date that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period,
in each case after the delivery to the Corporation of the Notice of Conversion <FONT STYLE="color: black">(the &ldquo;<B><I>Share Delivery
Date</I></B>&rdquo;), the Corporation shall (a) deliver, or cause to be delivered, to the converting Holder a physical certificate or
certificates representing the number of Underlying Shares being acquired upon the conversion of shares of Series G Preferred Stock (including
shares of Common Stock representing the payment of accrued dividends otherwise determined pursuant to Section 3) or (b) in the case of
a DWAC Delivery, electronically transfer such Underlying Shares by crediting the account of the Holder&rsquo;s prime broker with DTC
through its DWAC system. If in the case of any Notice of Conversion such certificate or certificates are not delivered to or as directed
by or, in the case of a DWAC Delivery, such shares are not electronically delivered to or as directed by, the applicable Holder by the
Share Delivery Date, the applicable Holder shall be entitled to elect to rescind such Conversion Notice by written notice to the Corporation
at any time on or before its receipt of such certificate or certificates for Underlying Shares or electronic receipt of such shares,
as applicable, in which event the Corporation shall promptly return to such Holder any original Series G Preferred Stock certificate
delivered to the Corporation and such Holder shall promptly return to the Corporation any Common Stock certificates or otherwise direct
the return of any shares of Common Stock delivered to the Holder through the DWAC system, representing the shares of Series G Preferred
Stock unsuccessfully tendered for conversion to the Corporation. </FONT>Notwithstanding the foregoing, with respect to any Notice(s)
of Conversion delivered prior to 12:00 p.m. (New York City time) on the Issuance Date, the Company agrees to deliver the Conversion Shares
subject to such notice(s) on the Issuance Date and the Issuance Date shall be the Share Delivery Date for purposes hereunder, provided
that payment of the aggregate Conversion Price is received by such Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Obligation
Absolute</U>. Subject to Section 6(c) hereof and subject to Holder&rsquo;s right to rescind a Conversion Notice pursuant to Section 6(d)(i)
above, the Corporation&rsquo;s obligation to issue and deliver the Conversion Shares upon conversion of Series G Preferred Stock in accordance
with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the same, any waiver
or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or
any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other Person of
any obligation to the Corporation or any violation or alleged violation of law by such Holder or any other Person, and irrespective of
any other circumstance which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance
of such Conversion Shares. Subject to Section 6(c) hereof and subject to Holder&rsquo;s right to rescind a Conversion Notice pursuant
to Section 6(d)(i) above, in the event a Holder shall elect to convert any or all of its Series G Preferred Stock, the Corporation may
not refuse conversion based on any claim that such Holder or any one Person associated or affiliated with such Holder has been engaged
in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to such Holder, restraining
and/or enjoining conversion of all or part of the Series G Preferred Stock of such Holder shall have been sought and obtained by the
Corporation. In the absence of such injunction, the Corporation shall issue Conversion Shares and, if applicable, cash, upon a properly
noticed conversion. If the Corporation fails to deliver to a Holder such Conversion Shares pursuant to Section 6(d)(i) on the second
Trading Day after the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated
damages and not as a penalty, for each $1,000 of Stated Value of Series G Preferred Stock being converted, $10 per Trading Day (increasing
to $10 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after such damages begin to accrue) for each Trading Day after such
second Trading Day after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion. Nothing
herein shall limit a Holder&rsquo;s right to pursue actual damages for the Corporation&rsquo;s failure to deliver Conversion Shares within
the period specified herein and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity
including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit
a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">iii. <U>Compensation
for Buy-In on Failure to Timely Deliver Certificates Upon Conversion</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to any other rights available to the Holder, if the Corporation fails to cause the Transfer Agent to transmit to the Holder
the Underlying Shares in accordance with the provisions of Section 6(d)( above pursuant to a conversion on or before the Share Delivery
Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s
brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Underlying Shares
which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Corporation shall (A) pay in cash
to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for
the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Underlying Shares that the Corporation
was required to deliver to the Holder in connection with the conversion at issue times (2) the price at which the sell order giving rise
to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the shares of Series G
Preferred Stock and equivalent number of Underlying Shares for which such conversion was not honored (in which case such conversion shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Corporation timely
complied with its conversion and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Corporation shall be required
to pay the Holder $1,000. The Holder shall provide the Corporation written notice indicating the amounts payable to the Holder in respect
of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Corporation&rsquo;s failure to timely deliver shares of Common Stock upon conversion
of the shares of Series G Preferred Stock as required pursuant to the terms hereof<FONT STYLE="color: black">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Reservation
of Shares Issuable Upon Conversion</U>. The Corporation covenants that it will at all times reserve and keep available out of its authorized
and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Series G Preferred Stock and payment of dividends
on the Series G Preferred Stock each as herein provided, free from preemptive rights or any other actual contingent purchase rights of
Persons other than the Holders of the Series G Preferred Stock, not less than such aggregate number of shares of the Common Stock as
shall be issuable (taking into account the adjustments of Section 7) upon the conversion of all outstanding shares of Series G Preferred
Stock at the Conversion Price and payment of dividends hereunder. The Corporation shall take all action required to increase the authorized
number of shares of Common Stock (including, if necessary, seeking stockholder approval to authorize the issuance of additional shares
of Common Stock), or any other actions necessary or desirable, if at any time there shall be insufficient authorized but unissued shares
of Common Stock to permit such reservation or to permit the conversion of all outstanding shares of the Series G Preferred Stock (including
any dividends payable thereon).The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue,
be duly authorized, validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Fractional
Shares</U>. No fractional shares of Common Stock shall be issued upon the conversion of the Series G Preferred Stock. As to any fraction
of a share which a Holder would otherwise be entitled to receive upon such conversion, the Corporation shall at its election, either
pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price or round
up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>Transfer
Taxes and Expenses</U>. The issuance of certificates for shares of the Common Stock upon conversion of the Series G Preferred Stock shall
be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery
of such certificates, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer
involved in the issuance and delivery of any such certificate upon conversion in a name other than that of the registered Holder(s) of
such shares of Series G Preferred Stock and the Corporation shall not be required to issue or deliver such certificates unless or until
the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established
to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all transfer agent fees required for processing
of any Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Status
as Stockholder</U>. Upon each Conversion Date, (i) the shares of Series G Preferred Stock being converted shall be deemed converted into
shares of Common Stock and (ii) the Holder&rsquo;s rights as a holder of such converted shares of Series G Preferred Stock shall cease
and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or
otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate
of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation&rsquo;s failure to convert Series
G Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">(a) <U>Stock
Dividends and Stock Splits</U>. If </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Corporation,
at any time while the shares of Series G Preferred Stock are outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock
(which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of the Series
G Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of the Common Stock any shares of capital stock of the Corporation, then in each case the Conversion Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment
made pursuant to this Section 7(a) shall become effective immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification<FONT STYLE="color: black">. Notwithstanding the foregoing, no adjustment pursuant to this Section 7
shall cause the Conversion Price to be less than the Floor Price.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Fundamental
Transaction</U>. If, at any time while the shares of Series G Preferred Stock is outstanding, (i) the Corporation, directly or indirectly,
in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation
(or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition
of all or substantially all of the Corporation&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders
of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by
the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Corporation,
(iv) the Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Corporation, directly or indirectly, in one or more related transactions consummates a
stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the
outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Corporation (each a &ldquo;<B><I>Fundamental
Transaction</I></B>&rdquo;), then, upon any subsequent conversion of the shares of Series G Preferred Stock, the Holder shall have the
right to receive, for each Underlying that would have been issuable upon such conversion immediately prior to the occurrence of such
Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 6(c) on the conversion of the shares
of Series G Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Corporation, if
it is the surviving corporation, and any additional consideration (the &ldquo;<B><I>Alternate Consideration</I></B>&rdquo;) receivable
as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which the shares of Series G Preferred
Stock are convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 6(c) on the conversion
of the shares of Series G Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any conversion of the shares of Series G Preferred Stock
following such Fundamental Transaction. The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation
is not the survivor (the &ldquo;<B><I>Successor Entity</I></B>&rdquo;) to assume in writing all of the obligations of the Corporation
under this Certificate of Designation in accordance with the provisions of this Section 7(b) pursuant to written agreements in form and
substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for the shares of Series G Preferred Stock a security of the
Successor Entity evidenced by a written instrument substantially similar in form and substance to the shares of Series G Preferred Stock
which are convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the shares of Common Stock acquirable and receivable upon conversion of the shares of Series G Preferred Stock (without regard to
any limitations on the conversion of the shares of Series G Preferred Stock) prior to such Fundamental Transaction, and with an conversion
price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the
shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares
of capital stock and such conversion price being for the purpose of protecting the economic value of the shares of Series G Preferred
Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance
to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Corporation&rdquo;
under this Certificate of Designation (so that from and after the occurrence or consummation of such Fundamental Transaction, each and
every provision of the Certificate of Designation referring to the &ldquo;Corporation&rdquo; shall refer instead to each of the Corporation
and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally
with the Corporation, may exercise every right and power of the Corporation prior thereto and the Successor Entity or Successor Entities
shall assume all of the obligations of the Corporation prior thereto under this Certificate of Designation with the same effect as if
the Corporation and such Successor Entity or Successor Entities, jointly and severally, had been named as the Corporation herein. For
the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 7(b) regardless of (i) whether
the Corporation has sufficient authorized shares of Common Stock for the issuance of Underlying Shares and/or (ii) whether a Fundamental
Transaction occurs prior to the initial date the shares of Series G Preferred Stock become convertible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">(c) </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subsequent
Equity Sales</U>. If the Corporation or any Subsidiary thereof, as applicable, at any time while the shares of Series G Preferred Stock
are outstanding, shall sell, enter into an agreement to sell or grant any option to purchase, or sell or grant any right to reprice,
or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock
or Common Stock Equivalents, at an effective price per share less than the Conversion Price then in effect (such lower price, the &ldquo;<B><I>Base
Share Price</I></B>&rdquo; and such issuances collectively, a &ldquo;<B><I>Dilutive Issuance</I></B>&rdquo;) (it being understood and
agreed that if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase
price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights
per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per
share that is less than the Conversion Price, such issuance shall be deemed to have occurred for less than the Conversion Price on such
date of the Dilutive Issuance at such effective price), then simultaneously with the consummation (or, if earlier, the announcement)
of each Dilutive Issuance the Conversion Price shall be reduced and only reduced to equal the Base Share Price, provided that the Base
Share Price shall not be less than the Floor Price. If the Corporation enters into a Variable Rate Transaction, the Corporation shall
be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible price, conversion price or exercise price at
which such securities may be issued, converted or exercised. <FONT STYLE="color: black">For the avoidance of doubt and notwithstanding
the foregoing, (i) no adjustment pursuant to this Section 7(c) shall cause the Conversion Price to be less than the Floor Price</FONT>
and (ii) <FONT STYLE="color: black">in the event the Conversion Price has been adjusted pursuant to this Section 7(c) and the Dilutive
Issuance that triggered such adjustment does not occur, is not consummated, is unwound, or is canceled after the fact for any reason
whatsoever, the Conversion Price shall be readjusted to the Conversion Price in effect prior to the such Dilutive Issuance.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Calculations</U>.
All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Notice
to Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation shall
promptly deliver to each Holder a notice setting forth the Conversion Ratio after such adjustment and setting forth a brief statement
of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Other
Notices</U>. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the
Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Corporation shall authorize
the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any
class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all
of the assets of the Corporation, of any compulsory share exchange whereby the Common Stock is converted into other securities, cash
or property or (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of
conversion of this Series G Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon
the stock books of the Corporation, at least 20 calendar days prior to the applicable record or effective date hereinafter specified,
a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or
warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger,
sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the
Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
8</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Conversion, shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier
service, addressed to the Corporation, at 969 Pruitt Place, Tyler TX 75703, telephone number (914) 233-3004, or such other facsimile
number or address as the Corporation may specify for such purposes by notice to the Holders delivered in accordance with this Section.
Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered
personally, by facsimile, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number
or address of such Holder appearing on the books of the Corporation, or if no such facsimile number or address appears on the books of
the Corporation, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be
deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile
at the facsimile number specified in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the date immediately following
the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section
between 5:30 p.m. and 11:59 p.m. (New York City time) on any date, (iii) the second Business Day following the date of mailing, if sent
by nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Lost
or Mutilated Series G Preferred Stock Certificate</U>. If a Holder&rsquo;s Series G Preferred Stock certificate shall be mutilated, lost,
stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated
certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Series
G Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such
certificate, and of the ownership thereof, reasonably satisfactory to the Corporation and, in each case, customary and reasonable indemnity,
if requested. Applicants for a new certificate under such circumstances shall also comply with such other reasonable regulations and
procedures and pay such other reasonable third-party costs as the Corporation may prescribe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Waiver</U>.
Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate as or be
construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation
or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate
of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter
to insist upon strict adherence to that term or any other term of this Certificate of Designation. Any waiver by the Corporation or a
Holder must be in writing. Notwithstanding any provision in this Certificate of Designation to the contrary, any provision contained
herein and any right of the holders of Series G Preferred Stock granted hereunder may be waived as to all shares of Series G Preferred
Stock (and the Holders thereof) upon the written consent of the Holders of not less than a majority of the shares of Series G Preferred
Stock then outstanding, unless a higher percentage is required by the DGCL, in which case the written consent of the holders of not less
than such higher percentage shall be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 25.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;
<U>Amendment</U>. Except for Section 6(c), which may not be amended or waived hereunder, this Certificate of Designation or any provision
hereof may be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent without a meeting
in accordance with the DGCL, of the Required Holders, voting separately as a single class, and with such other stockholder approval,
if any, as may then be required pursuant to the DGCL and the Certificate of Incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 25.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Severability</U>.
If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate of Designation
shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to
all other Persons and circumstances. If it shall be found that any amount deemed interest due hereunder violates the applicable law governing
usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under
applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Next
Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall
be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Headings</U>.
The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be
deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Status
of Converted Series G Preferred Stock</U>. If any shares of Series G Preferred Stock shall be converted or reacquired by the Corporation,
such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series
G Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: -4.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[<I>Signature
Page Follows</I>]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: -4.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black"><B>IN
WITNESS WHEREOF</B>, the undersigned has executed this Certificate of Designation this </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15<SUP>th
</SUP><FONT STYLE="color: black">day of </FONT>May<FONT STYLE="color: black">, 2025.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="color: black">&nbsp;</FONT></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NANOVIBRONIX,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stephen Brown</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Brown</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNEX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF CONVERSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(TO
BE EXECUTED BY THE REGISTERED HOLDER IN ORDER TO CONVERT SHARES OF SERIES G PREFERRED STOCK)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned Holder hereby irrevocably elects to convert the number of shares of Series G Convertible Preferred Stock indicated below
into shares of common stock, par value $0.001 per share (the &ldquo;<B><I>Common Stock</I></B>&rdquo;), of NanoVibronix, Inc., a Delaware
corporation (the &ldquo;<B><I>Corporation</I></B>&rdquo;), according to the conditions hereof, as of the date written below. If securities
are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect
thereto. Capitalized terms utilized but not defined herein shall have the meaning ascribed to such terms in that certain Certificate
of Designation of Preferences, Rights and Limitations of Series G Convertible Preferred Stock (the &ldquo;<B><I>Certificate of Designation</I></B>&rdquo;)
filed by the Corporation on May 15, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date hereof, the number of shares of Common Stock beneficially owned by the undersigned Holder (together with such Holder&rsquo;s
Attribution Parties, and any other Person whose beneficial ownership of Common Stock would be aggregated with the Holder&rsquo;s for
purposes of Section 13(d) of the Exchange Act and the applicable regulations of the Commission, including any &ldquo;group&rdquo; of
which the Holder is a member), including the number of shares of Common Stock issuable upon conversion of the Series G Preferred Stock
subject to this Notice of Conversion, but excluding the number of shares of Common Stock which are issuable upon (A) conversion of the
remaining, unconverted Series G Preferred Stock beneficially owned by such Holder or any of its Attribution Parties, and (B) exercise
or conversion of the unexercised or unconverted portion of any other securities of the Corporation (including any warrants) beneficially
owned by such Holder or any of its Attribution Parties that are subject to a limitation on conversion or exercise similar to the limitation
contained in Section 6(c) of the Certificate of Designation, is __________________. For purposes hereof, beneficial ownership shall be
calculated in accordance with Section 13(d) of the Exchange Act and the applicable regulations of the Commission. In addition, for purposes
hereof, &ldquo;group&rdquo; has the meaning set forth in Section 13(d) of the Exchange Act and the applicable regulations of the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
calculations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
to Effect Conversion: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of shares of Series G Preferred Stock owned prior to Conversion: __________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of shares of Series G Preferred Stock to be Converted: ___________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of shares of Common Stock to be Issued: ______________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Make-Whole Payment Shares to be Issued: _________________ (of which ___________ shares in excess of the Beneficial Ownership Limitation
shall be held in abeyance)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
Conversion Price: _______________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of shares of Series G Preferred Stock subsequent to Conversion: ____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for delivery of physical certificates: __________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
for DWAC Delivery:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC
Instructions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker
no: _____________________________________________________________________<BR>
Account no: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[HOLDER]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>5
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NANOVIBRONIX,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 25%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: ______</FONT></TD><TD STYLE="width: 5%"></TD><TD STYLE="text-align: right; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Issue Date: May 16, 2025</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on May 16, 2030 (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from NanoVibronix, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s Common Stock.
The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (the
&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best Market (the &ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on the OTCQB or the OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on the OTCQB or the OTCQX and if prices for the Common Stock are then reported on The Pink Open
Market operated by the OTC Markets, Inc. (the &ldquo;<U>Pink Market</U>&rdquo;) (or a similar organization or agency succeeding to its
functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair
market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority
in interest of the </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants <FONT STYLE="background-color: white">then
outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form S-1 (File No. 333-284973) filed with the Commission, including
all information, documents and exhibits filed with or incorporated by reference into such registration statement, as amended from time
to time, which registers the sale of the Warrants and the Warrant Shares, among others, to the purchasers, and includes any Rule 462(b)
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Holders</U>&rdquo; means the holders of Warrants representing at least a majority of the Warrants then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means the subsidiaries of the Company set forth on <U>Exhibit 21.1</U> to the Registration Statement and shall, where applicable, also
include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Trading Market on which the Common Stock is then listed is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, New York 11598, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB or the OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following
the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$2.04</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT>
                                                                        =</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the
                                            applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
                                            pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
                                            delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular
                                            trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal
                                            securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP
                                            on the Trading Day immediately preceding the date of the applicable Notice of Exercise or
                                            (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg
                                            as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such
                                            Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day
                                            and is delivered within two (2) hours thereafter (including until two (2) hours after the
                                            close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof
                                            or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                                            of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant
                                            to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
                                            Day;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
                                                                        =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
=</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                             the number of Warrant Shares that would be issuable upon exercise of this Warrant in
                                            accordance with the terms of this Warrant if such exercise were by means of a cash exercise
                                            rather than a cashless exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Mechanics
of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery
                                            of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased
                                            hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account
                                            of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
                                            through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the
                                            Company is then a participant in such system and either (A) there is an effective registration
                                            statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares
                                            by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise
                                            by physical delivery of a certificate, registered in the Company&rsquo;s share register in
                                            the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
                                            is entitled pursuant to such exercise to the address specified by the Holder in the Notice
                                            of Exercise by the date that is the earlier of (i) one (1) Trading Day and (ii) the number
                                            of Trading Days comprising the Standard Settlement Period, in each case after the delivery
                                            to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
                                            Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for
                                            all corporate purposes to have become the holder of record of the Warrant Shares with respect
                                            to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
                                            Shares, provided that payment of the aggregate Exercise Price (other than in the case of
                                            a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the
                                            number of Trading Days comprising the Standard Settlement Period, in each case following
                                            the delivery of the Notice of Exercise. If the Company fails for any reason to deliver to
                                            the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
                                            Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
                                            for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common
                                            Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
                                            to $20 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share
                                            Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant
                                            Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
                                            agent that is a participant in the FAST program so long as this Warrant remains outstanding
                                            and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the
                                            standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
                                            primary Trading Market with respect to the Common Stock as in effect on the date of delivery
                                            of the Notice of Exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 4:00 p.m. (New York City time) on the Trading Day immediately
prior to the Initial Exercise Date, which may be delivered at any time after the time of execution of the Underwriting Agreement, the
Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date
and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be [4.99%/9.99%] of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise
of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>c) </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
Rata Distributions</FONT></U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">. During such time as this Warrant
is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets)
to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash,
stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement
or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such
case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein
if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any
limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which
a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock
as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the
Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of the Company&rsquo;s
assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their
shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or
50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; provided, however, that if the Fundamental Transaction is not within the Company&rsquo;s control, including
not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of
this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Common Stock will be deemed to have received common stock of the Successor Entity (which may be the Company following such Fundamental
Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes
Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the
Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility or (3) the
365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C)
the underlying price per share used in such calculation shall be the highest VWAP during the period beginning on the Trading Day immediately
preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental
Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(d), (D) a remaining option
time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
(or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and
substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of
shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under
this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this
Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the
Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally
with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall
assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect
as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the
avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the
Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction
occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. <FONT CLASS="DeltaViewInsertion">Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. </FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having
a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. The Company and, by accepting this Warrant, the Holder each agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Warrant (whether brought against the Company or the Holder or their
respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the
state and federal courts sitting in the City of New York. The Company and, by accepting this Warrant, the Holder each hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The Company and, by
accepting this Warrant, the Holder each hereby irrevocably waives personal service of process and consents to process being served in
any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to it at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If the Company or the Holder shall commence an action, suit or proceeding to enforce any provisions
of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable
attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Underwriting
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,
addressed to the Company, at 969 Pruitt Place, Tyler TX 75703, Attention: Stephen Brown, Chief Financial Officer, email address: Stephen
Brown stevebrowncpa@gmail.com, or such other email address or address as the Company may specify for such purposes by notice to the Holders.
Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,
by e-mail, or sent by a nationally recognized overnight courier service addressed to the Holder at the e-mail address or address of the
Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective
on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth
in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such
notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or
later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by
U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be
given. To the extent that any notice provided by the Company hereunder constitutes, or contains, material, non-public information regarding
the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on
Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take any action herein prohibited,
or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Required
Holders. Any such amendment shall apply to all Warrants outstanding and be binding upon all registered holders of such Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NANOVIBRONIX, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Murphy</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:
<B>NANOVIBRONIX, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744; in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744; the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to
exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set
forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U> </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U> </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 17%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 33%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>6
<FILENAME>ex4-2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIVE
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NANOVIBRONIX,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: ____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: May 16, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
REPRESENTATIVE COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or
its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior
to 5:00 p.m. (New York City time) on May 14, 2030, provided that, if such date is not a Trading Day, the date that is the immediately
following Trading Day (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from NanoVibronix,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Engagement Agreement, by and
between the Company and Dawson James Securities, Inc., dated February 11, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (the
&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best Market (the &ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on the OTCQB or the OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on the OTCQB or the OTCQX and if prices for the Common Stock are then reported on The Pink Open
Market operated by the OTC Markets, Inc. (the &ldquo;<U>Pink Market</U>&rdquo;) (or a similar organization or agency succeeding to its
functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair
market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority
in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form S-1 (File No. 333-284973) filed with the Commission, including
all information, documents and exhibits filed with or incorporated by reference into such registration statement, as amended from time
to time, which registers the sale of the Warrants and the Warrant Shares, among others, to the purchasers, and includes any Rule 462(b)
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Holders</U>&rdquo; means the holders of Warrants representing at least a majority of the Warrants then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means the subsidiaries of the Company set forth on <U>Exhibit 21.1</U> to the Registration Statement and shall, where applicable, also
include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Trading Market on which the Common Stock is then listed is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, New York 11598, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB or the OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following
the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$2.04</B>, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.36in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of
    the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable
    Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
    within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading
    Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
    of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the
    close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
this Warrant, as adjusted hereunder; and</FONT></FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance
                                            with the terms of this Warrant if such exercise were by means of a cash exercise rather than
                                            a cashless exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery
of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period,
in each case after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case following the
delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice
of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice
of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share
Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds
such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date
of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 4:00 p.m. (New York City time) on the Trading Day immediately
prior to the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company
agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the
Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the
extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other
than cash) or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return
of capital or otherwise (including, without limitation, any distribution of stock or other securities, property or options by way of
a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to
sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the
outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock
or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon
any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to
any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary,
in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option,
exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the
date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder
an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date
of the consummation of such Fundamental Transaction; provided, however, that if the Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company
or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised
portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental
Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock
are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided,
further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such
holders of Common Stock will be deemed to have received common stock of the Successor Entity (which may be the Company following such
Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based
on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation
of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S.
Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction
and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility or
(3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C)
the underlying price per share used in such calculation shall be the highest VWAP during the period beginning on the Trading Day immediately
preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental
Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(d), (D) a remaining option
time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
(or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and
substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of
shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under
this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this
Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the
Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally
with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall
assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect
as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the
avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the
Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction
occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. The Company and, by accepting this Warrant, the Holder each agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Warrant (whether brought against the Company or the Holder or their
respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the
state and federal courts sitting in the City of New York. The Company and, by accepting this Warrant, the Holder each hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The Company and, by
accepting this Warrant, the Holder each hereby irrevocably waives personal service of process and consents to process being served in
any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to it at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If the Company or the Holder shall commence an action, suit or proceeding to enforce any provisions
of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable
attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service, addressed to the Company, at 969 Pruitt Place, Tyler TX 75703, Attention: Stephen Brown, Chief Financial Officer, email
address: Stephen Brown stevebrowncpa@gmail.com, or such other email address or address as the Company may specify for such purposes by
notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in
writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to the Holder at
the e-mail address or address of the Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder
shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via
e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day
after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following
the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom
such notice is required to be given. To the extent that any notice provided by the Company hereunder constitutes, or contains, material,
non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take any action
herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent
of the Required Holders. Any such amendment shall apply to all Warrants outstanding and be binding upon all registered holders of such
Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NANOVIBRONIX,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Murphy</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NANOVIBRONIX,
    INC.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify">&#9744;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify">&#9744;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ___________________</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: ____________________</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>E</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xhibit
<FONT STYLE="text-transform: uppercase">10.1</FONT></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Amendment
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Amendment Agreement (this &ldquo;<U>Agreement</U>&rdquo;), dated as of May 12, 2025, is by and between NanoVibronix, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and the holder listed on the signature pages attached hereto (the &ldquo;<U>Holder</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">WITNESSETH</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Whereas</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
in connection with that that certain Agreement and Plan of Merger, dated as of February 14, 2025, by and among the Company, NVEH Merger
Sub I, Inc., NVEH Merger Sub II, LLC, and ENvue Medical Holdings, Corp., the Holder was issued shares of Series X Non-Voting Convertible
Preferred Stock, par value $0.001 per share (the &ldquo;<U>Preferred Stock</U>&rdquo;), the terms of which are set forth in the Certificate
of Designations of the Preferred Stock (as amended, the &ldquo;<U>Certificate of Designations</U>&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">whereas,
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pursuant to Section 4.1 of the Certificate of Designations,
as long as any shares of Preferred Stock are outstanding, the Company shall not, without the affirmative vote or written approval, agreement
or waiver of the holders of 70% of the then outstanding shares of the Preferred Stock (the &ldquo;<U>Requisite Series X Holders</U>&rdquo;)
issue further shares of Preferred Stock in excess of 57,720 or increase the number of authorized shares of Preferred Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
pursuant to Section 8(d) of the Certificate of Designations, &#8239;the Certificate of Designations or any provision thereunder may be
amended by obtaining the affirmative vote at a meeting duly called for such purpose, or by written consent without a meeting in accordance
with the Delaware General Corporation Law (the &ldquo;<U>DGCL</U>&rdquo;), of the Requisite Series X Holders, voting separately as a
single class, and with such other stockholder approval, if any, as may then be required pursuant to the DGCL and the Certificate of Incorporation;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Whereas</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
the undersigned collectively hold at least 70% of the outstanding shares of Preferred Stock and thereby constitute the Requisite Series
X Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Now,
therefore</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, in consideration of the premises and mutual
covenants and obligations hereinafter set forth, the parties hereto, intending legally to be bound, hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Definitions</U>.
    Capitalized terms used herein but not otherwise defined herein shall have the respective meanings given such terms in the Certificate
    of Designations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Amendment
    to the Certificate of Designations</U>. The parties hereto hereby agree to amend the terms of the Preferred Stock as set forth in
    the Certificate of Designations of the Preferred Stock in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<U>Amendment</U>&rdquo;).
    Upon the effectiveness of this Agreement, the Company shall promptly file the Amendment with the Secretary of State of the State
    of Delaware.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Counterparts;
    Facsimile Execution</U>. This Agreement may be executed in one or more counterparts (including by electronic mail, in PDF or by DocuSign
    or similar electronic signature), all of which shall be considered one and the same agreement and shall become effective when one
    or more counterparts have been signed by each of the parties and delivered to the other parties. Counterparts may be delivered via
    facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic
    Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission
    method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all
    purposes.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing
    Law</U>. <FONT STYLE="text-transform: uppercase">THIS Agreement SHALL BE SUBJECT TO THE PROVISIONS REGARDING GOVERNING LAW SET FORTH
    IN SECTION 9.4 OF THE Certificate of Designations, AND SUCH PROVISIONS ARE INCORPORATED HEREIN BY THIS REFERENCE, <I>MUTATIS MUTANDIS</I></FONT>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Terms
    and Conditions</U>. Except as modified and amended herein, all of the terms and conditions of the Certificate of Designations shall
    remain in full force and effect.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
pages follow immediately</I>.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Company
Signature Page to Amendment Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">In
witness whereof</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, the undersigned has executed and delivered
this Agreement as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company</B>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NANOVIBRONIX,
    Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Brown</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Investor
Signature Page to Amendment Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">In
witness whereof</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, the undersigned has executed and delivered
this Agreement as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investor:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of signatory:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
A<BR>
<BR>
Form of Amendment to Certificate of Designations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NanoVibronix
Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TYLER,
TX &ndash; May 15, 2025 &ndash; NanoVibronix, Inc. (NASDAQ: NAOV) (&ldquo;NanoVibronix&rdquo; or the &ldquo;Company&rdquo;), a medical
technology company specializing in therapeutic devices, today announced the pricing of an underwritten public offering of approximately
400,000 shares of the Company&rsquo;s Series G Convertible Preferred Stock (&ldquo;Preferred Stock&rdquo;), par value $0.001 per share
and Warrants to purchase up to 4,901,961 shares of common stock, par value $0.001 per share (the &ldquo;Common Stock&rdquo;) of the Company
at an exercise price of $2.04 per share (the &ldquo;Warrants&rdquo;). The combined public offering price of each share of Preferred Stock
together with an accompanying Warrant is $25.00. The closing of the public offering is expected to occur on or about May 19, 2025, subject
to the satisfaction of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dawson
James Securities, Inc. is acting as the sole bookrunning manager for the public offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross proceeds of the public offering are expected to be approximately $10 million before deducting underwriting discounts and commissions
and estimated offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for (i) the redemption
of the principal amount of its outstanding debenture with an aggregate principal amount of $1,300,000, initially issued on February 14,
2025, pursuant to the terms and conditions of such debenture and up to $700,000 to be applied to the partial repayment of an outstanding
note issued on January 17, 2025, in the aggregate principal amount of $2,497,308 and (ii) general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
public offering is being made by the Company pursuant to a registration statement on Form S-1 (File No. 333-284973), as amended, originally
filed on February 14, 2025, and declared effective by the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) on May 14, 2025.
The securities may only be offered by means of a prospectus which forms a part of the effective registration statement relating to the
offering. A preliminary prospectus relating to the offering has been filed with the SEC and a final prospectus relating to the offering
will be filed with the SEC. Copies of the final prospectus may be obtained, when available, at the SEC&rsquo;s website at www.sec.gov
or from Dawson James Securities, Inc. Attention: Prospectus Department, 101 North Federal Highway, Suite 600, Boca Raton, FL 33432, investmentbanking@dawsonjames.com
or toll free at 866.928.0928.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of that state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
NanoVibronix, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NanoVibronix,
Inc. (NASDAQ: NAOV), is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and
home care settings. Headquartered in Tyler, Texas, with research and development in Nesher, Israel, the company focuses on two distinct
technology platforms:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acoustic-based
                                            therapeutic technologies, including PainShield&reg; and UroShield&reg;, which utilize proprietary
                                            low-intensity surface acoustic wave (SAW) technology. This technology is designed for use
                                            in a variety of medical applications, including the disruption of biofilms and bacterial
                                            colonization, as well as the treatment of pain. These devices are intended for use in home
                                            or care settings without the need for continuous professional supervision.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ENvue&trade;
                                            Navigation Platform, developed and operated by ENvue Medical, with offices in Arlington Heights,
                                            Illinois and Tel Aviv, Israel, is a minimally invasive electromagnetic navigation system
                                            intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. FDA
                                            510(k) cleared for adult use, ENvue offers real-time bedside visualization of tube movement
                                            and supports informed decision-making during the placement procedure. Future platform expansion
                                            may include pediatric and vascular access applications.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NanoVibronix
/ ENvue Medical aims to advance standards in non-invasive therapy and minimally invasive navigation, with a commitment to patient safety,
clinical usability, and technology innovation across a range of healthcare environments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains &ldquo;forward-looking statements.&rdquo; Such statements may be preceded by the words &ldquo;intends,&rdquo;
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;plans,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;projects,&rdquo;
&ldquo;predicts,&rdquo; &ldquo;estimates,&rdquo; &ldquo;aims,&rdquo; &ldquo;believes,&rdquo; &ldquo;hopes,&rdquo; &ldquo;potential&rdquo;
or similar words. These forward-looking statements include, but are not limited to: statements regarding the completion of the offering,
the satisfaction of closing conditions, the use of proceeds from the offering, and future expectations and plans and prospects for the
Company. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various
known and unknown risks and uncertainties, many of which are beyond the Company&rsquo;s control, and cannot be predicted or quantified;
consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and
uncertainties include, without limitation, risks and uncertainties associated with: (i) market acceptance of the Company&rsquo;s existing
and new products or lengthy product delays in key markets; (ii) negative or unreliable clinical trial results; (iii) inability to secure
regulatory approvals for the sale of the Company&rsquo;s products; (iv) intense competition in the medical device industry from much
larger, multinational companies; (v) product liability claims; (vi) product malfunctions; (vii) the Company&rsquo;s limited manufacturing
capabilities and reliance on subcontractor assistance; (viii) insufficient or inadequate reimbursements by governmental and/or other
third party payers for the Company&rsquo;s products; (ix) the Company&rsquo;s ability to successfully obtain and maintain intellectual
property protection covering the Company&rsquo;s products; (x) legislative or regulatory reform impacting the healthcare system in the
U.S. or in foreign jurisdictions; (xi) the Company&rsquo;s reliance on single suppliers for certain product components, (xii) the need
to raise additional capital to meet the Company&rsquo;s future business requirements and obligations, given the fact that such capital
may not be available, or may be costly, dilutive or difficult to obtain; (xiii) the Company&rsquo;s conducting business in foreign jurisdictions
exposing us to additional challenges, such as foreign currency exchange rate fluctuations, logistical and communications challenges,
the burden and cost of compliance with foreign laws, and political and/or economic instabilities in specific jurisdictions; and (xiv)
market and other conditions. More detailed information about the Company and the risk factors that may affect the realization of forward-looking
statements is set forth in the Company&rsquo;s filings with the Securities and Exchange Commission (&ldquo;SEC&rdquo;), including the
Company&rsquo;s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Investors and security holders
are urged to read these documents free of charge on the SEC&rsquo;s web site at: http://www.sec.gov. The Company assumes no obligation
to publicly update or revise its forward-looking statements as a result of new information, future events, or otherwise, except as required
by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brett
Maas, Managing Principal, Hayden IR, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>brett@haydenir.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(646)
536-7331</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOURCE:
NanoVibronix, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>naov-20250512.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayO6bP9z5Z8iekhvWB8bZka3yUln1zVrieHtMRGQXAE -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:NAOV="http://nanovibronix.com/20250512" elementFormDefault="qualified" targetNamespace="http://nanovibronix.com/20250512">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://nanovibronix.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="naov-20250512_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="naov-20250512_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>naov-20250512_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>naov-20250512_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nanovibronix.com/role/Cover" xlink:href="naov-20250512.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nanovibronix.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *Z L%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( *Z L%I,B*7C[P   "L"   1
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M);OM[@<"?Q.5<F/(<(W9G%>8OH?;]GO2D1U!'F=R(THI<;G9+GI?)-^#%8W
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " "N@+!:1L=-2)4   #-    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *Z L%I,B*7C
M[P   "L"   1              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( *Z L%J97)PC$ 8  )PG   3              "  >$!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ KH"P6IZ&7DQF!   %1$
M !@              ("!(@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( *Z L%J?H!OPL0(  .(,   -              "  ;X,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ KH"P6I>*NQS     $P(   L
M         ( !F@\  %]R96QS+RYR96QS4$L! A0#%     @ KH"P6JK$(A8S
M 0  (@(   \              ( !@Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( *Z L%HD'INBK0   /@!   :              "  >,1  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *Z L%IED'F2&0$
M ,\#   3              "  <@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  !(4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001641172-25-011246-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-011246-xbrl.zip
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MT8[HHSQG9Y=-]+#UE[0K=[P9NT+&AS"MR24K^V/>TR*$3LG/@L\[\-B09U3
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M(Q3T#';"/NQ80ECVS-NY<Q9-UI,@_:6@LDHZ*+RR46GD:U)_BJ[R%41VR1N
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ML+?#@X&9-L#(7LUH"Z6K9JUX"]]VBB5(=O/VM5+7##7AX@4+E$1/9:M;@A9
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M"+VZ4VY;,JU)R<KM?=;DM&N/".5R2\U&)R%U%L2O%\0)3%FKAFZ'L2)D.LE
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MK<T0O4<[92RFNK"F@H<'AEV6LP,)Q@HAHOK+&YD*A<5!*LSKFDG6%G".4*"
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M=>_7Q/"+.%:U<-U8N*E<;E>),!0K;7-X(]^+GW3;U,6^_3+&H]?)=1UFM3@
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MTT.A9[=\(?"7[?'MGNY_Q86]7BLL$)8W!EM0L_ ,Y.NH:7I7TJS\65FS[9!
M/#)&\*-]4%#OHZ)&.&K1>)14?E<NL/%F538-TO^S9$G?B=;\A;:E':V:H)V>
MGCO_^R\3L:]#% J\K1/NAE5[YJ=4AJR(G?,G3M@-B)Y \0CV3WZ%M$3KF"9A
MKUSD.\4\JZV;T2"ZK>"YX%  9A.OX%A3%8D6KI@%:TDE^L@/OW ]0>]?YN92
M$JK,)7%$B<A8F8:%*+$7G(,?,,E<4W.++^QOQL6]L62N:PPB5,E%E2PO_58'
MAX?HO_^Y)3&[O7#37OB&]@*(_13,IO]X=04]=?2Q;?B"K[_5X$5*ZX-V\Z[.
M?N(#ES="E??\/NI*S8!_#1.74VABI@J:F>$PYR*Y, ;E*F@[M9\O* WE.793
M-BQF'&\:CQC?0?E'JB_$]%5_60+E;&WCKQBWFEM/[NM49$LE\%9BJ$HZ\5#.
M2E5-*U*&XY!6:&@04U:-Z %H5+U$ ;O=]!<-?VL'_G3_6U(#M@6-=$+Z ]@H
M+1O"'"N'0%%!Z/U=8WG;EP!.3N3AR!1EH,>0]PSPSE85YXEQ WL0F,;G%\=#
MU0+W>@HT'3F_=9KDH*4<,"@ ##=:/DG:L^#\.K1+YVF,J>=JY/[C7,JV.9YC
MM<! 7_C.B'\\.CJ3XQD]+%U9\=NGW"=QSCRLAKQX!X:!JQ#K0W4:U.6*R+^U
M>J(L\O6GKQ$8,,$B,=;"@E $U2%+,S1:ZN>%TE6IUVT^2C!;+D@:7PI(B*ZP
MI:5$<C22:?NZ9GI\M!G1F<QV+GC/AZ8H;\BU/]WEVN\SU_YTEVO?&0']U&0'
M=)AV*.A[3E,&(UGF8CI4PQ@]JJW48+==8]U"L@OU*@P1"ZJV"+O,4JRT.XH'
MIO6V9_@@&8>.^WU0& 9PPY/KRU(N$2$(""JT]@]//.%*M\P<W)F ?!Y\SK/_
M(93M!:%+*Y8>#B.TG0\M ,%GN?Z<E1\F9W9;]F+\ >^D[*^3,B;7@G/J59:N
M9M0;YN4*/<.NS,%QKFY\MWAZ*/. %A5&2L64:P7ML8]5F1M,B9-MCRW9)?E!
MF-Z*#%Y05D724/?W:5(;[BM>+>I'N2DN0(8+<U$*(%K)!6%$A1>4"'9'P1&M
MS&LD6]N^-;6FKU-*7W?(W1GY@<8C]Q)(8#?IPLV2)7C?V-O>]_"C\EIPON[*
M=-5=BX!V$.Q3-[8!'L"W/@\@@6AXOK['T8J[M6 T^XA<QOO93FTP NQ!*FT2
ML(C;9?MEO/RBJG4(;0V$HU<B*#5.A$S.E2'[G-K=2\R[7K$+TDKZ8'0=-5+%
M@ D']*&KG)D.[Z:Y-E*<QS$3Q1QQ%EV7:KFJ9I<@2W(1I8!:[V/:)0_R</Y\
MC.KM@GG2'+'UAL4TT<$L?5M(.,3!:3]RCB$S$0+F,G38]9Y%VQ^/>B!=UPF5
MUW']-C*-HP:0!\U7>4[.-X.XG&\WI2;S_/!9GF0+[R7J_>W[2RX23-3W+$^?
M$X6&*R&6I<=]:C^9MW;$[ASXZ\X!KK;M0,'X%#B=2ZTCEY5@1S8^QQ$_D+1*
MDO"RS;@*5/O:(3&ERB"'B\"*.$1#D*-?H ,GK*_,?)O@!D)-X''*$8"';!>_
M="Z AM5^E=W,MEZT53^B;AS9@@ '_*6(!\!RQ!>1!OD;RT6JLY2FFO!<KZY@
M:O2WQ#4A*"_<V57&<V V!MSG+2Z].?C"Y;4B#:B(2XCXFL$R#4K9\\BF-;F@
MS= B*=../D!BQQY<S%^!/>U][18?@^[\F3L&75K**E$O)#VPW*&]JR41!/=4
M=C?-:LF-6@B;^)-J&EV5'JM!R=3U+1;U R-H"LJB5QE72.4PPS;""2@['=U7
M)V"KR@?>2E;[M[^@L!Y:8;JNWNFT:6%APV$?,OR $A1U4Y:IL^=2I_@QU'!1
M2@-7X<&AHY<WBYAT/4D($NM8]87X"XU**+@F!DLAY: ;V%5%IU#3[SDI9+ $
M26V7ZB%L<V]WEOQU9\E3K^7-L=>5!M\6?_I2\*]HHPXYMZ:H5^**^M'[R]LW
MS!F/[J%C3H>1YU,ZQ@C?NB.#M7=3+'9?>]0>_+5++# RUQ*\)W=IHS,>W7,?
MG3^\*.TCWJ/<I(K+CS.S=/X='*N+I7-P;$=)8;F%/VZ_K ],4=P0V'^V"^S?
M9V#_V2ZPOSL$^P]!KJ)KL=6#"J8H !QLSZ4*"$PH:5O8B/'']>N]@)<8'?5O
MOSLXB)+]Q7XTL0CA8PJNP:#V% CK.07C$:%U"T$\?FRL"GP)+GTV;T6%*"K'
MR!BV73<_L,]0)P.0>#XPF"-AB/%(8B#J5MA"=SQ7.C&?5O!13I'>Q@V(V$'0
M#6>$$UNBE#'GH@2V^,/Q*!A4W=L*6\<@;;R[\*9(NX3X/4:"N:L+&#R-?F9=
M(LS/?_ OY1B5L_B[#(XM.)0%6_4%7L(G:TC)&["TLZ%GL&_7>4CW)[=Z4C@V
MJM#7FSI7 EO)^G@JO/,E*"TAI<^3-;K^?/2CE-)84KN!VLPP%+_*M(4RFA$2
M'+0RAYUOVJZD@S#: "I?QJ!>7I""^1UT/3KOB=;,JRL<H+!ER6B)'_S6%!>H
MI(7T0P:ARL&](+3L7JQ@)OA[V+G6;0W)/8N O:BU7^8^ [ R/3;1,]SARYM4
MRCP#9Q&,:AT#UO"$D8@G!R <W8]#4+[7FZ; ,E")]X,6!MU*K BR-!(=48+^
M*N5ZK%F)!8%M0@U7U"##>V"&W?8,'PX_!N:_\[*%YPB@K*.S/%',:,F!9MX>
M4R;NX-U 72TZ)1FE*I\>6*C5-39QZ>DL*REA>PG'^'HT4^:O,_(AU>U1=VVM
MP#,.^T<)7E]+.T^[&T #3#/V:>-H66:8ZESBW%R5'!+6K5U3*/0[Y1E1Q>N3
MZ"&\1]@I*:W!5E>/$*9$D<LEK"'%5C!8=6%["W!L"+]P4:<D+9=-9RF5.:F[
M5(+!=E0H2&(<)+]@Y!<7<A9Z;4 4F2H]N-KC([OE*JN:%6E1+JN@!=E!4?_R
MX<-^Y2J'<X.Q$XL)\2G6Q41U;;N<=1G:?PB@KN@^PFK<-0[52V?&.[J4KD2:
M8=@A-DR,XBD5$W5L8^1+W"!+#O'3GHD1-FKQH!YSIN3H6C-I%S3@]P9M$'M8
M:2,XQ*[3B<WGJ%@:/V=%ME@M=M+ZUTDKUR&\=BP&74E]I:5<?F[$<28B]R@V
M/0"Y*["PAS"X(MJ;NA\$K!DD(0AOO@VTV8_U$5%!V00 _T!$^_D7E*I1D#I"
M"HG9$+PQ4;IR+T?[C=?.ABVP/E]-BN%*&IZ.S7#";P-!!*GZ<(3,QVHM:PK)
MFW#F\T^Y;VA.SU<5&9#\$F+V7SU'$8.B\G(H6]U9W09N+B 2:VZ'#XP=CSSF
M9*1)D^T]Z5?YR71ZTE=*Z0XC02_/8\X0Z'%2AZV0+$OHQB5B  J_<?NV4KMR
M?=/QNY42Q0'HO3H#<>VK3Z,D%+FE*!L\4L]/"X=K-;GWCDGIR_.ET*<MW,EX
MU!/;]OGOLT*3H>AGUD%?IL#:Y_(Y$FV/OY)7P2>5<:'JZ9IY/9C'TQ%K;I(Y
M1Y-SE_UNX/%9)TL6GD0$-ZK* @'R%J>I5*7XBY>&<A38XN=]!>HTQ OQ1 W6
M$,'Z7R+[,#A/%1=+,(,QV:,W,"5,UUJ8N$S6EJYP+G.^:1B>X-TTDCXL$V?*
M[3I8N.H#.V)OB,Q_M8O,WV=D_JM=9'YG/O:;CUR_]LZA8$[ M <5C<RE.[J[
M_T:B"J*[VV#2(_,YO,#)MP=[&'VL-X8?-T7S42BRE ")7C _%@I8.-I+#N$D
M/BB6G42Z0U&NI&&UARVKT/CB=K(^X$PL\#X7%7X2_(T">@72^3DK,AXH"\E?
MVQ%R@\S6V<=H\I4CZ]\@L5V?;4K!-R(P(_@@/$6@8>Q>DKPRC)M%-I18"14R
M K]#P]Y%H[M]D=U-6AESZ(=&R;!<%99XK9SO(<52F3-F!VR@*B/+^AQ7[+W#
MLN]KM!9T]^!%J+TU>KLP"<)%?#R\30_9;@<T5T2QTB8FKP#!:8S73\V4'&+#
MYT/=:O&&H6#!J&92;%K&EA"1QH<_9@BH A]C:2^"#J6T221J 8J%$=E,[*.^
M!Q2$J+#)T1Z#83UL*0':8X<\%>: R@XLJJ0R1Q)-^+W@Z\$=Y0(+I!>+E8CL
MBE\[VNHLB^K=T4]I<'Y$HXY:(/GVX'T@J^.T8E+[G,&#MD\UI?P&7P-\.'FQ
M9[MDV$6( ^"MG;@4!,A,/8@1HR$Q%MG@Z.H2V_[,5UARPCNW,\SHEJ.DC63)
MVJ03M?Z,*Z/9C6=7FJKX#/<C4<X*"M8["@LF G3%#S;_T,)ARCM8L'_M=;(.
M-BZ!KTE;U"*_. 52#ZV](]29PJ Q1,3:*L^@WLBR(E26"(.<5<A_%G/KN9;6
MP1(#/DZ]MTP2KF]#24-3RLW.##<U)3SJ59FE^DK2<C458GK_3<E0L,@MK5O5
M%S:D8&E)8H^41$)K"#,@A+"-)U@^0O=[?@@L#"P0QJDQ(2(!(0H+J&P2>M4T
M36[)_\/Q72 864A(*.JC'_0/?#RZV\B[$Q\:N)3=#*K=FGM&!CDW>U#AO9I<
M:%:8VCXK?@,[26#Z>6;F04F)Q\&VA$E0Z,TFE_1M*JP L7VI=RQBX$C49Z36
MFM6PZ,_BED^3!?A>.UMJ6Z9%[8W;I6J-CU"/&<.D_%'HY7E($PYQ4RM2QJUP
M">H)P4BC4RM2@C7A\L%R6-X]Z>[>9B=5_V5.\=/]QP<VOYE4H#1.8:6P>0>>
MQ#?4N9(L$*3,TVY>]%GNF("QME9*7_MIB@PNC3:P8PI7)G)KM0K,[( <"V96
MJ;@Z&E(Z)Z9)0=2<::;9=RK>J(QOTF#CN80DWC6DQ<N45@<[.2' R-B#2<M<
M;C=/*@9$_G/\,<'8/%H:,ECL>)'6!?OSI&X8:%82PJD&4]S>7*GP^A!Y'@[P
MGW+@VZY)-'8N G4<CDB57JO_TEH]9//L8<,?C_Z\VLGV4@>3IN25X$[F\)8:
M2XAD:E%/Q)U:H15A9TSM@NR3>?[F(\'-+ 0DJP)9VRR_R%-N!9B>.'7%MB*H
MTBPQX,+TU[\BDH*9\0!R'0,&QS8H>N[5C4<=R;]IX_8@X!#Y0^^2"T5F@:F)
MU-J\FVKM@-UJ!PK[UZ]-<"5)K0*DF-9+'.V@)!M-<93)\MK2,JFQ;O]DJ65(
MG-\(CKKLD9-Z2=V";/E*5FQRDP+/X(%%-V](JWR]2ZO<9UKEZUU:92LB][R2
M!RC,+0&GS[K"<:_<AB]^.#I_?WK\^F0\^A>HFQ?WQW;X5\_KY<FKHU]>OQ^/
M7OP[^N7-RY/S7\]/WY^<O[O72=YH]W^6J:D$?KZ)_"7.R^D<D?,]4?7^ZHUY
M@A"QTA&$$*0I63O8H&,_\._I<*P:F6A;-,Q5JS76 T]0& ]%'2>N>)[0\E-M
M+:+IH]3,$ZQ[D?FAK=8Z[*4ZIU5%Q"'%O@(CXD/$? 7?.0O;N_#-BK)XU/\]
MMEFA591>Q^3"M%H<:H,%Q(8Q80C8+D^^ O-F54E.@*.M6.Z ;+AP2M@N412Q
M#A^HB0K\BHUUN["='AB,WEJ@C46%KVS2@D?&+X7BM/@V7'<-*DQJ-PZ(;WCS
MPPN(HPVX8E#<0G%@L@=I+DH#]A>GO_X)8QSD7<BZ!GV:;KU<_9.RJ\.>JEYM
M,>6WFVC,P#)D]1:Y<XT['&*W=TG;?I&WNU3^>14HNAZEI1$V"NX3<GCP/\-[
ME;E X"IV .,!*7/A18&4F13] ,-UY&LJ.Z(<;Z5L/Y38<=X[3[$>G*/K88IN
MO'U(\'J\6FGO8\ED;=9"GRR,)"_8N^SFE^9#^3L>_ WOC%]5O?E=Q;TOJY7N
M"+<'ZA=XB(6!VD P)Q&8)#LH?73@.$MOT=6M&Q2@UZ591\9!1=L-6<,'7'9&
MU4U':-N#@OS7J:2(]Z-301!>V:[ NF[2H'KC7DM\G25,7OH4,,EXY3S?U3\8
MU<_'1M^@!K5G$Q5V4-E8[.TNTE$X2()=Q/T]L3CEV7?:$'?*'SIN<+ V)^2Q
M**OS;^-LK4[&08-B&(:/!7;MT\(B%AL"8:_>I!Q](%($;>CA!S"TF0=E,#BC
M+ R(R,"C#/-<D><F&+0LXKR*)*^9I]AKAZC1;G<(4#;EROC&07O3TZ'HQ+L=
M%+>_XX92[2A57S/&/S>@\)""W9_9]3J]7]_KSY_**7A8/[\Y?75Z?/3^].V;
M;9[-EN=0OMH_%-;_U"R*H,6F+5,0I<P)E7<N2-IPO:8V/7,GT]3DY76+1M("
M[3-YTMH%/R^3:I&;NFZUK>0C#VEA$K(OF+=3>3SAO&RG;_AXP!,]FV5+I=BT
M*07.R_>VRX@F=*_$PR)IO\OQB!M>>A"D/3<JOE.8TK$I^AB?F\TTT.O:HMB?
M<UVJ:P.(_+Y>,X2VHZEHQK 59S1QHY:F#;DK>@W&+6X9 4A,4D@IA^W.\ZR_
M-0^>EWH-IMQL097?_$03($KJ@$<7F!^P"/90BCF-$DN>/O(:$\+,DZ8NT?+V
MZFI[D"=Z?W!?\ '4:]!BGKS.N+:P)>.R*3+(..= M2/<%T\Z:U*?&C/7NGEO
M)C!L*36)F;FVF&GW&*).+LACD/<B=<]V)H2%H8%A1H>>L[+'L1S^2FS:.9';
M-9;PC(W7<FGC95:E0G3@,U+L.6.=O!&' H0_%V+_(,^S335Z%%"!+,2=5Q^X
MGI0M7&$?!ORTH37#GI_)=8L[M_*>H/UXM?,N)4LJ3F&&"X>+8(%L]%2\<F5"
MS@;E(^7OP*%S7\ZIT9O0DU!B+2":(MY+N.O9_]_>M36UC67K=U?Y/ZAR^DQ!
ME9H8"+GV294!I^,> A2&I/,H6S*H8R2/)$.87W_VNNRKY NT:>Q$-0^3-K:T
M+VNOO2[?^I;1)E:;E/J<DLE;Q<9(?P.MBR<+M(U^ -=G6V;J1I"7LU&D'=@L
MQ6ZW7'6KN]U&X>8[A?2B5"1-B].TV(F[(.0@NR2H?;GK9;/1OU,\(=)O$%^$
MX^24_DZA*28$6JQ[%:N\;4F)&&@R'*K17!0@%ZJ[J$XP([A:.A1PNR"+@#D!
M%]BZ(<\:^.Q,2&Z688%#OVFJRD]J_)_DRIFZ\AUN%C91\53]H;P=,\>E\ R>
M#KL3^8;CI@EGT)=X)7%9C(!=>@3>N1Z8\29S0-!ZE1O:E#&]QJF0XS!%8#C)
M$BK><G[*#I+9Z]KJ64-\<G?.?IKMMMV^VHS^A4$-,>Q0T3>=@K0E@L>!^@*>
M8N@M*V34K99ELE-C,!((^DY&"U+S,:P,U&<X0,IQE[6!@]_ (3+?)RZ+72>)
M^ A<!(618/*[&&OSQ/4!@0D^#X,X$]("."= U](*&CKY%MAN0<S)$1?#'44!
M 3 G"9A'1K]R*7-J4K<!'Q'T^XA=4^R2#'S2$09YD,PS<\3$2>17(3>,.(-Y
M%_7IYH&;3;BO0Z27+5U8#%\847 <6TDECZEX,1A@/H^E2#42IW)'J5MIPQDU
MRR.K4!?X%'U859@$.8I(>6]Y7^RE(^1BU:U5);0SOR?WFRZ4^>O&EG=AP'R)
MGE]=?U;T0;@&1@0B3K#FF[')U/ZQW/'!LX-ABHIDMB&(FE8:@E71">J]EU=!
M8@ >/E9EN,:.PXF @5_&-]1$,#>X[LDTQMY2&1<WW[&85@\5+42V6@LJ_8E3
M-5VM^A- FB@7:HJS 4RY$V7]>X'%=T5.D&. VUR;A.71^*_"""'C::<WSA0>
MR%GU(QQSEI$W40JA^:#GM>:!,#(+ 3=OKUKS0'9*%/.&$)_!]NO</:A4$#%3
M4<]M!:)L/GSV)14?@1@/TRZ7'$*I>=ER5S:@9=ES)1?'/?-*S'+*;208P2/]
M.A./C>4RKO<UM<F#9).S/5*B#C1WGQ20\P22D8?IP1^W_? <Q-#K&C&T3,30
MZQHQM!:(H7\^HDBMA[#Y>2CN"]UJ0D<]H" -J3 *(]IBIXB"4I@+$RIE%>ND
M.IA*1]HZP,6)7G1NO\Y4[F:+!\/Z\2M8,O&3BH&5AV59@W(4_I1^ 8Y+)GL4
M\*T0<]]B:54@VF&@J-<M) 11_XC+Y3J2&3C3K)+],4V/' TVC$WB_0B/1(80
MJ.E*)^+'(V\CM\.^9D-6'38H&VXRP^BLF(]L-8ZIO"D!,^J6IJ91,J@'L>>'
M;P>OC)TRQN0M39VN==E "C"\<NYL_^.KB,2\S]2M0Q7+E7%'N0;RM[J<I&"[
M>*J1Z[/]N=ALV"Z#>)6S?>X0RF\NRPNN"EJ#J@UAB,E3*8CEJ$&53>/(FB=%
M34:IRB]6 !>.C8=JV,SR)!R4*Z'&U+AGOT*\@XK)9#8C,H*AF!>(<G/*1I@8
MZ+4@GZO;9&0J9<XOS4T2.VR S@)SS4H',!YE&+U1]8NG)[5ZICB.]D:9Z+:T
M8@ X<X$/9(;.6"++(S?=P<I%VO05:ZW4J%R]:I_^9J/R#&#\(LT8W@: +ZOA
M54:A%V%294ETEULYG9(*V; K_X1_)HP?*2:;ON?F:60ER505(#:T#R]VA'I&
MSS2G09H1,E:AGJ$+WO !-[.X7IJNL0U6,17(#?KI325_0$DPA,BB?J9/%1\W
M1=#,"E7S52S-4K'KH]J/;')GR>S\@SD2ZS/\EUN[L]*W+!QD@75<YUCAW/#\
MPO[^E<9(+[A0MM9\@Y#V6)6VS\M\0F 7JL%TKK,4%OA;.<IF8Z>E21^-1-7?
M3%&&43[(XKZ.E.@^2CJTYF)3T<0HVY' $<B)2;(GL F[&V9U(SBY&<+A*.:4
M2*']5; _PW\@R.K\EQMB!1/'C;'>,\1JQ+<UFP4R.&)W-3?,[5?%N8$#8L%
M=^DZ*H>WR]^IC&Y3Q*]ZY<7I>>REKXAN&RN/@U/+WVQ,6W\$, X(W*Z<.7VM
M9M-]+"M)+*^^U#)"= ]86T;MR/W\E7KP8BPH@T2'.M/K]*J=SBG^9+E:P;['
M26V&V+Z7X]EPLYOZM^0(:H3*C!5?^&65YP!^HJG"&19B93K+-I7]&T_^1'O=
MNY#]JEB1OEU;K>\E<])#4#&TV5AO">SIW\V^LQ/Y7*HVS0=<,L!]B5E;FJDM
MU@_&96,AY=UU(>AH1<-DL3Q&E+N<:]F=/BNL *>[NA*0;J./K"F:[^1+OMG
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M_?H#R:*?>=&OU]!Y1!P3X27*T"H.C3X/PPP)EA1Y+H\\%YM*6-4QH5GQ ;Q
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M@_D@E^WN1'#59\3U:129R$3CTC,4QJ31UI*D:DI'W",Z_(%>4+B::QQ&)$)
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M?>NBWD>%)Q>]&ZO?Q5>=^A]D8-GDO->W+PV2=A>N-&UH0GXO'Y/>N>[GT>W
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M+]3+=4HZ^+EJ!3_^9(>;5\%6ZVZ**\>'GV^,?X'G3/])'OS+/?\%4$L#!!0
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M6M:./>ERQF04_X%YQ";B L<W@@,-3ZJ@@(F,J-L?\F@2Y3ET^K3,1I^#<53
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MHD^"D#;1/H7.ZB.,)Q>VB7-T+1\4/AZET,"(:>H(YB6+S,]_-SKB_;:!7<?
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MS1;B(8R^1*-Y2=<D;!!#<UO *XN)&C%Y;7THE$<\CJ8IJ/FU+_D:AD6!5V.
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M^*Q9G,KWP(E;PZ!BR4!K,3E[13^HV9QK@).:+'5V=+BEOM?P:)B7Z^)&R'V
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M2GU/5H!/[1[UG').*4]G&U?N<8,3U->+:KA;FC21%V"$@18,PAQ#F34]T+S
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MD(-W6&-RDQKPO<'H9</HT8I5_'CO^. WW/Z/?SE[_^[-_P=02P,$%     @
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M8I!B&TQ)P>]TY@Q02D>-P+7:_!C4YIU?!\8)Y8-GA&TN>?9Z5]%GI<T0'0Z
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M<&/L<ECDGVMB:8>1R:B9D8!1TSY$(XVB;:*Y PU*4<LGX+>BRC9.BJG3C]J
MAH4<DN7$*,_KXIB'&'L'"BK'>FA"P\80=RT^W1XSJL-(1!F[X]!)S384U3+.
M\$1JSN/(<9$QX;I1-8>5^4YR3 E 1[EXQEO(AK&W0CHIQ,-&J$B:Y\Z7 1-H
M;2L9N\X<#F/7.*68=JM'IGEIJ=\_,!%IWNT&U$V9.S!OZ@N"HL.1Z,)C 0IS
M\3*F"+HW2Q<X-(:"+B\I<'?I(BH]B,5VM2JA!.1,7Q9SF2S49\59VX+HBC6H
M?-EP;["*P9Q\J5 ;0N,-4=%PTH7$QST,.U@B,$FN"<<YZN))OE54T;5*P38Z
M5RF#@Z?3BOK&SEG3[KY[\_#D!!/=I4W8CXBK^\_R+,=]W/' 'VMAD'HH5X2K
MBNGJMN^_?Z;ME(.T:NI%K"(OR?1GD8]#6#&;Q]!>FN@6N<A^[)':*M6%<QJ.
MAV47>_G"%R)XAPI-IH_,V3 6G[YA9H0'VGZ-8$U_><B1)10$.2$6:D'5=-\A
M+*^:SBH5>P4Q78R,^[]D3D276!</O2HUTA0?X!1#02?@+A[$:H2R:CX_7=M/
ML,DHC9I\JHYT&GGLE(-M'K"DQ #9Q>5?Z0)3V#+QTU&#1;"PC!'$+ 21$A=-
MJ1P0)"7OL*Q%-A_((>32(\?:<X8-M;5E W'"JZ1L*,W+DG!ASV@J@H[$RZ!&
MY,9V-)S6** DCY6K6^#5251-NT@JU_V'W7"C"X&?QKVE'@K"I=D9G,^K?H\&
MC[B-= 0D/\+J$9PUY^B,,$!"G:8I[RZ+?Z(W_HO:4U!J&5R@<5?LPLMY&ELU
M2^Z?ONY=%-M2Z^7P+8=UUR'VN83K>OMBWC)-?;D3\^>M$_,ZG9@_;YV86R?F
MMRR+C=3CO-][7;!Q@>TP1=,I@I-1D<S8X 2"&]M'2O-(B8_X#=&;SQEI*WH1
M,5A/E:UC$E.L7@Q;_3ZQ>\CH:Q@UK(%9"ZN&DF=T"G&..KIAFX^5]%Q2S%)6
MOXUNBSJ"5-PZ4)>^ *?7,^"WF7L[S#4_J9\1H\(FJ#:B9)C<C"6=L PM<S(@
M$,$>I*WY0>3.YB_KG)V8K^#0)O!<OW<:?9%TL4/I!R6^'B?GO;4V5KI_:.6*
MBF(G=1U3Y^BQQ>@V3ZRB+\:;00W#R4=.J/,TC1;UU$W#;X9>RU!C_,LU-0LS
MC:Z6];<*.8S1\MX&(Y%(<4=.NEQT_FM!_Y:HO^DH/[5 KV>#/\=#T4%L/  X
M&?CD++]0(/7I@T!7.1,+.S?93BU5U5SC8F<;R6QLL+M]_J$?L[DX4^2<D9B.
MA$.:UBWZWG /G1SW/4*!)R[UFCJD4$\5VR+%;\WB.Y3J./I3!-<2[9?Q3-!#
MH=V0_$)=)6[B_L"RYU/XWQBT^D0<BF"%3(>@/"NT'C1E>@3ID*&\V,M7@\TP
MZ9CX;\UG2:W5C)I.??]@B^_'A+Z78_=0P=SK@.&G@G9X[5A93-CN6A_N",UG
M"C8:&$9)B3L\2E5$*&8Z!QRW2>P:LDRY/9]MNC?HF#-)H2+/P"Q:'J';,O\-
M6=:YA+!>@8%.ECD<YWZ>?RZ;97@4'D)'%X.+H592HIDJ)0-#_!97/7%3"](T
M\*YFF=*N,]#.D$V5)MC+=[X5S 3XW=:NO<2N_65KUUZG7?O+UJZ]"W;MS17A
M*X(=\!V;CC'UQC@?6_BM;80E*<_X82>S9%6AV42K&<^WD0O&F'&B(N[[6M,+
MO&ACJ-DR;*'1/3G>*>YTF;@V,(VVS@\Y$RDQ)1UUC>I,9XTNK>3PRN-VJGRB
M2.DQH:F:*WD/=+X4/?*E[=[.:M)[5908UD#+%\4?Z9((5X1V;?M; U$3VTNW
M[5!26B@CN$G^>U55)$-.V'W/,$9N.', DD\#?V4*M=4(FY[E%V2]8U2P-&E,
M^^:)X-T%R-GR+)DY9.5!+U/SN0'';4S&;*Z[DDN>M E32++P98&GQAQ;E7=4
M%IR=P8]:-L$D3:&;7CEQ+U)+.L9?$1FM[J%W0GFZ;3/OF"FDYD:6,$.9%FP\
M3HOC*)=N"[^_ [\-<PWJ?GVN,J'@1)9G-@.OXX+V>Y=NO*73VO;#']IVWY0.
MVJD5:%>!,"Z=P.G<F1P6HL)L^:'*GZV]9 X.MQ\V<@+G)B03>!$9\PYO<P]-
MO!9,%<E0YVYFSK<#!LXRLR_<Z&:4YI-\;FPJYUNFB8=N5KC>/O=[EVXTMEG%
M)FB!Q_82#;M=CQ>&?HJ[I@.;\H5U;7:2-$7B ]HV'6(*>SI"D'4Q_CM T1X^
MQF[H<D0PQ[,H T5B;U09 [R8IT(HA4%M+SW(]LJ)P2457R5@JQ:DK;Y[C:0$
M <OW7+GU@+AN:*+7)1>7,A4PIMVQ-N(CG8NS:3F@]Z)E@NP"UI?HOBTDE=%G
M0;O@1FR'F%F3-G:7-@.G 9+=%942K>^DO"1KGC$+1-V:WN=9Y.%2XLOQ02&<
MNC/*3"B4;!=6Q#:O9PMY^W(0]^!R3CY@E GM>.O@8;7Y.?0JEP'/(8B3<E2H
MMC0/?7#4OK?4/*JU(K>>=R&8+TWY[6TLT<M7[&P+W_O&C>WWOF5G:Z793DW/
M"CI$6'>_Z7,BU3++W?0(>.,YJL(+$1V4;D;:W BV(AHMC*/6VV<OCY#C\"YY
M1R8$PYH9YO3,2U+6\,XHN/'$>SA]SSEJ?LFU,SUI]^2DQ5S"K9/,3*[9]M-M
M8MJN7(16T4<7<H&\BMIYKOD>SB$8I^Q]ADD)A$XC=6&:EQ6EZ)F"T63$8B_#
M !*W@V .Z.2'O3()<"'7U$HI%;N]0\*PB>#=A 3#[YX#*8WPM?D<#HH\M[Y/
MGK!O7M6_5TMZP63*VG>J9CXI%L%2F)#$[TI*G;.E@N2!7].CHVU4T';H%!D@
M4;>%5\VT6])C55\=?%_*H Z8528%?5^7'H8S=.=_Q/XYVZ%X+=)INV4=MA\=
MO%'$J-N[EZ_5I1V&-F&G9ILV]*_5%-PRT>E7,5<@EI:1<H1FG1VX<!JAL.7N
MY*@N9ZF.M><(O?]ZLOOKKW_]Z5?\___6>]%VLOIRM=&EUUAFR8%XD;.._*/5
M3"LW,4V2Q.0>^HE0(5U\P5I0G.XH/_M2J-]K-65;^OWZ7-6O^%S%.DXR:OM'
MD3/)M@UH^^GN?M_M;]"7M^FBN;J0.2KM"I-=LE,:4"]'W7I.QX2ZY6(WV,N<
M Q(=K&T/^SUG$TU<8*@<S#7;>_WGAX2 45:,@$%=L9RL>)VHN*S]^&GKHJB[
M(?=[MNP(5E56Q5P:K228G(IB1$<])1IA\S-TH2]\*8'C0<:+4;%JT06([NTD
MI:D6!9N?7@?J8$<,!JVA<=1B4"_PUOM%<6*</"*B:7\%40I:@4C5EQ$SFZO]
MGC4CN-A\BG#2K-9PILQ\)IL"AI9"9Q*",=!U+)-"9U/"=H.D3[E[==V19XT6
M/AO[N]<$4YLQ]6,B:F/P''@=S@!&M\A3WZ,6[I;ALBZ/\OQM&^6YSBC/W[91
MGCL1Y;D9I.R/+TT9V6,.XF X'2@;H8OV3&I>>:THT[>'DVT^@XXH9B=FTT%"
M=0TQV_\GLS1I+^X-/806D/&I:CAD'#61FZ?.$%\OXBP*[GRLLM@+L9'P1D\'
M>L&L08/"VOF]I!9N1HM$8\C73PO'D2ZU$+GYR2E^<DPQ72"2.&\FZ!C[VAU2
M9=@]'9WG2:P5VCB?#ZO0"4+JB([8OEUA'%7/P&LW/$QR[D":=Y;S(>]>N8K=
M!@H5!0HP-[%H*/BAM!P<Y=,A:#&E5]N'%7/DPL(TE@*U<CZ[$NEBL,;@Y13!
M!-I&IYZ'YP/>CQ*'!.TRC<J2H1+$U^<9([5C\3=Y%,T23%[CB=8-;/(*>+Y!
M]H)YR;XVN=/+"XZ\A&BB!6,SJ2*J<@>X="7OR@Y'V,C<1Q-D7BS,MNCZR2Y3
M2ZIR.:'ZG%SLGI^4?>993C[%M6>VW,"S@UI7J7DEV?=4D;Q:G-(FI(("SJ:#
MC*5;MG$G=VWB=N*3-N*%_&8.,X)YQA9!S$:?DT).&;Q^XI5C]6#?'#-'0HVU
M)E]S9SBN23BRL6 U,8DTPA=.)EG9VE:>G<8.C_08(G7@7&-6_9Y]@&;6@'H2
MGL+>2V8&D>:]A;KO7\D?Q$K9_&4-6;;/AR5I^97&ZPC> 3E@BFS9"6M@KT@[
M] ;=#(I ,+=RU %7HDT(E"?4_!U9D4K3DI-QNH+<1'0\4;>&I.1@P(4@_82>
M*U6T"#'D*THXQC9KD?:NR,74EXXC]OT>4?8R+EUYGL[W>C(6^*2E+-]%&*E5
MQ$0C2>,VQ3CD;X$-L0E VN]0&RRL<<#:GYO%.2-;'BW#QKI#L#R!E=+D65LM
M^83?8MDZ19^!MW7S]QV=YH!S+F)-7:X'Q14/[#5R/.$<7ZGG2:S@[!RTR4OM
M"\<Q>;<B31<(&@_*9V8@"R;L>]>>2_+CZ_X&[:>3$\X'NECI[[47AW9TUQ'?
M3II=^X]@N1S+=>(0+3,F!]NRV08[]7*+H+7:HB7EK1E%[O=L\;(&G64A0\I9
M<WA)%((E@HJEA9&0)#NF=9SPTF!M[<YIN:\=M&XMFC^UMFE9&&=:[@[AGS0S
M3<RF=L89T821U;4?0&VH@6VJO7Q*1E^B6XL[/%0+,D0T%<@VDD-:JGF0*Q-I
MXN%2<!)M)CDSJ4?A$^%,E&\]E>OKT;?)_IJOT@)>O=D[.?G[O0.55M&G1%T<
M9:4B+?G>5;ES1J CP'W7J_YXA?OYOLA!XT 9?.":[V:#KW*LW>!@3D4_AN+K
MP-;]GN^4T" >M3!UC/9G00QTJCM3-IP5-?\$.R% D5#(63WM102O\\" 6/BE
MS#[T[.]J7F2N?>MY359)*ZQ/F*#SM4%OEF4UJM!J4OC7&<MJ.Z7(; KH83.,
MZX_'8<-X#YT^'&#CXCE,!)L7,\NX_,[YF*2L3$6JM!SPIX&/C.02E:^(M<,'
M^TV,W  ["A&;-(04!(IAU-66Y#*AXLY+"U"L*>N0HBZ*C?,ZR2W$$->E.MLR
ME>&*5#87.N02G:V5!K]=93-.EW:=K;'UUZJ0]7M&(PLZ%3)[FA)];Y+'=U;#
MO+%OBQ)6OR]U%4RFUJ6)=7M9I;ZAIH@M&6Y@<PILHF'S2Y<K83Q77;=M8**<
MAA-W1R>[74Z;Y:'E7[>AY>L,+?^Z#2VO8*I<LTY_"ZV8JVMI_'J>Q=&4  KZ
MO5.K&NH@Y9J!R9 "DUZ,B.$IT@6G*.G?2#O$U%4T"S@5EY.P'?6TU&[VDBO!
M%47<.#.<.(-Q_[M6!V4^T5BD:+EU>J%M3F@JB"2XB3[=!%2E8C'HG+(_'?0&
MA4"'I-:FR0@!05#N:)B*T !!A)R^RA+-M7@(B$&7'1"R)<8-<"\K+A<2^)&6
MG&H4Q60=V6V,P-HH) VV;3=U:-(Y%7>!H0-8.*995QIX?<S;KG1V.W^R(Y4-
M!BW:R9?V]YW:7&A%V8>;8QW140SK_CG=.975'71VVXDY4X+1DL($R\:M!ABA
M'>6.2QN5$],Z,!IA496-(3MS>OK@KX9.Y3C<D%XM6-[OM3Q_GE/J]0PT40-P
M.^+OZ8AZ+;9*8=QON$E@%3N''[BDV[0JP>(H)E&6_.D$J<0T-I^U9:[RY<&C
MG:=EK@.N]ECT49.);NV!6NC>AML(5507 ](-=@XY7O%<.0K>M7MD$J_)B(CC
MS*=3+JT)C)'/JS7W)M*=<NPM'\Y+3 ,HO1B@XU]H]\='M0,)&\?!3H+[Y"2P
MC+'5!S#0!4+NE<2GN1H&'I8:8Y@+*LJZ#4W[X^)_*2^[%%VA\*+MB^[M,$5V
MRZY'L$.>!==[X4BRH";(_(B2A(K8AM.1O.XLD1:?11O(/8690]L^SP?W[D37
MM8X$'^BWN_%3CJ50A7)1JSJ6;MIBM*$<7QY)PHOA9BO#P;2CW04VGV:U= B>
MA\W=139"9%4'&<J+!EM$X/?$]"0NY\4YY\<[7[-%^CH(&U&Z.@AX)2^N12'W
M4M#7,5$"QG$>\WJ1\Q'3>:$53.TX7#.XXQ XU<7-3EYAARQ8]+*JP78:63J9
MM0\]N.S,_8(UNKS&.^)#$S:2-I;E"D4SY.9%4DM>T;4&9J$=)P<ZB=LOU*()
M=SQO[Z(/$H>"@9E\,Q/KLKN7Q7X9F4E>%U=(R_)AGN)]Z)QG1L(!^]/2=*4@
M0<KPM.^":TF!SYRC<6X.)4Y0<4-NAQ(;UI;9AC8= U*BXC+U#//[I1+L+*<U
MF*KXNHPFR6N4+_;RF>9GM+#.S:QG A@ZX>&-1[@QAT[Z2"H]=FGE0:</UW0C
M7GKHA%#M-A'$EQ)DM5/'!GI%P5H')Q*=&WRY9:OWE6NT5S3S/$1OX*(%J:/6
M9ZE6J,PR(?0+J%U;#Z;*@@8U3EP4J552=/CX =;AE!P,"/726$5R;G<G&Q)/
M,FI:A>,WUNZ]MD+.O-&AM^/M@]#MR>0>8I%/72("SCR+%LV*2 -P2A>'M$N#
M=$J>0?)/G8P0K+1D_U?;]N<U8 X/^:*K\#IO]B1V-Y:329:0X'-3QA8&XO;6
M.(_+CT1@$YQNX?4J7J+=//622:@A-++J\T;RK?G>?AYQ(_@#4KGSHFQ1J?*,
M0A2MN7OFW+KN0+\GE\#P@6HQ(XT>B[$H.N=+?RF(-8_;9,F!N2]MIYPW(4SL
M04H)EZ,V<N=@AH,AFUG*R@@L5(BIB[?6]%VOB8:M[NIB&:3*5V<:[,)?O@5(
M,-M#?;_+FDUG[)5*AZ1(+='O[9Z[D0LL (4IUT^4A5TD#)H^SJ52;E27>6NL
MW;T!XWF!DPT%,"/I%F6U[<85(&WK4T/!A8?&.U.;W'(]@/XJP[9UE:CC2I!]
M8,2B&$%>^G63]WM%@>XZNN66Y^T;7+:,7;<XN7DQ6IM+L_+1X'">8D;ONB_O
MZO?>L:&"RA!U=LYCE=I^-88/R%S>?=)C:N11?.U^FN>H7D^\TG*CY\0<;F^3
M5E:T]'M=;)*P=&1Z!J6!L1V,!H8P"!'V OE\?XSM(+ $L\"*?@K;4\$G L/$
MCN3YN'NR"^-(UGIADITCP4OP!1#)YZ&J+I1JBHO59*<'?-&U6 G> :DXBCNW
MIR+PA8R D G]X3Q'C3.5@A [U0FLJ6);1_<78MW!^49H6OX\?%#_&[ER'@]X
M&H]_?MKX*AG;>*#41Z7$4>[C%_#$&X3SVZ?3#EK9<8AECN_^DQO-Z"$9JD*<
M+_T>MK#*BX%#5QU=FYT;>+6'$R*.!?-7 @[A'D[<C6:FFX)PFWA]MUVT(Z^
MX2R9G"%]?OI][WT0<]H/S99I;Z@F248:3'YIAVJ-/G7%E+@C<>#EU[:3OW%@
M."K21!4<DU9\_5H6Y'E);#<9 >584MD08SW1 5U]H_*QE@W'A#?V)N]P<.K"
M$E'G:\)K.\3Y_JD*+$3GMCQ#X$_YA13-^VVOVU0B+<"H[@/3F3 YRT!@8R:7
M6T!A&N[ +:369#K1A)V-GF@=N,IH:KA(,@C&J"SL:\_J 1HB[:>FVQY8;#IW
MIQN*]1*MH@U;DUL-BK=#)+)BB;S,F@U,@R]/P2/]FR\T>[60\_ENJKK@]_Q3
MZ!HI83W*A7IQ DAN%ZZ:ML.=J/S</DTW?##N] _RT9SK&%;JDMBX)7[\1\!O
MC.N<WDIZJ:#G4SQLI*S38V&["&+$H6Z[Q0V#I.[PG&>. P4TC&@Q"%9RG_&N
M^&9U>P>YSDYX)C+"F2V.7A1I?\FB4\_33;)B"KE%9O,2PJR@F^K'#W7.G[.E
M@=U1S<(L.G]"**N>DY&J,VM*2[,Z+6^I%*2=;.JJ K<SB\@1Q?=EX%:1:N_1
MI?EWK'9IKZPTC/[&RHFEOL[5J"1D,M']XLS;6#9+F02#\?G#\0,&"LR,T[7'
M.P@N6D6?J:R0HMUP&>>9;JO-+L!^[]PU73MVU;V22QW(FBV8ERZ;8>C"(M7J
M8/REF&S]VF:P[6SR_UCAQJ_##:\<AZ<"7IY/062VVQS=T92Z0K%L\0,.+)AK
MTL61EMPVS0IV^SV#_^4'=(SS?*DWL'&MK.,\CBT"#JJT6GX8MPR;3$1BOLLB
MV"ES]A>P?9[%3K*O.\MBK6T3'9VT+FKY8.1#(]86K")UP-)21>$83^T+U/6J
M8V*\9:4BVA9M+WC6OK9S&ML*/]4^(V_VO_*$W*)TPK@HY+8#6[[[3>_Q(? L
M])6Y&KR+''LD=Y*;5*#7)%0NF8_K38SWCE),4)]838GP!VRJ%"N=K5DYYW=3
M6@!EG2;-$VN7+^OL=$BYWQ2+Q=8UL889U*-POCA'N(@^VF *&J[,FA<3_R[I
MJV;/+M.06$2E M2-*J_C=J-Z?9X?(@#;AC31' 1<D?RIXF5Q11P_Z6[%)#TJ
M25G6@W:JLL#3D2V4@<=3C[($]0\;W$)S8YLN2U_<YLM>9[[LPP?;A-D?M[;O
MZCINO+*>,J[H[_?VR."W'[L2SO#N6B,[T]HP(O?O2#+#W,\>_@347IUQ )BX
M=AO8;4N2A3_PBIDW'GJU0.80SHF3N,4NS4@BZ^0K\9R%V 5-QVFO!).E?1X_
MB+S8_&6-!]Q[%6$X*<V3E:%KQ2N[FV=X<ZW#N(F;19NC<_1SD[@@X/<ST&3/
MQ22L)2\!/S)Y6JX_@8V#FLE79UV^9Q7!T6>4J]ON2!N"-32-DA3[4#+^:Q.-
MNYY:9;&6'+0BG2C(N7S$_NP?-?NV[HNFKEP;. J&!39T1XAYSVV/O@'=\\&$
M8^U8/T@WNLU?EO0[=-C='L;W++4!:3H,$+/G:JCXM;)X6_=M:E%:*N(I9  D
MA5<!?4LF+].KGN6P[+*Q,+$13;,LSPKT-G/&+68XV9+\C(M)"A6KJ>?<]JOI
M$4:_,128R-H(E?!O9#JP4.:T3;^HOU'7^&..B2 2L3=RB+VYA^R)9BU(LNV[
M@>I,QJ.@$17:LU8(M S&Z22:!IPI2HWGS<41JSDXC!9D.K>T)*:TE5>8V%*M
M"8/DDCB53(7.Y:]72WBU2CG#(YB2)6KK@=R7JH$7H2E/\MHC4SN!)45&%E A
MO+RN0Q<*- Z1"GW\ HZJ5J]!4  M!1N';:3KD]-YGLZS2O"FD\S^"I<%]E'*
MU-,$SL=NZ47"BBW7.M"IC\=14I3NN5@\0[_929MTXKB?KE+7H.-&)M4"4MR
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MD[I+>;0#_]WEM+Q"V:9&U(1<0M("Q@2'.C95YY-K67"<<S6D -;8Z((M1C%
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M(<O*Z'[]ILA][WHTSN0C+ ENML1$-4GK12;/G#T.!1C@!?^22:J% 1 (C9-
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M;X?1T+\*QS)]DU0?E&CP<99:(RE\((V?+@6TR^$0_+Y0-1N$\H="H9'6P"/
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MRWF)%Q=K$[H@,2 [B< 02.N(\ZHXSB581^"1;F7%)%_098?;<Y&A;2,?JBE
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MWSAF"]@4>0X_8J6'G(RTG)#9H3-I5()5NT\C,(]SL,;+B*P;]-_8%J'H8O?
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M9*+K^,K3[>@7-S@N,3X# D"<@IVCYBX*/"&LB=45B)C?IEB='K2N1=1>$@4
M[8@GU/''>38ER"7(V]V\4*;)#9*]WYV/)"Y)UFY12BZ237!W><=DL)J\,WC
M#;^X)DGP:I8#,W:C0Q[ I"7$];JLX4/@_4S!5]M7&+F?Z$C_&Z3(,; X-S_I
MN4N3$D20HR3HNFF'3V6P8"%G^-2P&SAUU8B \ZD>;.N3G,;7\/A2?WPS;WP^
MP5YE08)@,H'!1?@273!OJXK]<RZN55:8KK7.^SGY8480$Q0/MF=62$6J8798
M06*1-:;'=] ?UQE-K('9;J-OSH'4C:27Z(R712KUR$&J#G\E.0ZS0!25<A:H
MM3@4<9=%Q0"@%[DG!AAI;[8BLM9><5S$[ -6J5.*IT@EM,7@):$LLB.E=<DS
MM0B'3%&WUN,WNNH!3%HB4<=)LZ@0. F?Q$IE_,>/A!3#?ZEF8H#<I#D0<HD2
M-Y]C5;A*B>%+!V$:DZ>EM)31*6R,S+/*'!MC*S@)/N))3^BADB7T,H&)FT#3
M6%6N0> 7:0X_0E]J<B1^22N/)8GE E:8&8B8>DO>@"Q/-Q?.N2/R\" /@71R
MV;7E_WQGW6+9V'HK\?C>;/[M3/C$O89]8RON #BZ5DVK?6G#]S@F(2O-T$KI
M/"M59$T4DJCR29D03V!X*%I5L(AZ8(!J)P-%V]JRJ!G7$R'?4*?HQ4EK\XP@
MCZ:;.& &V- 6S23EUM6V4Y<(&.@L01#T2C1BK=62C*VP;49)65(8674J.5Y.
MC:8+!O_BJTSV52$["58\K#-I#Y?0/VG/[J:=;,@B8Z@'H:D-Y9FF<JKUE6)'
M)"1RNF.%9QC**'4J5JJ4:XL]E@M/0R7.LS)W[TJPH&TA0YY<<)>9TX6V[IP*
M'[Y.9RX_O;XWWR35!R6^1$]#&1EACBF9M,<C$1A\8E.P!NGA)9QYEFOO3*4D
MC:\S6"Z]6H; '(^DS+ .7N4YS""]U%":SDWJP\)@^AC1;_94QPQ21U]+I_=1
MVI>:[QC[1!984U37AG2-6&V9(XH$[2,J*;#,"P85\#&HHPEQO[92>7Z'!:T,
ME$;2(RED(\S5A8#I_*]X^ #FI>(.($2'658&;6Y3[O2&6VKNO;D,;\@..J#(
MGU!7>N42H*4N$N+3%NXR/EF8=';1GUVH$3+<EXXOX-#?]X!K9TJ*U?"2"!Q>
M^*YM5,-N154N3L]$[_E-G[RR/RGKZZF!\8KG^#RA:DARUC&V"L?4;] 9L]5W
MIFL)4EQQS$)]H/N ?H$+4X[1-M!=[,"HH%H1A[=.CC-62=7AI1IC*RPQ,D3Q
M-K2_<+9/2[!.I@E!E^H:U+:-@%05H99PC:7VD=&S] H'B^IX;?HSNG=7QSW'
M'01LBQFQ4!I=MV,CP+H",(@Z^PKY%"MJD&40=&9%9>3MP#(^]E052#QF"X*&
M \Q GI8D2TUX@V.<5^(\>'M+H">I_*8N82W\N)3F5-+"0@.12;WB?=%N-@62
MVMM)R+R<L=_\;MU(44P,SX/M,BN"U:9*JE0W)W#F/1S@5^5"HNW-U2GCN4FD
M5]Y,ZUE3P47*+1&Q%I3*?ZJ)-%YTS"4UQ6TG*Y89Q9TIRS6:2"DAO&HF'>VM
MHJDUG>)2\SJ+U8.!OW&9+C6H]#<XHG6:3;R>"\1^QPL:^X::*O2^&K%!,>9C
MR0:JP];783,^J,OA =Z'>X1O $N7=:,3SF(;-^S3CBAM2\FA(5-]$,#>'F4>
M?;"IF!P.?"*0KKMV]?%B.*0Y8/J >"=-4(AQIQ;"8\C%_3WG$)X$_\5+<L6)
MW""D[M1,KH"0>KRS@4AM(%(;B-3#C)(+D^&_P#RNJ,[H=7)AJ0RINT<FK7XG
M\@D!QCJ)75W0#Z8>5LI+:P[V0T"RYG#Y=*>=;<-">K^F\,=H";] XJORV,[B
M 8;\4[NL' -H)C9VW(AWB:OQ[[+Z8!U32W;O%&3F2G?9FL(UB,$P3,4F%^:*
M\V)F5(N(@Z4&V6&%EE=;QD3?V,I!PJPX:3+AT;V2!%5KB?VEPU1[N+A(PU#8
MJ%O8FMEV00EC9;9%.7G9UE<+RE#],I8&B2W0!Z"0$P)SDNDTR]%WJ74?:6IC
MIR/ ,4>ZA50CIB+9@OXU4V@^H6L 0RR72AQPK)&I1U8JA'L 9D $D36WPM:6
M$[&8<>1-87<4C$TOT"6I,R8]TQW[Q+/48O#G]E'H@;*J4N?E1. 8B_$L:VH;
M7I'!^I:2[C7PB<..H[V2@R+PRS=)<88%O):+!FW45#A!2'(%%#]?-&[W!+8\
M'6XG'075;2QM'%&L8D^29/8ED7A-%G5M MP,J^A:'8HQU=)^F$^!L-N@FUJ)
MD8UUGQG6O)K4LCT;L6:\RF8Z3Z$Y<N;4B%OJ1DT]%2Y(L/:ZLS7")W"]8R>6
MW_]F?$TVXZI*6CNJVL1P57&N"LKKP'\7RH:<[7<[Y0R&\<F"QM&ZVLPYPL"3
M%)#3:^O:Z$XE55CZ]]PR@K)8J$6=U5@Q^3'6=L )I]+.23FWO"[G61(YY1WH
M;'!$#WX@JBA,6]"5@NK%T,)0MQ$+:<)=T7\;"=I'%_<)DQ06G#%S#*XP5V?4
M\M$>-GU7T_(,99E:"2R*L$E#'9.GZUE471BB[X*CDJN>A3HF1#9XS0LIW*7%
M_$(JXTV7=$XMRKN(6<!&(J61\1P9EAI1Y7 E&=!&M[+6$V7M21ZL:;N8-<$F
M4\R$+A:?"[.6-$PHHW EG8M0$"F;J3I<\0Z'8"Z;C1=5;?,?4HY#3YKJ6\;)
MRX&D2L5D+0VL0&]*G:9NCU4W_#.R.14U14^I+4?J6@CG:,J<2H 8)@&O3$SS
M%A@K!H,]Z%?7D=@@1Q[ I(5O^#UB%_G^J"V*4X>^)Q^*\B)7Z:E6-1WY>N[*
MU)\I=8]6-J7[S%&JI)B<4VW0YMR)D7'1'K ZY@BY]$JUH]<84R).A.NLE//7
M-D6<C B:TAMQ?P"3/M75$079%XPY/1!5RH)_5)+1Q'*;JH2TOR&#RQ.Z@"QY
MG!5S>]$Y)FBA4S:-DTL2 @XTM(2J+XED/%HA\X-TW<0%]\-29/:ZI1>V.Z50
MHE(GH)J!%9C0P<4H A83_#K"CNDL\[$S%W0W55HCK2.5Z9 6]H/M*:20&Z_%
M.>V@@O%I[P3\,!SLZBZ <=CP!X\[9W]PSU CP4N04 ZVHC;$ DMKV/>^-9:H
M-<>]:VVL:#J\*$UFX)[5AG6Z/S6,S#\^42C?II1WH[RCL08<JXO&RL*W[+G1
M=79YO&B(=HY7E2RLV /R=-D+;GMVV!.!3LWG!*-6KA\>6^O!)T$BORG7[8P9
MNB.32A=.S;_P*;&G9465C2PC!$Q+VR^B]L!LE/ #F/29V^- -Q.1EEX"N"#/
MQU2-H76_*,3AK[G6@CRI3&G>  -!$SG6[*96%;<Q&\-!R(@F?. @L ?&S+"\
M&4Y355OF@!3[QB^GZ(IZA%YAS B*HA&R(7H+^>Y(.W!:$)[2N(U(#PO&"#$L
MDTL6:Z_0MA!S28._^_:[Z%T%SD<3O<L3_/C),L>>:K]&?__F[SM/XV@7V5_P
MG<^CXT;-SU01[57E!4STY1GRXK\"[5T0B_A;#F'% ;%Q\#TPH-2Y&N,_)_/D
M/T[QL]NP,;'!J/->23< <6GQWK0\R:X"Q=R<D-(X 07=S@6#!SX] 2NF^OHE
MQ6WUQI+B[/AP\-FV/ IVO+WAAGN:[VA^2=?2EE/O\T1"[9"8CLOR0\B2S>MH
MJ6X[EB]8/;,^3O,;<?NY,0[=89:66)P :KG-?:6WI/LRL6O@<##R)I2O=-T'
M]+O^:++:6?_S+!D.](*P/Q(L3QNLHXLE#;KEF^=/=Z+Y]FP[VM*!1XY$X@!'
M5->)-A]WN]>MHZG6PBGA@/-B.F1>S\2B3YL7V)-8B(J%+!PW9 <J\5N;5])'
MFZ"5ZRV 5Z_":!F*[6+'U=1[NNET+]!GR4E(7(U70H['3]O'VU<](4PPCV6N
MY.,)BTE03LC1%6+>QUR_N_)9';E5KYB*0<%=FUFY5V&L0;&,ZJR+8SE:2;'\
M&;B5AP./7#E:P:U\'\ !#Q/F\'@#<]C '#8PAX?I7F52O6]\&[R#7V<>B?11
MZ81'-(Q.DK%$$F8AW9CXILOJW-0-^;&"OJ@1<]WJLI:@F%[R3)$J%C,ER0G=
M8F'J(; Q?)2=P\UVJ@)+5_MF>(O#Q[F;"PXYUY,U-)D_&IY7O]B&>\S+3/T6
M&-5E+"6QZ8Y,5ZY]:59+MK=E,Q#J''XU 1,D0P!!:)4_,%%]D.?S-YURX>!7
MF&ZA<PC6?J;9_3B=W=G/@K@5^9SHFG-.FKHA0#2M*2.-\6P.;7+RI-TEA_FZ
M)V%EAXW>75IXZ":DX3 I[NO$;Q6XL2Z$3\%>H5ZJ&+A51<U*8"JF+Y)K>-%)
MCGHR)P_>V7#D$#)@2L@Z.JJ[F7*!&.CQE1QPU^ENZKXB$ UR701N)*%AT7L4
MI^A:(W89.)ZYI*9.R87,UIGIYG0_@$E_$#X*9&.HZ[+BV/XN493+67?(D)UZ
MV" =&;=%V+D5"1'@U'9HF(F1<TDQ985DJ2@.I HUS:2 DB1SS$W5;,ZV]H=M
ML1C,L=[JIJ>'==GW"%_!^HWUQ:K36C$@L$B-GZ[O;6\&2W.KAY2MG0I 5F2L
MLQ.*5KW5^\%>];[%LCF\#V#2N?!H8/TF)B'YO!X8/CDW&>N5O,>774%2BD*5
MH0+T#:/A7$MG;IOA0.QA>.I9-LZ(=@DCM8BO<LJ\Y!O:>@XB7/(IOD(1_%86
M""OU3S%VD^#*&Z$5U^3Q@JXS1>KO]<.]:+SD/&7-;"O$?*D;AAJ.<Z^M>H<.
M<LFB<7%MCSKNP*4?M#F-#V#2,[E*U7G0 ND7E'5,H,_!2,RH*0W9@_TX R>E
M(TASIX6   \3G2&R20P440+\#P=L^/K\%92?IVZ6J^ &]N7V)$=CW?P4GQYU
M/UQC;.6Q]@*#<VJ&Z)>Y:_B(?I.D<>0]5+:@ZP+D=XFI3>;&>:D#0G'U6>5\
MAB+\_<IN<S@?P*0+/IP_*DK_.%[LF?P&2ZK;W2C1N-/6G &6LY=9@<]5\0^%
MH'P, 4-L_$))$<<V_0B.FP%8W8H8M@.O7ZYT?=ZY_)^._]V/F;TX-!MUV$K5
M?+%3VCJFMGP+K"&G9, KRO#6H_LSR\[C=4EZ[<DFO;9)KWTAZ37?7/AR+R9_
M'K= IW5X!.[GX<G1P?%Q],N/!^\/WKZ*6U[T)"&K)VRHR*2MIMNH0QW(15:+
M0C<E=<D6_?:*TZRJ&R;WP;@>U3_>8,O!FT_36IW@ZH!01UQYMIZ*Z%4E7]&!
M=13&^B_H4"U?Z>-OU<FZS_N,ZPR*R@[KY5M<YJ-_?O7DRFMZ?4,4,6/6L[("
MV5O,YZI"&G1XR=X/1[M';W\^W'O_]NCPUYC'?GCT$L[ W@_NK$C]WI'],P+W
M#=X1-[.7GSS$.S_"9Y][B'=)=.[H9EPK0=7R^<HQ!>;SV#>?^8&WOY0;H;G1
M81TE,[5:;&Y%E*LL*7@D;Q;5_&RYD9!;&]8)0EKNGHA0Y0V/Y(#< 0S@2_E-
MM[2("WF[?M6U!I7VC,SLW5@$Z0[-\9+(TM--9&D36?I<D:6N]USK2?OB%<5G
M#JB# _OVY/#EP7#P]E5T\.O!^Y>'QP?W9WZW%<:Y,[$:,ZIKSK:N#(N<E-=C
MZ'SF:_':0SOWSC1Z8/'TK<<C[M-#X!=$B5KTJD+F">9TTY4:_R/_:W5?#3K'
M.L6-C=^)@-@RDLD9O,:00R+28#C(IDY/M:P@DGGIG4@P5.$1H&I*W7=%'FF@
M^%Q)(E^.X?6G7!O"="0"B!-TC^GJ((U3&$%T2["9A]69Y%8D_<D(T^=+!QU)
M6$_BX4$()];&@UQB&RTK)./RX^CYK:S1XUY0T3T1@E43_-O__N[OSYY]+Z.[
MOJ*\8CC(DPM0#E068SJE_%00')#X>^OOH[*Z<PNRV?%/FRWQ]G;VV>UMJ)#4
MQ-J@VQ7$?130J#06>>)S0=2+<>WT%8_=0C$L@O3ZD#5GIIV67)2SY&,V6\SZ
M!R<W,>FF\)9ML?,QR52*Q2?N((D^V!WEYLZ[I]/=>HIW7LY]@ZAS3XT]>]I-
MZHA3)9D99F_7&F1:,8=<B#[(IT3J\!!0H?+RXG9NRGOM%-S,I? _J_^WV=8O
M;W(G>/,%)]VAC-)41W)W&-*@:/^7W9?1+MQWV+3LB.ZAS;'>'.LO;.:;K;VW
M,]]L[489?UF36QEU_Z_CPW\=[9[\])X34C^^?;U_\/Z_[^4Z;##&EPSX+&O4
MHWJ>( JA*"^J9&XQE]<+7$7T%H\4/+Y#;E4!QM\!\M#<$!K03.W;SXW)O4NX
MK\Y=ON:",:=>3'9XUQ8T\!]+9B(*=QXKRC98T"]LQ[VSW+73FQW]PG:4D).;
M+;W!+;W.F6(GCONU/P\#Y7$)*O39!A6Z087>!"J4V.6N&13Z,$J0:>6N&2QZ
M\.N/AWN')\/!WGW'B'Z9<]D]Q@#*FX,CV*)7;]^_N1^SN@,5&N$D^RB-GEPS
MIQ$RGIPP$2R\5T,MU&F);JII'B:5_%SD+Q1\:50OB/#.T.\Y/1ZVH_V2FQG6
M[K=\WFSE\@7,33^TFLDG;Y1PY6YLQFWJ]MN:,VB1X>#GW=<_'43O#UX>'/Y\
ML!]WBZ%I@22$L)8 MM%,QY4RI,>U "J:<D,7<=]#N9URJT.YWUU[*'>UNRGO
M?>*;JY\QL'N#L[_;886;=F3=;5VYUW=F EL,3^,!OJNRHAEM-O-+W<P'?AAW
MI6?CU7?PLZK>S0YO3NA&W;;7XMU96<A*A#C'S<&]9WO]Q1_<![Y_!]P5&8>W
MN67O^V9O#NN7O7^8 $^?\_@"\"K\'$<!CG6SOU_8_G[J^13]2S'+C?*]HYO+
M387^5M6_+\KO:QZG 10^#\_SYB!_R7N]N6B_[/WK.JO:/.XZJ??UJ'Y^?-J-
M9](N :-]\WWT=DY=)Y]'KY.ZV6#3'GC'AZ_WWN[_&T_ US^>O'G]P_\'4$L#
M!!0    ( *Z L%J+6.Q48A   .9$   *    97@Y.2TQ+FAT;>U<:W,;N;']
MSBK^!US?C4NN(BE*LF7K$5=H2XJ=R++6DC<W'S$S( EK.* !#"GNK[^G&QAR
M2$J[JXV56B:VJRQR'D"C'P>G&RT?O[O^</ZZV3A^=]H[P4]!?XZOWU^?G[X^
MW@X_<7<[WCY^\_'DG^+J^I_GIW]^TC>%/Q0[W;$7UWJDG+A04_')C&31"A=:
MXDI9W7^"%_'JY4/?.Q(C:0>Z.!3=(^'5K6_+7 _P-56%5_;)Z^.SCQ?7]5';
M?3G2^>SPU\;E9YW^604Q,-*;UT^+Q(V/CK??8-TT+GY<?FO!K1X,_3>6^_1V
MJ!/MFXV#@\[.XXJ_L7I_%,$O9&%^THDUA;YM-GI%8<HBQ2"75J>Z& C3%S_L
M=,4'G>?:%.*R3'*=BH_]/H8,MR^MPA>K,G'E37HC9)&)?TAK9>'=!BKDWV')
M+Z7SNC_[EI+3$)]:S<;U_XFG12;=\$A\D#.Q\Z(E=KN[+^87Z_9NB?=%VA%;
M%[VKD]Z/A^*B]_&G9V+K:9Y]+<U1_<FGEB\)8X4?*A&?>&M&8UG,XLUG+2'%
M2&4ZE7FSX54Z+$QN!C.1AL>$&ZM40P,_D^/H@D:R<JQ*#X?*U$2GM#YO,H@M
MHQ]F/-UXX8NR$&61*3NUVGM5B''P1U/S1SD>6W.K1]*K?-9L/.]V6]UN5[BA
MM- H'J AYZ([$MVQ6G'WK[A13)3U.LG5FF=7FEFYOEC_6%HQD7FIQ _=3K>[
M(\;*AHF;C7I88)60W*9#Z90HQ_3U>>N@N],ZV-^I"0K%C1!SCB;YI<'%UK)1
MZ*4ER596#6$\:5+=*IMJ%Q2L.-1W.]WG]PQ<"5\-VA'7N D9$UU %:N6F(^I
M9#J,PZVC!1S%#!1Y@IAJ/R2I9!H=AD:)DPKM(-L++#O.FAL7S<T.LC(WGE:W
M\#9/#F2$2=/2"B@%[BL34_H0&@<A-%K"E<D7/$RR\'!.>NWZ,O6$>&0'A"N"
MT,[F\Z:FR#3==IV-0HD*W#9(Y!,Y=:9H-OXFZ;TK!5-"\_0&@Q=,38:"3:0+
MQC.(W,28&UL6!5W')'( _^I'\%IQEN\&?.R=:0CT&UCC'##!I$IE[KZX)8RH
M!VZBEM&<J<@H4I%$P:(*.T=6!@>8;PST)=,NQ18"K"7@)235SE' !B166":-
MF2TFIXD+AZ6-Y4P2_">S.F@&X(E?L'UA]\D8R$L *#U7*+]88-^:$5^=#T_N
MMZ6?\47 GQJ-"3^:C4H5>"C58YD+.2*Y244:T@.MG(?$O":5@/&46/0<*P<#
MJP98QYWO_[#3V@N[7PL"0R\RAPZAAY+678@SE=B28&WG.9A#P$)L2ZXDQ(U8
M"((UJG1881Z-[4J@^D(@>B!L9#^\C!ONW'ZY#M;D94I+8D #T/)(!3FQD-HR
MFXW"8$$+,?\FBR#ERPJP WGXM=7OMIX?O(0&7K%T6QK*'Z@"G"/'6NS86'ZS
MQ"=8_3L,/#H,:,3>'3MUH@)*9ZL1M^2+$BXST,[#:)HY$8P7_ =^;.Q(7+5W
MQ-:91MQ>F([8V]MK[[Z"_?>(EL*!\2R0H@4*H+%@"H1FHX^GUP(ANABY3*;2
M7!)541 7&#.92_BY<]6I[47\].DM^%PQ8/$CV,P9X]7IVP47*P+]B%-UP-EI
MVUH,-L)=4R!2DP@?D #SCI0,H2<)9HA,^]*)Z5 C$ $N%*4<7A6X+H2^1W-6
MY9*Q,L0F05'<$D4/4ZA<CZ I:*4VW<H["T."RD)>,/*@5 8H>@ K9^U(W(#:
M?\M8S<84$$^K7Q^K ^V.]8+'KPU*RB.])5X2+6U!01!*3J3."=1A6%^--2?_
M4Y4X#2S K>ETVH$I.@,S@3YLP/% 0<0]#*1'B0BI]A#D=B['B2);D)Y;"( =
M.*7%*LX _(0_[_1@.)4S1$M)$^\30K\QJ12?I#>(I;-S>/#SO5V"N@GV*AHG
MD<4-M/.7C*7Y0L)TL*^QF-Y 87VK> VO]O<[![NO.EWZ9Z,P8G-A#1D;.[2B
MC"XS& *;&&V9F-"7Y%M%\&]R=J=@K<A&05>1W'I9Y1KUYY*2T<;5T:&%@3D[
MPQ"4-BG>9"F[EKFJV,32&[1;\@,4^#3M%]QP2--Y2MP,$,(;.D_=6A'*\MAB
M:LH\H]G*(I?3?DEAI]GWE@'&V&;C:PF-]W4:KC Q"ZM=2(4Q8A3#9>^4[;OO
M/K+(QV]>]R@=;C;6JT(;5P#;W-+=DO*;C3MJ<BU.<ZOBFKBCMB:SB2RX2)88
M[#.%*=K8.:2C[9^V7^SDR'>8_E>7$>1EH/,RY>PLS?$0C8\7FHVA&2F14D;F
ME*=MVG7$.R5!8K"O,2<!=%S/<L*+:W4KL4#>J(&$2MIT&!G41.5FS'0#CU\H
M-Z3GWSLK5=YB2*A6T#=I2=D7\,)/#>5OF)2+,HO5CD$8F.H<;I2![X:&Z]Z;
M\U/Q]O3\_+)W<O+^XJ]_?M)]PM^O+GMOJ^\/7M949WY(CW;_5*VQ[<V8UQF_
MPD6\&>$*%GG]Z>%3<($4CE*I#,/3Z=CQ]<GO%K?;V7VABR=T6G?R^IL,].VL
M][\'^R\/%N;[O0(^LI/U4D.#INT$%"2+9Z"_\4^]$C\/-R8;",&\Y.+#)?CT
MU5"K/'N*[?Z(P_NS-;5+K<@D,$P.P8B5@R$HCQ3B8>+D9MKF @M8.7A+:?LR
M!8S%!8JI!'IM7?7^\:R&A%2> 4C6P +?,N6@;D 5%5^ +@\3@WB3F$A:PHR8
M2@6_7-((U&9)0X1F@"U;CBLREVB#%";63Q*9 C<U'8X\1(H4JRGTSSP=I[)3
M8H^QV.FMDKXJHXQA(:Y2$04-YRE<40NUJH46:&&$[@^3 ^\N[0:,]E1+#[6O
M.#P8+^Z6L!29OZ\X#8;.7#E6=J+=$JVC2-J^_D3_$!;^ZT@>_G8  '>&6[RH
MH0P:NOT(6/$=Z;\C_6,C_>G%I%1/D6YEZNAA,7PA)WH0<K++2*5:%4=# !-*
MX8/ENG@R$SR1^!!@+]([9(@,+,"0G@5A''@,]DY12XAK/4R:]SG>-SJ@X[7*
M16^B)PMR&"CO.F]%DIUZ"TT!V6D[*!:+<C/GU>BA*!_1D8J,@"OG(Q'65&[#
M,D$ZF5CW@7$,\V7"ZX]5JX%$YFMH%"*LQ,XM@+XCSDYZ#Q/DQ4YWZ^89)E=<
M<R0TE5F9>X+L5K0%Y^=4:$!(>G@)TO',Z4P)0"NEW#_/ZP@DI1B9"9?Z'B8(
MF0-X/3;6TSK)2Q070QF^VR-YPX<1I:TV/=)0*"GR^0?N**R_Y(.!BK+3\0H4
MRD<>#Q&&ZGEAB\58,(#T%C8G$>$.:9E+2P?&5'VI;\O_?7O,'SH!6FXRVEX&
M%B'UB _20@ZK!!\$29MQ]"UELH&GSN[+:!=($,%*AH._P)"HYP(WZ:.3?7 Z
MP-4\Y2V=3,!:<9$'K]/(HC"3$%8Q3Y;"<IT?439$(/HA\R)53#062%/])QPF
M0>C_:;?%&;'[0Y#_@3K" %]+!0OA1=%NQS[+XY/W/U5B+)&0L5^C(?MT+3$V
M4W9^[0W XT;L0"%4=<R(J#R$+L71P))S.780K?JTPH_6ZT4+/G0'RUE6>J[Z
M_,:<"]2&7NAO%6J.MZ&:.[24 +YOVN'X^A ^2:JM:V[_#LU%D1^BF249CTFN
MA?SK771+ZOJ-:ZHYR#9Y2'"*/[J[;VZA$)*?&3L%-+9S8V[XJ.RJ.LY[Y%[+
M[X;XE4,?RGR1@+NJ7:Z_;*G%N:OK5-V45W3DLKA>G5UB7)"H0,&)7DT-[85Q
MV-AXTHIC-!OQ.MZMKE6/TBGJZC70L<*M7@PM-VN7)5)Y:JH LUT;QIHO]5?F
M8D!V.KU9GR+VVZQ/@LU_]5JB<HVD9.WZ$,G)NBB&CU]E/A>%#JPT# MJR*JK
M:B+W6Z1BF"V1E)YK)G1Z1^??H1'IL/XLM9S8><&'RM>YFK/NVC$VZ,6=S81K
M+82A#DZ%&2KBW-M!%)A)/]#J8#(9Z_>XSH8-G^(AM*LZWIJ->0O3V?TJJ%8]
M*"5U7*IPQAZG0U)())[H68N?Y"(CU>I3[)V2*F7.E:&E*4C!I:+05TG,B\IH
MID30W!1F6H1VH2)\MMK=N'@ECA8..D=T+  90E619U4S4V1W-O!2^%F3!R6E
MU#_L8RR1/Y*L5GRE9A+=URJ#E]#9+/,9GQ/I2WW);4D.&5>(Q$SS.2QYK0V=
M4]$DQK'^*?K#N'H4>IR263A%_870#S$_7W*SL;3FA1]6Q37VP4AI[U$4J=X@
M6_6Q5>*0V\P AC?*<VXT]DRK[^E\5K=\TC((?7$%,! .1"UUCI:6*V3XPUEU
M#5E@+F=,S&_4+$[BCD)S54&]6,3#J<Q84/\(M]'-.;:W>J%B?@<O(64.Q#L<
MC*<E]4HCQ)#9>6-GH?]O(O.Y-X?#Z'L64XE.HT^>A=S>A2!%C%8'WO1F5<P-
MA5)<S;!-V&CC$8S4; ! !G1:-8*\$-.'2F8XKX+>,0>FJ!1#BPWK2'/"-+JK
M%[>1J?1A-8X/OA4[ 5<74&$.?+\DT"A#0TPJQV'XJMF(M<M6+2C,V/OQ.-4,
MN(9!]\(\K&-74MF&<Q_RUT)F<'TZ<K=*CY+2N@@"\."! 1WF-":<!&[C!4.)
M%\&9MAGW&,VH29(J$951?LD0MW<OM6[WDE/X?DE1%EIW0HY'+DY?R) YU7U*
M*I_3P8)B(2S /R!K2F)7H/P+TD"8G+H5\KFKUIS-*BY5()YC3S$-5LOQ0GTI
MNE"SP5U@K$_2@P+;6.I?X.GNL?.2_3!3KKCD AB)2JUPM7(@<CM3D)%:-&H<
MENKNW+9N)?7QRRQL*>2F<JS)@K@W4LK?*40$]Z2$!('*?"VUK?8#*@8F>4RH
M,>L ^@JQ0XX9^S8(S>)4S0:A9L3=6L.5L16Q28UCL,TTG3P'[1/*ZI3*7-2H
MSZ9GM=T7(+1MQG[?N=SWZ;_9 $R'W;:,%8:%?JB#!N!&&PVO0KKY(  ABSQW
M!FR,+7W<*MK/2W+ J XZ(7.^.B_G0D-95/6G^O"!!B#(,E7$1YV/O]XQCE[
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MDMH_$UW5Q@#*Z[OE62,]"$<.>[/4!LK>TBOE?JA?VCUH<<)N]7.O9[@%_J
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MP9X*![XPRXAQR[G,^OZ/2J'&?7ZJ>XQD+6ELAZSE#Y !5NH%C?N#^YE6!)]
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M(P58'"&]2*#8XZL7*YIWJQ214J4J3MK/;M+"F-XA60Q2U!4KWL([%J4 X_D
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MI][7D\WO;T^_KWY<+9?_WOW[WP_?.V_>\!E9;7G6"/_NACUG^_\!4$L#!!0
M   ( *Z L%IV\8;L+0,  .X+   1    ;F%O=BTR,#(U,#4Q,BYX<V2U5MMR
MVC 0?>],_T'UNS&&0 .!9-*D29F!)(6&9/+2$?8"&H3D2C*7?'TE7[@9*-#6
M3_+JG+.[VEW9M:O9F*()"$DXJUMN+F\A8![W"1O4K>>.?=VY:30L='7Y\0/2
M3^V3;:,[ M2OHEONV0W6YQ?H 8^ABNZ!@<"*BPO4Q30T%GY'* ATP\<!!05Z
M(_941>5<WD.V?8!L%YC/Q7.[L9 =*A7(JN-,I],<XQ,\Y6(D<QX?'R;845B%
M<J&6G^63YS!ZBTAO0:Z46X'\/&N3UP&P\_ 6LZE\P?/'<N^I\EYZ.R<P&DY>
MOISWWD:X.'^FS'WO"@+?5*M]__WU^FOLLB:](8PQTK5@LFZ9_)+TIL4<%P.G
MD,^[SFNKV8EP5@RLSBAAHVUPMU*I.-%N"LT@9SU!4^FB8[9[6,)"6>^2/7C"
MI,+,6\/[:D%8!9><>',-2K9"RS&4I% ?-G 2O-R 3QR]H?&%LQ082GN <;
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MQF;2A*6N"8H1BS$0C4*+"K$G(OZQE6?L1-!]+Q0MI6LN *LF&H8L*#KLWD!
M*KE?1I8"LS11 U@O)&VI\],-P&SKU,/0!<4)8 X^):GT?DE9/!)*U>T S/H'
M%)O8-2VP89.7MC(H8D![(#-Y!"I#PL'F\D6MSN4R:6!C:WJ?\+1L=_%3B8-%
MR'0XD*(\#*DX3R35;D/T,-12NJ8'L&IR8\B"(L;N#62ED*-<[Q^22Q8/0J32
M^0'$L&G'HQ0%"$?361\:4NT3C*LDC3 MO%S);6E'\RQ:UX" =DU(6L*@0('<
M@; 4 9J9/,0K,/\B6 S#I:;T TO+JAV52A8@**:W/DR4W@LDLZT0#=?PC -+
MG=V4[3%;W9\%=$& TF.N==>VD#= \30#7;(LR?;J<;J;[69%A*5Q;8DK-B!S
MF@FS/ @6 %,F X4,*1TJA%YZ7M\E8)EZB!%LCBES2X#=9)."IB8@$JS& !H.
MVOR94B]$S.3()#"=LYCL?B%[L%TMG5LF )M-* Q10%38G0%8E&*4JY&4>P'C
M3B0;+/:+).J9*MI"MVA 1IMLF*J X "L 724:K28SWS.)$N\F\<2U.0A*9X'
M[Z$$U+N%I<=VDQE '! ZW0X!@F00:D;Y!&G.(BZ>>>UQAQG?R@%P/^,QO$+I
MB7(+U: F--'J# D(L"$^ <P:H1^*9U(05Z_QY!4@58,7XB[B6!ZHM/SG.F'D
M!&R_5>N6K@Z[3:8LPH!(@MT!_)3*#_H#4C'HEH4"S?0-39WZAV8Z%)IIT-!,
MWP/-\I4' LWI&YIZZA^:TZ'0G 8-S>F[H)$=[W6LF<F/MV+)7VT/9X-*+\BT
MK5J!.<C"PZ7EK0\6%:#6,RK$)R;YPNI6W G^DK (7C)#<B_  *:MU!C:\-"Q
M&^SCIUH0ZSBO8TVQ*._]DFB9GU&F:=(^Q!2:\"!I&NL=7 JU3R3N>)IA^N_D
MN?-$W"[V@H?5L!62AC(\5&SV^H I8I ,\G%B7>*J;FA87R4SRMV] FRQ=7@%
MN%88! 0V1^U7@(NK)X7(=3<K1@7!P(C0+';6R19351_7RL+HXK:A5@_GWVNI
M\?%%5ME=Z-TC9_ # FV)JYZ&S.G>-LN#Z'' E-GKN0SE.D]7XU6&B=0^?-?*
MG,WLIIUJ(M<%0?2NZ:8U3>MRQ[WYFT@RN><9WVRVK+S+8WMN$-"YZN5.F[K'
MK:(@>K_+F4E"J45-L6,L%IPF49(E;/VK//D4";:URB9R!01L4-/05@2! FC+
MY. @1%KI&(([012$1'9$_A*@2BPD;A\>K+-]E]@5%/V&-1RP,@A(>NV9L,B
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M/[Z7  "#X0, "0              @ $     97@Q+3$N:'1M4$L! A0#%
M  @ KH"P6IV5GY_!"P  P&<   H              ( !Y9<  &5X,3 M,2YH
M=&U02P$"% ,4    " "N@+!:"D)@KR,*  !A20  "0              @ '.
MHP  97@S+3$N:'1M4$L! A0#%     @ KH"P6HV36.=>3P  __L!  D
M         ( !&*X  &5X,RTR+FAT;5!+ 0(4 Q0    ( *Z L%I++V^]T4\
M /X. @ )              "  9W]  !E>#0M,2YH=&U02P$"% ,4    " "N
M@+!:6VJ4Q=!.  !K%@( "0              @ &530$ 97@T+3(N:'1M4$L!
M A0#%     @ KH"P6HM8[%1B$   YD0   H              ( !C)P! &5X
M.3DM,2YH=&U02P$"% ,4    " "N@+!:4Q/L@<@E  "4%P$ "P
M    @ $6K0$ 9F]R;3@M:RYH=&U02P$"% ,4    " "N@+!:=O&&["T#  #N
M"P  $0              @ $'TP$ ;F%O=BTR,#(U,#4Q,BYX<V102P$"% ,4
M    " "N@+!:7KB=Z?T*  !_A@  %0              @ %CU@$ ;F%O=BTR
M,#(U,#4Q,E]L86(N>&UL4$L! A0#%     @ KH"P6@%6SA1:!P  W%<  !4
M             ( !D^$! &YA;W8M,C R-3 U,3)?<')E+GAM;%!+!08
."P + ($"   @Z0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="naov-20250512.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326706</identifier>
        </entity>
        <period>
            <startDate>2025-05-12</startDate>
            <endDate>2025-05-12</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-12" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2025-05-12" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-12" id="Fact000005">0001326706</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-12" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-12" id="Fact000011">2025-05-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-12" id="Fact000012">NanoVibronix, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-12" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-12" id="Fact000014">001-36445</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-12" id="Fact000015">01-0801232</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-12" id="Fact000016">969     Pruitt Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-12" id="Fact000017">Tyler</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-12" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-12" id="Fact000019">77569</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-12" id="Fact000020">(914)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-12" id="Fact000021">233-3004</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-05-12" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-12" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-12" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-12" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-05-12" id="Fact000026">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-05-12" id="Fact000027">NAOV</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-05-12" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-12" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 12,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NanoVibronix,
Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">01-0801232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">969
    Pruitt Ave<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tyler<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(914)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">233-3004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NAOV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanovibronix.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>naov-20250512.xsd</File>
    <File>naov-20250512_lab.xml</File>
    <File>naov-20250512_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>28
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "NAOV",
   "nsuri": "http://nanovibronix.com/20250512",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "naov-20250512.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "naov-20250512_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "naov-20250512_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://nanovibronix.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
